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Background: Gastrointestinal (GI) endoscopy and computed tomography 
colonoscopy (CTC) are important diagnostic and therapeutic tools in the investigation 
and management of gastrointestinal diseases. Current measures of patient 
satisfaction and experience within GI endoscopy are clinician derived and measured. 
This study aims to develop a patient reported experience measure (PREM) specific 
to GI procedures, derived from the patient’s perspective. 
Methods: The study comprised three phases. Phase 1: This qualitative phase 
involved semi-structured interviews with patients who had recently undergone 
endoscopy/CTC. Thematic analysis identified important aspects of the patient 
experience. Phase 2: A questionnaire bank was developed from the thematic 
analysis. An iterative process of review and revision within the wider study team 
refined the questions. Rounds of cognitive interviews with patients who had 
undergone GI procedures were used to further refine the questionnaire. Phase 3: 
The resultant PREM was prospectively administered, for self-completion, to 1652 
patients following a GI procedure. IBM® SPSS® 24 was used to investigate the 
psychometric properties of the instrument.  
Results: Phase 1: 35 participants participated in semi-structured interviews. Six 
over-arching themes were identified: anxiety, expectations, information & 
communication, embarrassment & dignity, choice &control and comfort. Phase 2: 
Areas related to these themes were structured by procedural stage. Ten rounds of 
review and revision within the study team were conducted, followed by five rounds of 
cognitive interviews (total n=15).  Phase 3: 799 participants completed the 
questionnaire (response rate= 48.4%). Of the 59 questionnaire items, a ‘ceiling’ 
effect was present in 24. No questions demonstrated ‘floor’ effects. Individual item 
completion rates were high, with only three items having >5% missing. Exploratory 
factor analysis identified potential scales within the questionnaire. 
Conclusion: The ENDOPREM™ is a tool which assesses all aspects of the GI 
procedure experience.  Potential future uses include assessing patient experience in 
routine care or comparing experience associated with different endoscopic 
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Chapter One: Introduction 
1.1. Overview of gastrointestinal procedures 
Various gastrointestinal (GI) procedures exist to evaluate the upper and lower GI 
tracts. Widely performed endoscopic procedures include 
oesophagogastroduodenoscopy (OGD, upper GI endoscopy) and colonoscopy.  35% 
of the population will require a GI endoscopy at some point in their life and 
approximately 1.5 million procedures are performed in England alone each year 
(Seeff et al., 2004; Department of Health Knowledge and Intelligence Team, 2010; 
NHS England, 2016). In England, OGD accounts for 39.0% of all endoscopic 
procedures and colonoscopy accounts for 32.6% (Centre for Workforce Intelligence, 
2017). Most endoscopic procedures are undertaken in patients over age 35 
(approximately 91%), particularly in patients aged 65-69 (Centre for Workforce 
Intelligence, 2017). The estimated annual number of OGDs performed in the United 
States of America (USA) is 6.1 million, compared with 11.0 million colonoscopies 
(Peery et al., 2019). Most procedures in the USA are undertaken in adults aged 18-
64 years, with fewer OGDs and colonoscopies undertaken in those aged over 65 
years (Peery et al., 2019).  
Generally, GI endoscopy may be performed by consultants (gastroenterologists or 
surgeons), non-medical endoscopists (such as nurse endoscopists) or non-
consultant grade medical endoscopists, such as associate specialists and trainees.  
Other GI endoscopic procedures include flexible sigmoidoscopy, endoscopic 
retrograde cholangio-pancreatography (ERCP) and endoscopic ultrasound (EUS), 
but these are not considered further within this body of work.1  
Computed tomography colonography (CTC) is a radiological alternative to 
colonoscopy for visualising the lower GI tract. Precise data for CTC are difficult to 
establish, however; it is estimated that 100,000 CTCs are undertaken in England 
annually (Obaro et al., 2018). CTCs are performed by radiographers, but nursing 
                                            
1 OGD and colonoscopy are the most commonly performed procedures, with CTC the 




staff may also be present. The images are later interpreted by a radiologist (after the 
patient has left the department).   
Broadly, these procedures may be undertaken in symptomatic patients (for example, 
to exclude cancer), as surveillance procedures to monitor a disease, screening 
procedures or to enable therapy to be undertaken.  
For the purposes of this thesis, OGD, colonoscopy and CTC will be referred to 
collectively as ‘GI procedures.’  
1.1.1. Oesophagogastroduodenoscopy (OGD) 
Oesophagogastroduodenoscopy (OGD) involves passing a thin, flexible endoscope 
(approximately 10mm diameter) into the oesophagus, stomach and duodenum via 
the mouth. This allows visualisation of the upper GI mucosa and biopsies, in addition 
to therapeutic uses in patients with, for example, acute upper GI bleeding. OGD is 
considered the ‘gold standard’ investigation of the upper GI tract (Harris, 2013; Beg 
et al., 2017). Indications for OGD include; suspected upper GI cancer, for example, 
patients presenting with dysphagia or weight loss in the context of reflux or 
dyspepsia; non-urgent indications such as dyspepsia or to take small bowel biopsies 
for the diagnosis of coeliac disease; surveillance and screening procedures, for 
example, surveillance of Barrett’s oesophagus or ‘screening’ for oesophago-gastric 
varices in patients with portal hypertension (Harris, 2013; Fitzgerald et al., 2014; 
Ludvigsson et al., 2014; National Institute for Health and Care Excellence, 2015). 
Patients may have the procedure with local anaesthetic throat spray or intravenous 
conscious sedation, defined by the American Society of Gastrointestinal Endoscopy 
(ASGE) as a “drug-induced depression in the level of consciousness” where patients 
are “able to make purposeful responses to verbal or light tactile stimulation” (ASGE 
Standards of Practice Committee et al., 2018). Alternatively, deep sedation using 
propofol administered by an anaesthetist can be used, however, this practice is rare 
in the United Kingdom (UK) (Sidhu et al., 2019). During OGD, carbon dioxide or air 
are used to distend the upper GI tract and allow both insertion of the endoscope and 
mucosal visualisation.  
Although OGD is traditionally performed using the per-oral route, transnasal 
endoscopy (TNE) using an ultrathin endoscope is increasingly being used as an 
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alternative (Parker et al., 2016). The proposed benefits of this approach are reduced 
need for conscious sedation, superiority over per-oral OGD in terms of reduced 
cardiovascular stress and reduced gagging due to less oropharyngeal irritation 
(Preiss et al., 2003; Alexandridis et al., 2014; Parker et al., 2016). 
1.1.2. Colonoscopy 
Colonoscopy is the most well-established procedure for investigation of the lower GI 
tract. Following a regimen of laxative preparation to clear colonic contents, a thin, 
flexible colonoscope (approximately 12mm) is passed into the colon via the anus. 
This allows mucosal visualisation and detection of pathology, biopsy of areas of 
interest and therapeutic techniques such as polyp removal. During colonoscope 
insertion, carbon dioxide or air are blown into the colon to distend it and allow both 
insertion and mucosal visualisation. Various indications for diagnostic colonoscopy 
exist which can be grouped into three broad categories. ‘Alarm symptoms’ are those 
considered to be suggestive of cancer, for example, blood mixed in with the stool or 
iron deficiency anaemia in males and non-menstruating females (National Institute 
for Health and Care Excellence, 2015). More routine symptomatic indications include 
persistent diarrhoea, abnormalities seen on radiological investigation and abdominal 
symptoms in the context of a raised faecal calprotectin (a marker of colonic 
inflammation) (Harris, 2013). The third group includes surveillance and screening of 
patients, for example, surveillance of patients with known inflammatory bowel 
disease (IBD), those with previous colonic polyps or a family history of colorectal 
cancer (Cairns et al., 2010). Colonoscopy is used within many screening 
programmes including the National Health Service (NHS) Bowel Cancer Screening 
Programme (BCSP). The English NHS BCSP sends faecal occult blood or faecal 
immunochemical testing kits to individuals aged 60-74 and offers colonoscopy to 
those who return a positive result (Public Health England, 2019). It is also performed 
within the English BCSP following positive flexible sigmoidoscopy where polyps are 
found and a ‘completion’ colonoscopy is performed. It may also be used as a primary 
screening tool, for example, in Poland and USA (Rex et al., 2000; Zavoral et al., 
2009). 
In the United Kingdom, colonoscopy is usually performed either under conscious 
intravenous sedation, with analgesic use of nitrous oxide or entirely unsedated 
(Sidhu et al., 2019). Deep sedation (usually propofol) is used widely internationally 
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but is not commonly used for diagnostic colonoscopy in the UK and tends to be 
reserved for complex, prolonged endoscopic procedures (Sidhu et al., 2019).  
1.1.3. Computed Tomography Colonography (CTC)  
Computed tomography colonography (CTC) is a relatively new radiological approach 
which provides cross-sectional imaging of the colon (Vining, 1996). Patients are 
required to drink oral contrast prior to the procedure, with or without laxative 
medication to clear the bowel. A thin tube is inserted into the rectum to insufflate 
carbon dioxide into the bowel. A CT scan is then performed with the patient in the 
supine and prone positions, which produces two and three dimensional images of the 
bowel (Rex et al., 1999). Although there is no significant difference in detection rates 
of colorectal cancer and large polyps when compared to colonoscopy, smaller 
lesions may be missed by CTC (Atkin et al., 2013; Halligan et al., 2015). As cross-
sectional images are obtained, incidental extra-colonic findings may be detected, 
necessitating at least further discussion with the patient if not further investigation 
(Hanly et al., 2012). It is not possible to take biopsies or remove polyps at CTC and 
there is a small cancer risk due to radiation exposure (Brenner et al., 2005; Steward 
et al., 2014). The indications for CTC are similar to colonoscopy, however, due to the 
limitations of the test in terms of biopsies, the test tends to be favoured in patients 
who may tolerate colonoscopy less well, or who are at lower risk of significant 
pathology (Jensch et al., 2010; Neilson et al., 2018). CTC is also used within the 
NHS BCSP for patients with positive FOBt tests who are either unsuitable for 
colonoscopy or who have an incomplete colonoscopy (British Society of 
Gastrointestinal and Abdominal Radiology, 2014). CTC is seen as less burdensome 
by patients in terms of bowel preparation and discomfort when compared with 
colonoscopy (Jensch et al., 2010)  
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1.2. Quality of care 
1.2.1. Quality of care: the concept 
Quality of care is a complex concept, but can be considered broadly as the ability of 
patients to access care and the effectiveness of care in terms of clinical outcomes 
and experience (Campbell et al., 2000; Hanefeld et al., 2017). A 2008 report into 
improving quality in the NHS recommended that quality of care should encompass 
three main domains: patient safety, effectiveness of care and patient experience 
(Darzi, 2008).  The Francis Report detailed the outcomes and recommendations of a 
public inquiry investigation into an English NHS Trust with high mortality rates, 
concluding  that loss of sight of patients at the centre of care contributed to many of 
the clinical quality issues raised (Francis, 2013). The report recommended that 
patient experience should be measured, reported and acted upon. 
1.2.2. Defining patient experience 
Although they are different concepts, the terms ‘patient experience’ and ‘satisfaction’ 
have often been used interchangeably. The use of the term ‘patient satisfaction’ in 
the literature is widely variable and as a concept it is complex with uncertain 
constructs (Williams, 1994; Gill et al., 2009; Batbaatar et al., 2015). Historically, 
surveys used to measure satisfaction have questionable validity and reliability as it is 
difficult to discriminate between levels of satisfaction, which is usually rated highly 
(Williams, 1994; Gill et al., 2009). Items included in previous patient satisfaction 
surveys, such as hospital amenities, are seen as separate to care quality by patients 
(Cleary, 2016). Patient priorities with regards specific diseases or procedures may 
differ from overall satisfaction with care and identifying these priorities could allow 
more specific improvements to be made. This has led to the development of the 
concept of measuring patient experience. 
Similarly to the concept of satisfaction, there is no single definition of ‘patient 
experience’ (Wolf et al., 2014).  The NHS Institute for Innovation and Improvement 
describes patient experience as “what the process of receiving care feels like for your 
patients” (NHS Institute for Innovation and Improvement, 2013). In contrast with 
satisfaction, patient experience encompasses what actually happens during a 
healthcare episode and to what degree patient’s needs are met (Beattie et al., 2015).  
Experience questionnaires do not ask patients to rate their treatment/ care but 
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instead ask whether, or to what extent, certain processes occurred during a 
healthcare episode (Beattie et al., 2015). The Picker Institute has defined eight 
principles of patient centred care and these encapsulate what are considered to be 
important aspects of patient experience; respect for patients’ preferences; 
coordination and integration of care; information, communication and education; 
physical comfort, emotional support and alleviation of fear and anxiety; involvement 
of family and friends; continuity and transition; access to care (Picker Institute 
Europe, 2019). The Picker Institute describes the importance of examining specific 
events during a care episode but also notes that patients are usually asked a 
question regarding ‘overall satisfaction’ (Redding et al., 2009). The rationale for this 
is that this question is likely to be informed by answers to the preceding experience 
questions and the responses can be analysed to identify which domains correlate 
most with overall satisfaction (Redding et al., 2009).  
1.2.3. Patient experience as a healthcare priority 
Over recent years, increased emphasis has been placed on patient experience in 
healthcare. A systematic review which explored the relationship between patient 
experience and clinical outcomes found that overall, a positive association exists 
between patient experience and health outcomes, healthcare resource use, care 
delivery and adverse events (Doyle et al., 2013). For example, overall patient 
experience ratings were positively associated with adherence to clinical guidelines in 
acute myocardial infarction. The NHS Outcomes Framework (a set of indicators used 
to measure health outcomes in the NHS) stresses the role of a positive patient 
experience, the need to measure care as perceived by patients, and the need for 
healthcare systems to respond to and act on such feedback (Department of Health, 
2012b).   
1.2.4. Measuring patient experience 
Patient Reported Experience Measures (PREMs) measure patients’ perceptions of 
their experience of healthcare. They should address aspects of care that are 
important to the patient (Coulter et al., 2009; Hodson et al., 2013). This implies that 
patients should be involved in the development of such measures, to ensure that all 
aspects of care important to patients are addressed.  
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PREMS are a separate entity from Patient Reported Outcome Measures (PROMs). 
The latter measure patients’ perceptions of their health status, functional status and 
health-related quality of life (Higginson et al., 2001; Coulter et al., 2009). An example 
of such a measure is the EuroQol EQ-5D, which measures health related quality of 
life across five domains: mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression and overall health (Herdman et al., 2011). This measure is not 
disease or procedure specific. Within the NHS and internationally, more focused 
PROMs have been developed for specific conditions, e.g. patients undergoing hip 
and knee replacement (Feng et al., 2014; NHS Digital, 2018; Prodinger et al., 2018) 
or those with colorectal cancer (van der Hout et al., 2019). These PROMs examine 
the effect of the condition on a patient’s quality of life. 
In England, the Care Quality Commission (CQC) undertakes annual surveys as part 
of the NHS Patient Survey programme, including: the annual inpatient survey, 
community mental health service surveys, cancer patient experience survey and the 
friends and family survey (Care Quality Commission, 2016). The Picker Institute has 
developed patient experience questions which can be added to patient surveys, 
however, these are generic and not procedure-specific (King et al., 2013). These 
cover issues such as: whether patients’ needs are assessed, patient involvement in 
decisions, support from social services and who to contact if the patient has 
questions (King et al., 2013). Outpatient surveys are undertaken on a cyclical basis, 
including those treated for cancer (Quality Health, 2019). These surveys were 
designed by the Picker Institute, Europe, using a number of pilot studies to ensure 
that patient priorities in terms of experience were addressed (Reeves et al., 2002). 
The surveys are used to measure and monitor patient experience both nationally and 
at individual healthcare institutions. However, studies analysing the impact and use 
of survey results suggest that their use should be extended to inform quality 
standards and improve patient experience (DeCourcy et al., 2012; Groene et al., 
2015).  
The realisation of the importance of measuring and acting upon patient experience is 
not restricted to the UK. In Europe, the Organization for Economic Cooperation and 
Development (OECD) has identified that patient experience should be measured as 
part of the Health Care Quality Indicators Project (Arah et al., 2006; OECD, 2017).  In 
the United States of America (USA), patient experience is measured using Consumer 
Assessment of Healthcare Providers and Systems (CAHPSÒ) surveys, which focus 
8 
 
on areas such as communication, access to care and information and customer 
service (Agency for Healthcare Research and Quality, 2014). 
1.2.5. Quality of gastrointestinal procedures 
Patient experience is also becoming an increasingly recognised aspect of quality 
within GI procedures, however, there are no fixed standards on how this should be 
measured and it is suggested as a research priority (Bisschops et al., 2016; Rees et 
al., 2019). 
In endoscopy, high quality investigations are crucial to ensure patient safety and to 
maximise detection of pathology. For endoscopic procedures, variation in quality has 
been demonstrated; for example, an audit of UK colonoscopy practice found 
significant variation in quality of colonoscopy procedures across 68 English 
endoscopy units (Bowles et al., 2004). Such studies have prompted quality 
improvement programmes and development of key performance indicators (KPI), 
which are measures used to assess performance against an agreed standard (Rex et 
al., 2006; Gavin et al., 2013; Rutter et al., 2016; Rees et al., 2016; Bisschops et al., 
2016). In the UK, the British Society of Gastroenterology (BSG) has developed an 
Endoscopy Quality Improvement Programme (EQIP) with the aim of raising quality 
across all endoscopic procedures by identifying and supporting achievement of KPIs 
and standardising training pathways (Rees et al., 2019). KPIs tend to be related to 
procedural elements, pathology detection and complication rates, however, more 
recently items such as ensuring the provision of patient information sheets have been 
included (Bisschops et al., 2016; Beg et al., 2017). 
Within the field of colonoscopy, certain KPIs have been shown to correlate with 
clinical outcomes; for example, colonoscopists with low adenoma detection rates 
(ADR; proportion of procedures where at least one adenoma is found, expressed as 
a percentage) have significantly higher rates of post colonoscopy colorectal cancers 
(Kaminski et al., 2010; Corley et al., 2011; Wieszczy, et al., 2017). This has led to 
innovations aimed at improving ADR, such as new technology to aid detection of 
adenomas, educational sessions with feedback on performance and the 
implementation of evidence-based interventions into routine practice (Rajasekhar et 
al., 2015; Wallace et al., 2017; Ngu et al., 2018).  
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Variation in practice and quality in upper GI endoscopy have been evidenced by 
variable rates of ‘missed’ cancers, that is, upper GI cancers found following a normal 
OGD (Menon et al., 2014; Veitch et al., 2015). Quality improvement initiatives and 
KPIs have been developed following the success of similar approaches in 
colonoscopy (Rees et al., 2019). These KPIs include procedural aspects, such as 
time taken to examine the stomach, biopsy protocols, pre-procedural aspects 
including provision of patient information sheets and broader recommendations such 
as the minimum annual procedure count to maintain endoscopist competence  (Park 
et al., 2015; Bisschops et al., 2016; Beg et al., 2017). In addition, patient comfort is 
considered a performance measure and has been highlighted as a research priority 
area (Rees et al., 2016). 
The incidence of post-imaging colorectal cancers following a normal CTC is low, i.e. 
patients diagnosed with colorectal cancer following a normal CTC (Obaro et al., 
2018). Standards have been established to optimise technique and minimise missed 
lesions (Neri et al., 2013). These standards include technical aspects of the 
procedure, such as patient position, but also include standards for reporting and 
interpreting CTC (Burling et al., 2010; Neri et al., 2013). Furthermore, these 
recommendations include provision of written information for patients and informed 
consent.  
1.2.6. Measuring patient experience of GI procedures 
A systematic review demonstrated that patient experience is linked with adherence to 
treatment and utilisation of preventive care (Doyle et al., 2013). This may be 
particularly important in the context of GI procedures, as patients may require repeat 
tests to monitor conditions or require treatment based on the procedure findings. 
There is some limited evidence within GI procedures that suggests that 
colonoscopists who deliver high quality procedures also provide better patient 
experience (Ekkelenkamp et al., 2013). One study, conducted in four English centres, 
compared polyp detection rate (PDR), sedation use and caecal intubation rate (CIR) 
with nurse-reported comfort scores and patient responses to a patient satisfaction 
question(Ekkelenkamp et al., 2013). It found that colonoscopists with better 




Current practice nationally is variable in terms of measuring patient experience in 
endoscopy. In the United Kingdom, the Joint Advisory Group on Gastrointestinal 
Endoscopy (JAG) grants accreditation status to endoscopy units which meet quality 
assurance standards across four domains: clinical quality, quality of the patient 
experience, workforce and training (Joint Advisory Group on Gastrointestinal 
Endoscopy, 2016a). Assessment of patient experience is undertaken using the 
Global Rating Scale (GRS) (Joint Advisory Group on Gastrointestinal Endoscopy, 
2016b). However, the GRS simply states that patient experience should be 
measured and advises that a range of methods may be employed, without 
recommending a standardised or optimal approach. This allows individual endoscopy 
units to choose how to measure patient experience and means that results are not 
comparable between units.  
1.2.7. Limitations of available tools to measure GI procedure experience 
A systematic review identified available tools which measure patient experience of GI 
procedures and found that a variety of methods are reported in the literature (Brown 
et al., 2015). Common themes covered by questionnaires included anxiety, 
satisfaction and comfort or pain (Brown et al., 2015). However, tools were developed 
from clinicians’ perceptions and expert opinion. Furthermore, the timing of 
administering such feedback tools varied; some tools required patients to complete 
surveys in the endoscopy department as researchers were concerned that sedation 
would affect their later recall, however, others were completed once patients had left 
the department and had test results. Currently, no patient-derived measures specific 
to GI procedures exist (Brown et al., 2015). 
1.2.8. Current approaches to measure GI procedure experience  
For colonoscopy procedures undertaken as part of the English national screening 
programme, data on patient experience is collected routinely by the BCSP, both for 
colonoscopy and CTC. A postal questionnaire sent thirty days after the procedure 
asks detailed questions about the screening and invitation process, followed by 
questions about information leaflets, comfort, follow up information and symptoms on 
discharge (Ghanouni et al., 2016). These responses are then reviewed at regular 
local BCSP meetings. This tool is not suitable for use across the symptomatic service 
as it focuses on the screening process. Furthermore, it is not patient-derived. 
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Patient experience of OGD, colonoscopy or CTC in the NHS symptomatic service is 
not routinely measured. 
Across Europe, the European Society of Gastrointestinal Endoscopy (ESGE) has set 
out quality standards for lower GI endoscopic procedures, which recommend 
measuring self-reported patient experience using a ‘validated scale’ (Kaminski et al., 
2017). The guideline acknowledges the lack of a standardised approach.  
The Gastronet is a commonly used questionnaire for assessing patient experiences 
of endoscopy in Europe (Hoff et al., 2006; Kaminski et al., 2017). This clinician-
derived measure asks patients to complete a short questionnaire on the day following 
their colonoscopy. It includes three questions about discomfort (before and after the 
procedure) and one question about satisfaction with the information given about the 
test and results (Hoff et al., 2006). 
In the USA, the American Society of Gastrointestinal Endoscopy (ASGE) 
recommends that a general satisfaction scale, which has been modified for 
endoscopic procedures, is used to assess patient experience (Johanson et al., 2000; 
Rizk et al., 2015). This comprises nine questions which cover: waiting time for an 
appointment, waiting time in the department for the procedure, personal manner of 
the endoscopist and support staff, explanation, overall rating and willingness to 
attend for repeat procedures by the same endoscopist and at the same facility 
(Johanson et al., 2000). The limitations of this scale are that it is not specific to GI 
procedures, was not developed with patient input and it has been pointed out that 
this does not assess comfort (Yacavone et al., 2001). 
Patient experience of CTC in the NHS symptomatic service (i.e. patients with 
symptoms who are not undergoing BCSP procedures) is not routinely measured 
(Hansmann et al., 2013). Measurement of patient experience and satisfaction of CTC 
in research settings tend to focus on comfort and bowel preparation, excluding other 
aspects of the patient experience (Zueco Zueco et al., 2012; Gareen et al., 2015). 
Earlier studies comparing CTC with other imaging or endoscopic modalities used 
clinician-derived questionnaires including the above components but also asked 
questions regarding patient preference (Taylor et al., 2003; Jensch et al., 2010).  
The Gastrointestinal Endoscopy Satisfaction Questionnaire (GESQ) has been 
described as a measure of patient experience (Hutchings et al., 2015). This tool was 
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designed with patient input, however, questionnaire items were identified through 
review of literature and guidelines, rather than directly from patients themselves 
(Hutchings et al., 2015). This means that it is not clear if all aspects of patient 
experience are covered by the tool.  
1.2.9. Developing PREMs 
The systematic development and validation of PREMs has been undertaken in a 
range of specialties and disease conditions, for example, cancer care, paediatric 
emergency care and sickle cell disease (Davies et al., 2011; Department of Health, 
2012a; Chakravorty et al., 2018). For example, the paediatric emergency care PREM 
involved the Royal College of Paediatrics and Child Health collaborating with the 
Picker Institute, Europe to devise a questionnaire which was patient-derived and 
covered all aspects of the emergency care experience, as reported by patients 
(Davies et al., 2011). The methodology involved four stages, including: literature 
review to identify current tools and aspects contributing to patient experience; a 
qualitative stage including relevant patients to identify themes important to patients 
which could be used to design the questionnaire; questionnaire design; and cognitive 
testing of the questionnaire (Jenkinson et al., 2002; Davies et al., 2011).  
The remainder of this thesis describes the methodological approach used to 
systematically develop and test the Newcastle ENDOPREM™- the first patient-
derived PREM for use in GI procedures. This PREM may be used in the future in 
routine practice to monitor experience in an individual clinical site or compare 





Chapter Two: Study Overview 
2.1. Overall Study Aims 
This study aimed to develop a fully patient-derived PREM - named ENDOPREM™ - 
specific to upper and lower GI procedures. 
2.2. Study Design 
This mixed methods sequential study comprised three phases. The aims and 
overview of each phase are described below. 
2.2.1. Phase One: Describing Patient Experience of GI Procedures 
The aim of this phase was to explore in depth and detail the patient experience of 
OGD, colonoscopy and CTC (referred to collectively as GI procedures in this work), 
based on accounts of patients who had undergone these procedures. Semi-
structured interviews were undertaken with patients who had undergone GI 
procedures. Thematic analysis was undertaken to identify over-arching themes which 
were organised by procedure stage. This phase was used to identify the aspects of 
experience that matter to patients and therefore to generate initial item content as a 
basis for questionnaire development. Furthermore, this phase was used to identify 
whether it was possible to develop a PREM that would work across different GI 
procedures.  
2.2.2. Phase Two: Developing the ENDOPREM™ 
The phase aimed to generate a question bank from the qualitative data and refine 
this into a pilot PREM. The questions were generated from the data gathered in the 
qualitative analysis. Several rounds of revision and review were undertaken within a 
wider study team. The questions were then pre-tested using cognitive interviews with 
patients who had undergone GI procedures. Five rounds of cognitive pre-testing 
were undertaken. Analysis of each round resulted in refinement of the questionnaire 
with the refined draft tested further in the next round of interviews. The pilot PREM 





2.2.3. Phase Three: Piloting the ENDOPREM™ 
The final phase of the study aimed to investigate the psychometric properties of the 
pilot questionnaire. The pilot PREM was prospectively administered, for self-
completion, to 1652 patients following a GI procedure. Statistical software (IBM® 
SPSS® 24) was used to investigate the psychometric properties of the instrument 
including: missing values, ‘floor’ and ‘ceiling’ effects, completion rates and 
exploratory factor analysis. Recommendations for final refinement were made on the 
basis of this analysis. 
2.3. Thesis Structure 
The methods of each phase are described together in chapter three, with three 
results chapters following this. Discussion of the findings and strengths and 
limitations of each phase is contained in each of the results chapters, with a final 
discussion on future uses of the ENDOPREM™ at the end of the thesis: 
• Chapter 3: Methods 
• Chapter 4: Results of phase one & discussion  
• Chapter 5: Results of phase two & discussion 
• Chapter 6: Results of phase three & discussion 




Chapter Three: Materials and Methods 
3.1. Phase One: Describing Patient Experience of GI Procedures 
3.1.1. Phase One Overview 
The design of this phase was a qualitative study, involving interviews with patients 
who had undergone different forms of GI procedures: namely OGD (per-oral or 
transnasal approach), colonoscopy and CTC. Semi-structured ‘one to one’ interviews 
were chosen over focus groups, which generally include three or more participants.  
Detailed, descriptive accounts of patient experience were required and it is accepted 
that semi-structured interviews best achieve this, whereas focus groups are preferred 
when patient’s attitudes or behaviours in social context are being explored (Ritchie et 
al., 2003; Barbour, 2014). It was also anticipated that some aspects of the interview 
may be sensitive and a one-to-one interview would allow participants to speak more 
freely (Elam et al., 2003; Ritchie et al., 2003). Lewis and Ritchie (2003) define 
interviews as unstructured, semi-structured or structured. The latter is a quantitative 
tool, which would not allow the depth of experience to be explored in this study. 
Semi-structured interviews were preferred in this study as a topic guide could be 
used to ensure a range of aspects of the patient experience to be covered whilst 
allowing flexibility with the order issues were covered and allowed probing of areas of 
interest. 
It was initially planned that all semi-structured interviews would be undertaken face-
to-face at the hospital site; however, subsequently it was decided to also allow 
telephone interviews. The rationale for this was to ensure that all eligible patients had 
access to participation in the study, including those who might struggle to attend for 
interview (e.g. because of work or caring commitments). Telephone interviews have 
historically been viewed as inferior to face-to-face interviews as it may be more 
difficult to build rapport, however, advantages include increased perceived anonymity 
for participants who may feel more able to discuss sensitive topics (Sturges et al., 
2004; Novick, 2008). In order to improve rapport and allow non-verbal clues to be 
observed, preference was for face-to-face interviews but if a patient suggested they 





Recruitment took place between February 2016 to April 2017. Patients aged 18 years 
and older who were referred for OGD, colonoscopy or CTC at South Tyneside 
District Hospital were invited to participate in an interview. For patients undergoing 
OGD or colonoscopy, a member of the research team (either the student- LN, or a 
research specialist nurse) identified and approached eligible patients on a series of 
endoscopy lists, in the department but prior to their procedure. The lists were not 
consecutive due to limited research staff availability. CTCs are scheduled throughout 
the week in the radiology department, rather than having dedicated lists like 
endoscopy. A research team member identified patients due to have a CTC in the 
next week and approached eligible patients prior to their procedure. Those potentially 
interested in participating were given a patient information leaflet (Appendix A), their 
details were recorded, and they were telephoned (by LN) in the week following their 
test. If they were still willing to take part a convenient time was arranged for the 
interview. Those who attended for interview at the site signed a consent form on the 
day of the interview. For those who underwent a telephone interview, a consent form 
was posted out once the interview was scheduled and the individual was asked to 
sign and return it; alternatively if the individual was due to attend the hospital for 
another reason the consent form was completed then, in advance of the interview 
(but at least 24 hours following their GI procedure). Verbal confirmation of consent 
was also sought during the telephone call, before recording commenced and any 
interview questions were asked. 
3.1.3. Participant Selection 
Purposive sampling was used to ensure a range of procedures (OGD, colonoscopy, 
CTC), age (<54, 55-64, >65) and sex (male/ female) amongst participants. Age and 
sex are known to affect both self-reported experience of GI procedures and the 
likelihood of the test being completed fully (McCarthy et al., 1993; Hsu et al., 2012; 
Ritvo et al., 2013; Valori et al., 2018). Diversity in socio-economic status was sought. 
As described in chapter 1, various indications exist for undertaking each GI 
procedure.  Therefore, heterogeneity across three broad categories of procedural 
indication was sought: ‘alarm symptoms,’ routine symptomatic patients and 
surveillance procedures.  ‘Alarm symptoms’ were those which indicate a high 
suspicion of cancer, for example, dysphagia (difficulty swallowing), haematochezia 
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(rectal bleeding) or weight loss (Harris, 2013). Surveillance procedures included 
patients attending for investigations to follow-up chronic conditions such as Barrett’s 
oesophagus or inflammatory bowel disease, in addition to those with a strong family 
history of colorectal cancer.  Diversity amongst participants was also sought 
according to whether they had previously had a GI procedure, grade of endoscopist 
(supervised trainee or independent endoscopist), completeness of procedure (i.e. 
caecum reached in colonoscopy, the second part of the duodenum reached in OGD) 
and result (normal examination, cancer and other abnormality). Ensuring diversity of 
participants in this manner was considered important to try and capture any potential 
variation in experience. Participant characteristics were examined as recruitment 
progressed, with unfilled strata then targeted. 
Participants unable to give informed consent were excluded from the study. As the 
interviews were conducted by a researcher with a dual role as an endoscopist and 
clinician, patients who had had previous contact with her in her clinical role were also 
excluded in order to avoid the possibility that this would influence the interview.   
Patients undergoing procedures as part of the National Health Service (NHS) Bowel 
Cancer Screening Programme (BCSP) were excluded. The English NHS BCSP 
sends faecal occult blood testing or faecal immunochemistry testing kits to individuals 
aged 60-74, with colonoscopy offered to those who return a positive result (Public 
Health England, 2019). The rationale for this exclusion was that the referral 
pathways, patient selection, pre-assessment and aftercare for the BCSP vary 
significantly from “routine” or other NHS referrals. Moreover, considerable research 
into improving uptake and experience in this patient group has already been 
undertaken (Morris et al., 2012; Ghanouni et al., 2016; Plumb et al., 2017).  
3.1.4. Ethical approval 
Ethical approval was obtained through the proportionate review sub-committee of the 
NRES Committee London-Stanmore on 20th March 2014 and ongoing approval was 
obtained from the Health Research Authority (IRAS ID: 14869, Appendix B and C). 
Local Research and Development approvals were obtained, and Newcastle 
University ethics approval was granted on the basis that appropriate NHS ethics 




3.1.5. Data Collection 
Recruitment and interviews continued until saturation was achieved (i.e. no new 
concepts arose in the last three interviews, identified in the iterative analysis) and no 
new experiences were identified, whilst ensuring at least 7-8 interviews were 
undertaken per procedure type.  A clinician-researcher (LN) conducted the interviews 
having undertaken training in qualitative methodology (a qualitative methods 
workshop and informal face to face training). The face-to-face interviews were 
conducted in a non-clinical building within the hospital grounds. It was not revealed 
that the interviewer (LN) was an endoscopist, in case this inhibited discussion. 
A topic guide was used to ensure that all “stages” of the procedure were covered, 
from referral to the results (Appendix D). The topic guide was used flexibly from 
interview to interview, to allow the interview to evolve and issues to be raised in the 
order that was natural for the participant. Participants were first asked their age and a 
little about themselves as an ice-breaker, then asked whether they had any previous 
GI procedures. The interviewer then asked them to describe their experience of 
endoscopy. The interview was generally guided by the participant’s discussion but 
any broad areas on the topic guide not covered were probed by the interviewer.  The 
interviews were recorded using a digital dictaphone (with the permission of the 
interviewee) and transcribed verbatim after each interview to allow preliminary and 
iterative analysis. Field notes were also made by the interviewer to enable further 
discussion or clarify points and to identify areas to be explored in further interviews. 
Using this method, emerging themes could be identified, and the topic guide could be 
modified if required to ensure complete description of the GI procedure experience. 
Throughout this process the topic guide was not substantially amended but areas 
requiring further exploration for clarity were noted (e.g. probing about what made the 
bowel preparation unpleasant). The initial interview transcripts were reviewed by LN 
and then by the supervisors (LS and JP), then discussed, to ensure adequate depth 
was being achieved.  
3.1.6. Data Management 
Participants were allocated a unique personal identifying number to ensure 
anonymity. Interviews were transcribed and anonymised prior to analysis. This 
transcription was performed either by a transcription company (JHTS Audio and 
Video Transcription Services, Birmingham, UK) or LN, depending on the scheduling 
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of the next interview to allow time for preliminary analysis. Where the interview was 
transcribed by JHTS, this was compared to the audio file by LN to ensure accuracy 
and clarify any queries raised by the transcription company.  
3.1.7. Data Analysis 
Thematic analysis was chosen to analyse the semi-structured interviews.  Braun and 
Clarke describe thematic analysis as “a method for identifying, analysing and 
reporting patterns (themes) within data” (Braun et al., 2006). An advantage of this 
method is that it produces a detailed thematic account of the data.  The transcripts 
were read and re-read in detail and an inductive process was used to code the data 
for each transcript, which were then organised into categories. This approach meant 
that themes were derived solely from the semi-structured interview dataset, rather 
than from pre-existing literature or the researcher’s pre-conceptions (Ritchie et al., 
2003; Braun et al., 2006). Data-driven analysis was considered important in this 
study as the aim was to produce a fully patient-derived PREM.  The data was initially 
analysed at a ‘semantic’ or ‘explicit’ level, meaning that codes were applied as a 
description of what was said by the participant (Boyatzis, 1998, Braun and Clarke, 
2006). Word processing software was used to cut and paste coded quotes into 
broader themes. The sub-themes were later explored using a ‘latent’ level or 
‘interpretative’ approach, by revisiting the data to identify what each sub-theme 
represented and to describe over-arching themes across the dataset (Boyatzis, 1998, 
Braun and Clarke, 2006). A member of the study team (LM, Appendix E) double 
coded three of the interview transcripts, one from each procedure type, to further 
strengthen the integrity of the analysis. Discussion with the supervisory team was 
undertaken throughout the process to enhance validity and reliability.  Several sub-
themes emerged and these were pertinent to all three modalities; therefore the 
results are presented together. Where an over-arching theme or subtheme was 
relevant to only one type of procedure (or not relevant to one type of procedure), this 
was identified. The sub-themes were subsequently organised into procedural 
“stages” to enable the findings to more directly inform the questionnaire development 
(i.e. before coming to the hospital for the test; preparing for the test; at the hospital, 
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before the test; during the test; after the test)2.  The results (Chapter 4) are presented 
in terms of the over-arching themes identified (which are described at a high level) 
and the procedural stages (which are described in detail). Illustrative quotes are 
provided to supplement narrative descriptions. Each quote is followed by the relevant 
anonymised participant ID number, consisting of 2 letters to identify the procedure 
(OG= oesophagogastroduodenoscopy; CO= colonoscopy; CT= CT Colonography) 
and a number. 
3.2. Phase Two: Developing the pilot version of the ENDOPREM™ 
3.2.1. Phase Two Overview 
The aim of this phase was to develop a pilot PREM by (i) generating a question bank 
(which involved decisions on the topics to be included in the questionnaire and their 
order, informed by the qualitative interviews and a focused literature review); 
decisions about question and response format; review and revision of question 
wording by the study team and (ii) pre-testing the questionnaire with patients who 
had undergone GI procedures. An overview of this phase is shown in figure 3.1. 
                                            
2 The sub-themes were organised in this way because this was the way in which 
most participants described their experience (see section 4.3) and was felt to be the 




Figure 3.1: Flow chart illustrating steps in Phase 2 
 
3.2.2. Literature Review 
A focused literature review was undertaken to ensure that no areas of patient 
experience had been missed. This step was deliberately left until after the qualitative 
interviews were complete to prevent the findings biasing the interviewer (LN). Search 
terms included “patient experience” and “colonoscopy,” “OGD,” “upper GI 
endoscopy,” “CTC,” “CT colonography” or “gastrointestinal endoscopy.” Streiner & 
Norman (2008) suggest that when developing a questionnaire, it is important initially 
to ensure that the questions cover all relevant themes and topics. This describes 
content validity. This literature review was used to ensure no aspects of the patient 
experience were missed and added further content validity to the questionnaire.  
3.2.3. Item Generation 
In order to generate a question bank, it was first necessary to determine what topics 
should be addressed in the questionnaire. The themes identified within the qualitative 





• Before coming for the test: the time between being told the test would happen 
and coming to the hospital for the test (but not including management in 
primary care) 
• Preparing for the test: for colonoscopy/ CTC patients only, this section related 
to taking the bowel preparation 
• At the hospital, before the test 
• During the test (i.e. the procedure itself) 
• After the test: immediately after the test and the days following the test 
Although the initial General Practice (GP) referral process was sometimes discussed 
in the qualitative work, it was felt that issues pertaining to primary care consultations 
and time taken to refer for the investigation were out with the remit of this PREM- this 
stage was therefore not included. 
Themes were mapped into stages (Chapter 4; Section 4.3). Item stems were then 
composed, where possible, using language used by participants in the qualitative 
interviews. It was anticipated that the question bank would contain more items than 
would eventually be included in either the pilot PREM or the final ENDOPREM™; 
and that the number of items would be reduced during the testing process. After 
items were generated, each one was assessed to ensure that it addressed one of the 
six over-arching themes identified within the qualitative phase.  
The choice of the response format for items is important as it can impact on both 
ease of completion and subsequent analysis. Categorical scales can be used as 
responses to a series of questions, however, this may create significant 
heterogeneity between questions and restrict psychometric analyses (Fallowfield, 
1995; Rattray et al., 2007). A Likert scale format was chosen as the response format 
for the majority of the questions, as this is well suited to measuring attitudes and 
most of the items in the question bank were related to people’s attitudes about 
different aspects of their experience (McColl et al., 2001; Streiner et al., 2008). This 
question style involved phrasing the question as a statement and giving a range of 
options for participants to indicate the extent to which they agreed/disagreed with the 
statement (Likert, 1932). A benefit of this response format is that scores can 
potentially be analysed as interval data, thus allowing the use of parametric statistical 
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tests (Rattray et al., 2007). Using this format also improved the aesthetics and 
readability of the questionnaire; using the same format throughout a questionnaire 
limits confusion (Fallowfield, 1995). The number of response options in a Likert scale 
can vary, but seven is the upper limit beyond which participants may be unable to 
discriminate between response options (Fallowfield, 1995; Streiner et al., 2008). 
Within the context of health surveys, it is recommended that where rating scales are 
used, a maximum of five response categories should be included (McColl et al., 
2001). Debate exists over whether a ‘neutral’ option should be included. Including 
such an option allows respondents to indicate when they neither agree nor disagree 
with the statement, however, people may interpret what the neutral option means 
differently (Streiner et al., 2008; Nadler et al., 2015; Simms et al., 2019). Omitting a 
neutral response option compels respondents to choose whether they agree or 
disagree, however, this can cause frustration and non-response, thereby introducing 
bias (Rattray et al., 2007; Streiner et al., 2008). In this study five response options 
were included as this was felt to provide a reasonable number of response options 
and allowed a neutral option, as it was felt that people might validly feel neutral about 
some of the items. The response options were: strongly agree, agree, neither agree 
or disagree, disagree and strongly disagree. 
Consideration was given to the wording of item stems, in terms of both readability 
and positive and negative wording. McColl et al conclude that a mixture of positive 
and negative items should be used in order to prevent “response set” bias, where 
respondents choose the same response option for each question (McColl et al., 
2001). This is generally accepted in the literature, however it may affect how 
participants respond to a question as they are more likely to agree with a positively 
worded question (McColl et al., 2001; Locker et al., 2007; Jaensson et al., 2017). In 
this study, it was decided that both positive and negative questions would be 
included (i.e. some statements were phrased such that ‘strongly agree’ would 
indicate a ‘positive’ experience, and others were phrased so that ‘strongly disagree’ 
would indicate a ‘positive’ experience). Equal proportions of each were not sought 
and the direction of wording was determined in the first instance by the theme or 
subject matter and what seemed to be more ‘natural’ (as judged by the research 
team), then tested in the cognitive interview phase. 
The questions were initially refined by several rounds of review and revision within 
the study team, which comprised a range of domain experts and questionnaire 
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developer specialists (Appendix E). This involved circulating questionnaire drafts via 
email, along with the results from the qualitative analysis, and inviting group 
members to comment, in addition to teleconference and email discussions. This 
iterative process focused on ensuring that all of the themes identified in the 
qualitative interviews were covered, in addition to refining the wording of questions. 
Team members suggested alterations in wording or variations in question style. 
Where there were areas of disagreement on question wording or the optimal method 
of assessing, the original interview transcripts were explored further or a focused 
literature review undertaken (for example, in the assessment of pain and discomfort). 
This process of circulation, review and revision continued until all team members 
agreed on the final question bank.  
The final question bank was then compiled into questionnaire format to enable 
cognitive testing.  
Two options were identified for timing of questionnaire distribution: giving patients the 
questionnaire pack on the day of their test or posting it at a later date. It was 
considered possible that having their test results may influence how participants 
would respond to the PREM. An advantage of posting the questionnaire to 
participants was that distribution could be delayed for a period to allow them to 
receive the results of their test, if they hadn’t already received them. However, 
participants in the qualitative interviews described varying methods and timescales of 
receiving their test results so it would have been difficult, in practice, to ensure that all 
participants had their results at the time of questionnaire completion. Also, creating a 
delay in posting the questionnaire may affect recall of the experience. The final 
decision was to distribute the questionnaire on the day of the test and ask individuals 
to complete it after they had left the department and to return it by post.  
3.2.4. Cognitive Pre-Testing 
The aim of cognitive pre-testing is to ensure that intended recipients correctly 
understand and respond to questionnaire items (Willis, 2004). The pilot questionnaire 
was produced using graphic design software, with the assistance of a graphic 




3.2.5. Cognitive Pre-testing: Participant Recruitment 
Cognitive interviews took place from June 2017 to July 2017. Fifty-six patients were 
invited to participate in this phase. Fifteen interviews were undertaken. Patients were 
identified from endoscopy lists and radiology appointments. They were approached 
by either a research nurse or the student (LN) and invited to attend the hospital for an 
interview. Some participants from the original qualitative interviews were also 
included. During the initial interviews, participants were asked if they were happy to 
be contacted to return for a cognitive interview.  The reason for this was to ensure 
that the questionnaire reflected the experience described in the qualitative phase, i.e. 
content validity. These previous participants were telephoned and, if still willing to 
participate, an interview was scheduled at a mutually convenient time.  
Those who were potentially interested in participating were given a patient 
information leaflet (either face to face or by mail for those who had previously been 
interviewed) and were telephoned a few days afterwards. If they were willing to 
participate, a convenient time was arranged for the interview. Those who attended 
signed a consent form on the day of the interview. All interviews were conducted 
face-to-face, as it was considered important that the researcher (LN) could see how 
the patient was completing the questionnaire and reacting to the questions. 
Interviewees signed a consent form at the start of their interview.  
3.2.6. Cognitive Pre-testing: Participant Selection 
Purposive sampling was used to ensure a range of procedures (OGD, colonoscopy, 
CTC), ages (<54, 55-64, >65) and sex (male/female) amongst participants. Diversity 
in highest level of education completed was sought to ensure the wording of 
questions was acceptable and understandable by people with all levels of education.  
Participant characteristics were examined as recruitment progressed, with unfulfilled 
purposive sampling strata targeted as the interviews progressed. 
Individuals unable to give informed consent were excluded from the study. As in 
Phase 1, patients who had previous contact with the researcher (LN) in her clinical 
role were excluded. Individuals undergoing NHS BCSP procedures were excluded 




3.2.7. Cognitive Pre-testing: Data Collection 
The purpose of these interviews was to optimise the wording of questions, identify 
problems with the content or response options of questions and to help filter the 
number of questions where more than one question per theme or stage had been 
developed. 
Beatty describes two broad approaches to cognitive interviewing, namely; ‘think 
aloud’ and ‘verbal probing,’ but appreciates that these terms are not standardised 
(Beatty et al., 2007). ‘Think aloud’ cognitive interviewing consists of asking 
participants to talk through their thought processes as they answer questions 
(Conrad et al., 1996). ‘Verbal probing’ requires the interviewer to ask questions as 
the participant responds in order to gain insight of understanding and response 
processing (Beatty et al., 2007). A ‘hybrid’ approach is suggested by several authors, 
which allows participants to verbalise their response process but also enables the 
researcher to probe the participant on areas of interest or perceived difficulty (Willis, 
2004; Blair et al., 2010; Ryan et al., 2012). The hybrid approach was adopted in this 
study.  
Using the methodology described by Willis, several rounds of cognitive interviewing 
were undertaken, each consisting of three participants. There is no consensus 
agreement on the optimal number of participants for cognitive testing of 
questionnaires, however, undertaking ‘rounds’ with refinement of questions and 
subsequent retesting is recommended (Beatty et al., 2007).  
In the interview, participants were asked to complete the questionnaire for the last GI 
procedure they had undergone. They were asked to ‘think aloud’ as they completed 
the questionnaire. They were asked to describe their thoughts as they completed it 
and highlight any difficulties or suggestions for improvement. Where participants 
seemed to hesitate, this was probed by asking them to explain their thoughts or any 
difficulty with understanding or completion. After they had completed the 
questionnaire, participants were asked if any parts of their experience had been 
missed by the questionnaire. In addition to this, different visual styles of question 
format and layouts were tested, which had been developed with a graphic designer.  
All cognitive interviews were tape-recorded, transcribed verbatim by the student and 
anonymised. Notes were taken at the time of the interview to identify areas for further 
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exploration in subsequent interviews. Rounds of cognitive interviews continued until 
all problems had been addressed and no new problems arose; five rounds were 
undertaken. 
Participants were each allocated a unique personal identifying number to ensure 
anonymity. The interviews were anonymised after being transcribed verbatim by the 
student prior to analysis.  
3.2.8. Cognitive Interviewing: Data Analysis 
Analysis was undertaken following transcription, using a framework proposed by 
Conrad and Blair (1996). Problems were identified according to their response stage 
(problems that occur with understanding the question and required task; performing 
the task, i.e. producing a response; mapping the response to the given response 
categories) and further broken down to problem type (lexical, temporal, logical, 
computational or omission/inclusion) (table 3.1). This standardised approach was 
used to identify patterns of problems to identify underlying issues with specific 






Description Example from this study 
Lexical Meaning of words not known 
or inability to use words in 
question or response context 
 
Participants were asked to 
identify what procedure they had 
undergone. They did not 
understand the terms used to 
describe the procedures. 
Temporal Problem with the time period 
or time spent on an activity 
related to the question, 
including misunderstanding 
the descriptions of time used 
in the question 
Participants were asked whether 
they had enough time to discuss 
the test before the test. They 
were not sure what time frame 
this referred to 
Logical Problem with question 
wording because of 
“connectives” such as “and” 
and “or.” 
“False presuppostions” 
within a question, i.e. a 
question is asked in such a 
way that it assumes 
something about a 
respondent which is not true  
Participants were asked if they 
were able to ask any questions 
before the test. Those with no 




Problem where participants 
are unsure of the scope 
which is covered by a 
question 
 
Participants were asked to 
indicate which test(s) and how 
many they had. Participants were 
not sure whether to include their 
most recent test  
Computational All other problems e.g. 
problems with long, complex 
questions, memory or use of 
mental arithmetic 
Participants were asked to enter 
their age. The response option 
was three blank boxes which was 
confusing 
Table 3.1: Description of problem classes, adapted from Conrad & Blair, 1996 
Analysis was undertaken after each interview round and the questionnaire was 
modified before the next round. The revised questionnaire was tested in the next 
round. 
3.2.9. Pilot Questionnaire 
The finalised pilot questionnaire was produced using graphic design software, with 




3.3. Phase Three: Piloting the ENDOPREM™ 
3.3.1. Phase Three Overview 
The final phase of the study involved piloting the questionnaire, through a survey of 
patients, in order to investigate its psychometric properties.  
3.3.2. Respondent characteristics 
Participant characteristics were captured as part of the questionnaire. This was to 
enable analysis of the properties of the questionnaire according to patient 





Question Response options 
A1 Please fill in today’s date DD: MM: YYYY 
A2 How long ago was your 
most recent test? 
Weeks: 
Days: 
A3 Please fill in your age (in 
years) 
Free text 
A4 Are you? Male/Female Tick box 
A5 How many years of full-time 
education have you 
completed? 
Free text 
A6 To which of these ethnic 
groups would you say you 
belong? 
White 
Mixed/ multiple ethnic groups 
Asian/ British Asian 
Black/ African/ Caribbean/ Black 
British 
A7 Please tell us if someone is 
helping you complete this 
survey 
- I am completing this survey by 
myself 
- Someone is helping me complete the 
survey 




- Transnasal Gastroscopy 
- CT Colonoscopy/ pneumocolon 
- I’m not sure 
A9 Have you had another 




- Colonoscopy- number 
- Gastroscopy- number 
- Transnasal Gastroscopy- number 
- CT Colonoscopy/ Pneumocolon- 
number 
- Flexible sigmoidoscopy- number 
A10 How were you referred for 
your most recent test? 
- I was referred directly by my GP 
- The test was organised by a hospital 
doctor 
- I have regular tests to monitor a 
medical condition 
- I have regular tests because of my 
family history 
- I was referred in another way (please 
tell us more in the box below- freetext) 
Table 3.2: Participant characteristic questions and response options 
3.3.3. Participant Recruitment  
Individuals aged ³ 18 years, undergoing OGD (including transnasal endoscopy) 
colonoscopy or CTC colonography were invited to participate. Those who were 
unable to consent for their procedure or who had difficulty conversing in English were 
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excluded from the study. Four sites across the North East of England participated; 
these were recruited following promotion of the study at a regional endoscopy 
research collaborative meeting (Northern Region Endoscopy Group; NREG) 
(Rajasekhar et al., 2014). These sites were: South Tyneside District Hospital (STDH), 
County Durham and Darlington NHS Foundation Trust, North Tees and Hartlepool 
NHS Foundation Trust and Northumbria Healthcare NHS Foundation Trust. The 
results from each site are anonymised and represented by the letters A-D in chapter 
6. Questionnaires were distributed from October 2017 to September 2018. Potential 
participants were identified from endoscopy or radiology lists in the department and 
were given a numbered questionnaire pack by a member of the research team 
before leaving the department. The pack contained a covering letter, information 
sheet (Appendix G), questionnaire (Appendix F)3 and a freepost envelope to return 
the completed questionnaire to STDH. Each questionnaire was labelled with a unique 
study ID consisting of 3-4 letters as a site identifier, followed by three numbers. Both 
the research team and questionnaire pack documentation reiterated that participation 
was completely voluntary. It was made clear that the completed questionnaires would 
be analysed and presented anonymously. Returning a completed questionnaire was 
considered to be consent for participation. A reminder letter was sent by the research 
team if the questionnaire was not returned after two weeks. Completed 
questionnaires were stored securely in accordance with Trust information 
governance guidelines.   
A recruitment log was maintained in each site to allow response rates to be 
computed and to compare characteristics of responders versus non-responders. 
Only very basic information was recorded, namely: questionnaire number, site, age, 
sex, procedure and local hospital number. To enable future analysis (beyond this 
thesis), clinical and procedural information was collected for the individuals who had 
returned completed questionnaires (date questionnaire given, return date, reminder 
date, procedure undertaken, primary indication, medication given, primary diagnosis, 
endoscopist grade and any complications) (Appendix H). On a rolling basis, research 
staff at STDH informed each site of the study IDs of the questionnaires which had 
                                            
3 A quality of life measure (EQ-5D) and an anxiety measure (DASS-21) were also 
included within the questionnaire booklet, however; these were intended to be used 
in analyses outwith the scope of this thesis, and are therefore not discussed further 
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been returned. The site completed the associated clinical details for these patients 
and returned the information to STDH for data entry.   
3.3.4. Timing of Questionnaire 
Patients were asked to complete the questionnaire and post it back to the research 
team. The reasons for this were: (i) if participants completed the questionnaire in the 
department, they may not have been given their results (or a plan to receive them), 
discharge or follow up plan and this would hinder their ability to complete the 
questionnaire; (ii) there was a question about how participants felt after they were 
discharged from hospital which could not be answered in the department; and (iii) as 
this was part of a research study, it was important that participants who had sedation 
did not complete the questionnaire until the next day, as sedation may impair 
capacity to consent. 
3.3.5. Sample Size 
The final sample size for the pilot study was determined by the number of questions 
included in the PREM. It was not the intention of this study to develop subscales, 
however, an exploratory factor analysis (EFA) was planned to explore whether there 
were any subscales within the questionnaire and to help inform further item 
reduction. Field recommends that 10 to 15 completed questionnaires per 
questionnaire item are required to perform a meaningful exploratory factor analysis 
(Field, 2018). The pilot PREM contained 59 questions; as six of these were specific 
to colonoscopy and CTC, and a further two were general satisfaction questions, a 
maximum of 51 would be included in the EFA. This meant that 510 to 765 completed 
questionnaires were required; the recruitment target was therefore set as 800.  
3.3.6. Data entry, checking and cleaning 
Question response options were coded for data entry and analysis: this involved 
assigning a numerical value (ranging from 1-5, left to right) to each response option. 
Consistent codes were used for N/A and missing options.  
An information capture company, NData (http://ndata.biz), entered the clinical 
information sheets and the completed questionnaires into a Microsoft Excel file and 
SPSS database, respectively. Upon completion of data entry, 10% of the completed 
questionnaires (n=80) were checked for errors by the student. These were selected 
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using the Microsoft Excel random number function, were checked item-by-item 
against the database for errors. Although no data entry errors were found, consistent 
errors in coding of two questions were identified (E13 and E16). These questions 
consisted of a visual analogue scale (VAS) to measure pain and discomfort and were 
the only questions assessing experience which were not in Likert format. Participants 
had been asked to mark a cross on a 100mm line to indicate the level of pain or 
discomfort experienced during the procedure (figure 3.2).  
 
Figure 3.2: VAS discomfort question 
The data entry company was asked to measure the distance along the line using a 
ruler and to input this as the response. Instead, the responses had been rounded, by 
the company, to the nearest 10mm. Responses to these questions were measured 
and re-entered into the database by the student. In addition, some participants did 
not follow the instructions for completion of the VAS. Some placed a cross either 
above or below the line; some circled a number or anchor; some both placed a cross 
on the line and circled a number; some indicated a range by circling several numbers 
or drawing arrows. Pragmatically it was decided that if a cross was placed in any 
position along, above or below the line then the distance from the beginning of the 
line to the point on the line which corresponded with the centre of the cross was 
documented as the response (in millimetres). For those who circled a number, this 
was multiplied by ten to give a response in millimetres. Where anchors were circled, 
zero millimetres was recorded for those who circled ‘no discomfort/pain’ and 100 
millimetres recorded where ‘worst discomfort/pain imaginable’ was circled. Where a 
range was indicated the response was coded as missing.  
The entire dataset was then cleaned by the student. First, checks were made that 
only plausible entries were recorded in the database by examining the descriptive 
statistics. For example, implausible questionnaire return dates were checked against 
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the original additional information sheets and with the research teams. The time 
since the procedure as reported by the participant was also checked (question A2): 
12 instances which appeared implausible were double checked and corrected 
against the procedure date and date of completion as recorded by the participant. 
Three participants reported that they were aged over 90. These were double checked 
on the questionnaire hard copy and recruitment log. One of these participants had 
not entered their age and this was recoded as missing. All errors (in any fields) found 
in this way were corrected.  
Data cleaning identified two blank questionnaires which were removed from the 
dataset. One further questionnaire had been completed in relation to an ineligible 
procedure (flexible sigmoidoscopy) and was also removed. 
3.3.7. Data Analysis 
Some variables were recoded and several new variables were created, including: 
• a nominal variable to identify the site (hospital) from which the participant was 
recruited 
• a continuous variable representing the number of days between procedure 
and questionnaire return 
• a nominal variable for the procedure as recorded by the site (i.e. by coding 
OGD and TNE together) 
• a categorical variable to order participant age into groups: £ 54 years, 55 -64 
years, 65 – 74 years and ³ 75 years.  
• two categorical variables to describe how participants had answered the VAS 
questions on pain and discomfort (E13 and E16). The values were: cross on 
line, number circled, cross under line, number written, cross on line and 
number circled, circled anchor and range indicated.  
• two additional variables were created each for question E13 and E16. The first 
included all responses regardless of how the question was answered and the 
second included only participants who answered the question correctly. 
The coding direction was re-ordered where necessary to ensure that responses 
which corresponded with a positive experience had a higher score. For example, the 
coding for responses to question B1 (I was happy with the way I was referred for the 




• Strongly agree (5)  
• Agree (4) 
• Neither agree or disagree (3) 
• Disagree (2) 
• Strongly disagree (1) 
Statistical analysis focused on: patterns of response, respondents’ characteristics, 
distributions of responses, levels and patterns of missingness, completion of pain 
and discomfort questions and exploratory factor analysis. Descriptive statistics were 
used to examine response patterns per question, including missing responses and 
floor and ceiling effects. Responses were observed to assess for individual floor and 
ceiling effects, defined as 40% of respondents choosing either the lowest or highest 
ordinal response option, respectively (Dean et al., 2018).  
Response patterns were examined for the entire sample and then compared, using 
chi-square tests, by sex, age, procedure (as recorded by the site) and site. The 
number of participants who erroneously completed Section C (i.e. they had not had a 
colonoscopy or CTC) was determined. Mean number of missing responses per 
patient were compared between groups using an independent t-test (when there 
were two groups) and one-way ANOVA (when there were more than two groups). If 
Levene’s statistic indicated the assumption of homogeneity of variance between 
groups was violated, and this was confirmed by Welch’s or Browne-Forsythe’s tests, 
the Games-Howell’s procedure was used as a post-hoc test (Brace et al., 2016). All 
statistical tests were two sided and a p value of <0.05 was considered statistically 
significant. 
The VAS scores for pain and discomfort (E13 and E16) were correlated using 
Spearman’s rank correlation, as the data was not normally distributed. For each 
participant, the difference in their answers for question E13 and E16 was computed; 
an assessment of whether the mean difference was equal to 0 was made using a 
paired t-test.  
The Likert response questions for pain and discomfort were cross-tabulated and the 




Factor analysis is a statistical technique which can be used to explore the underlying 
constructs, called factors, of a questionnaire (Ferguson et al., 1993; Rattray et al., 
2007). The factors represent groups of variables which correlate highly with one 
another (Field, 2018). A correlation matrix was produced for all variables. The Kaiser-
Meyer-Olkin (KMO) measure and Bartlett’s test of sphericity were used to assess 
adequacy of sample size and relations between items to ensure that the criteria for a 
satisfactory factor analysis were met. Spearman’s rank correlation was used to 
identify items which correlated poorly with others (rs<0.3) or very highly with others 
(rs>0.8) (Field, 2018) and these were examined to identify which items could be 
removed. In preparation for EFA, item-total correlations (ITC) were calculated for 
each question and those with ITC less than 0.3 were identified (Field, 2018); these 
were excluded from the EFA.  
Exploratory factor analysis was then conducted using principal components analysis. 
Scree plots were produced and the points of inflection used to determine the 
potential number of factors that could be retained. Only factors with eigenvalues 
greater than 1 were retained in the analysis, according to Kaiser’s criterion (Kaiser, 
1960; Field, 2018). Factor rotation is applied to ensure that variables load on to only 
one factor (Field, 2018). An orthogonal rotation was initially applied to the component 
matrix; this assumes that the factors are independent. Examination of this suggested 
that the factors were not independent of each other and further analysis was 
performed using an oblique rotation (direct oblimin).  Once an acceptable solution to 
the factor analysis was identified, the rotated factor loadings were assessed and 
themes were identified.  
In order to determine the reliability of the final scale, Cronbach’s a was calculated 
overall and for each factor. Cronbach’s a of >0.6 was considered to demonstrate 




Chapter Four: Describing Patient Experience of GI Procedures 
4.1 Introduction 
This phase of the study aimed to explore patient experience of OGD, colonoscopy 
and CT colonography, based on accounts of patients who have undergone these 
procedures. In addition, it aimed to identify themes that are important to patients in 
terms of their experience, in order to inform the content of the PREM.  
4.2 Participant Characteristics 
Participants were recruited between February 2016 and April 2017. One hundred and 
sixty-two patients were approached for an interview and 127 agreed to be telephoned 
to arrange an appointment. Twenty-eight did not answer the telephone call and 
seven agreed to an interview but failed to attend. A total of 35 patients attended for 
interview. Data saturation was reached following completion of 32 interviews. A 
further three interviews were undertaken to confirm themes and ensure heterogeneity 
of participants. Interviews ranged from 20 to 60 minutes in length. 
The majority of participants were male (54.3%). The mean age was 61.9 years 
(range 38-86 years). The time interval from procedure to interview ranged from five to 
44 days. All participants had recently undergone a GI procedure at the same 
hospital, however, a few (n=4) had previous experience of procedures in other 




Variable Number of participants (%) 
Sex Male 19 (54.3%) 
 Female 16 (45.7%) 
 
Age ≤54 12 (34.3%) 
 55-64 6 (17.1%) 
 65-74 12 (34.3%) 
 ≥75 5 (16.3%) 
 
Procedure OGD (including 
transnasal endoscopy)4 
15 (42.8%) 
 Colonoscopy 10 (28.6%) 
 CTC 10 (28.6%) 
 
Indication Alarm symptoms 12 (34.3%) 
 Routine symptoms 17 (48.6%) 
 Surveillance procedures 6 (17.1%) 
Table 4.1: Interview participant characteristics 
4.3. Summary of patient experience 
Six over-arching themes emerged from the initial inductive analysis: anxiety, 
expectations, information & communication, embarrassment & dignity, comfort and 
choice & control.  
When invited to discuss their experience, a few participants focused on a single 
aspect of the experience which was most important to them; for example, the taste 
and volume of the bowel preparation, or the effect of good communication from staff. 
However, most participants described their experience in chronological order, that is, 
as stages of a process, starting with the referral process (henceforth, Before 
attending for the test), then visiting the hospital (At the hospital, before the test), 
undergoing the procedure itself (During the test) and what happened afterwards 
(After the test). All of the six over-arching themes played out in more than one of the 
stages of the process; this is summarised in Table 4.2. Within each stage there were 
several subthemes. The results which follow have therefore been organised and 
presented in terms of the stages, and, within each stage, the subthemes. The 
following section will expand on themes identified at each time point. Footnotes are 
used to give explanations of clinical procedures and context.
                                            
4 12 participants had undergone traditional per-oral OGD and 3 participants had 










the test  
Referral process Long wait for test increased anxiety about it 
Shorter than expected wait increased anxiety about outcome 
Impact on cancelled appointments 
Anticipation of the test Anxiety about what the test will entail 
Anxiety about what the test might find 
Previous bad experience made them more anxious about the test 
Preparing for test Anxiety about preparation working 
 
Information about the test Talking to others increased anxiety about the test 
At the hospital, 
before the test 
Arriving at the hospital Concern about getting to hospital with ongoing laxative effects of 
preparation 
Waiting in the hospital for 
the test 
Anxiety while waiting in the department for the test 
During the test In the procedure room Procedure room is daunting 
After the test 
 
Recovery Anxious about time taken to recover in days following procedure 
Results and follow-up Concern about how to get the results 




Referral process Expectations about appointment speed 
Expected to come for test but it was an outpatient appointment 
Speed of referral differed from expectations 
Information before the 
test 
Information given helped patients to prepare for test as knew 
what to expect 
Some information did not explain test enough- differed from 
expectations on the day 
Talking to others impacted expectations 
Anticipation of the test Previous experience meant they knew what to expect 












Preparing for the test Effect of laxatives worse than expected 
Laxatives didn’t work as quickly as expected 
At the hospital, 
before the test 
Waiting in the department Waiting time in the department for the test differed from 
expectations 
During the test Medication Effect of pre-medication compared with expectations- worked 
better/less/as expected 
The test  Didn’t know what to expect 
Duration of test longer or shorter than expected 
How procedure was done: OGD patients- some expected it to be 
oral but was done transnasal 
Feeling of the test Operator explained what was going to happen as they went along 
so knew what to expect 
After the test Recovery Took longer to recover than expected 
Results and follow-up Results given in different way than expected 






Referral process Preference for appointment convenience versus specific 
endoscopist 
Able to rearrange appointment if didn’t suit 
Not given choice of operator 
Information about the test OGD: Choice of oral versus transnasal approach 
Some told of alternatives- choice 
During the test Medication Feel like nursing staff want them to choose throat spray rather 
than sedation (OGD) 
More information to help them choose medication would be 
helpful 
The test Felt able to stop the procedure 
OGD: felt it was their responsibility to ‘swallow’ camera 
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Referral process Written information about the test 
Clarity of information given 
Communication with person referring for the test 
Information about preparation for the test 
Information about the test Given information about what the test would involve 
Would like more information for the person organising the test 
Told about risks of test 
Information didn’t explain enough about test- differed from 
expectations 
Information good  
Information confusing about diet 
 
At the hospital, 
before the test 
Waiting in the department Not informed about delays in department 
During the test Medication More information about medication (eg sedation) needed 
The test Operator explained each step 
Communication with other staff 
Staff communication put them at ease 
After the procedure Information about how to get results 
Getting the results 










Comfort During the test Feeling of the test Discomfort of camera/tube insertion 
Feeling of mouthguard (OGD) 
Pain caused by biopsies 
Discomfort cause by air/gas insertion 
After the test Recovery Discomfort in days after test 
Throat pain after test 
Dignity & 
embarrassment 
At the hospital, 
before the test 
Waiting in the department Worried about someone walking in when getting changed 
Embarrassed waiting in gown 
Embarrassed waiting in busy waiting area 
Procedure room far from  
 During the test The test Dignity shorts helped protect dignity 
Staff protected dignity 
Effect of operator gender on embarrassment 
 After the test Recovery Toilet close to waiting area 
Table 4.2: Overview of themes and sub-themes from qualitative interviews, illustrated with examples
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4.4. Before attending for the test 
Four themes were identified which related to this stage of the procedure, which 
included the time from being referred from the test to arriving at the hospital for the 
test.  
4.4.1. Referral for the test 
Some patients described being referred directly for their test by a GP, whereas 
others were seen by a consultant in the outpatient department first.  Patient 
preference regarding this varied; a couple perceived being seen by a hospital doctor 
in the outpatient clinic prior to the procedure negatively as they felt that they simply 
repeated what had been said to the GP:  
“So it was the nurse who actually explained it to us, that they do quite often 
get a lot of patients that think they’re going for the camera there and then, but 
it’s a consultation. I just found that little bit of the process a waste of time, cos 
I’d told the doctor [GP] exactly what I told the consultant.“  OG3 
Others felt that an outpatient appointment prior to the test was beneficial, as it 
enabled further discussion about the test:  
Patient (Pt): “I would’ve liked to have come to have spoken to the consultant 
in an outpatient appointment really. I felt I was going in to it and not really 
knowing what was happening. Even though there’d been an explanation 
sheet, which I could understand, but I think it would have been, I felt it would 
have been better to have been to outpatients first and spoken to somebody 
about what was happening”. 
Interviewer (Int): “What kind of things would you have liked to have gone 
through with the consultant?” 
Pt: “I think probably, maybe a few more reasons as to what this test might be 
showing up or, I suppose, I don’t know, a discussion of my symptoms just I 
suppose to confirm that the GP was right in what he’d said or whether there 
was other options that were available or other things that it could’ve been or. I 
don’t know really. There wasn’t the opportunity to do any of it.” OG11 
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In some instances, the referral process differed from expectations. For example, a 
few patients arrived at the outpatient appointment prior to the procedure expecting 
that the procedure would be done on that day. Where this occurred, patients 
described the feeling of ‘wasting the consultant’s time’ and viewed the consultation 
as repeating things unnecessarily. Furthermore, where the outpatient appointment 
had been unexpected, it was perceived as an unnecessary delay to the procedure. A 
minority of patients had expected an outpatient appointment first but found that when 
they arrived the procedure would be done on that day. Patients said that knowing 
what to expect in this stage was important as it helped them to prepare for what 
would happen when they arrived at the hospital. Patients described being 
disappointed when the procedure wasn’t done as expected.  
Int: “How did you feel about that [not having the procedure on the day of the 
outpatient appointment]?” 
Pt: “Extremely disappointed and angry to be honest with you.” 
Interviewer: “What was it about it that made you angry?” 
Pt: “It’s just that you set yourself up for the test… all it does is tick a box that 
you’ve seen us, but nothing urgent has happened within those two weeks. 
Nothing medical or anything happened.” OG3 
Waiting time between the referral for the procedure and the investigation being done 
was generally perceived as acceptable. Two patients felt that private healthcare was 
an alternative if the waiting time had been unacceptable. One patient had sought a 
private opinion because the waiting time was too long. Another had private cover 
which they would have used if the wait “was lengthy I’d have jumped ship. But it 
wasn’t lengthy, so I stayed with the NHS appointment.” Patients preferred to be seen 
quickly following the referral so they could “get it over with.” A prolonged wait was 
perceived to increase anxiety about the test: 
“I didn’t have much time to think about it, which makes the procedure a lot 
better. I think the longer you’ve got to wait for it I think the more anxious 
people become.  So obviously it was easier… this time than it has been in 
previous times because I didn’t have that wait.” OG6 
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If the time to test differed significantly from expectations this also caused anxiety. For 
example, if the test was sooner than expected these patients inferred that this could 
mean a more serious outcome was anticipated:  
“You realised, you know, you were rushed through the system, um and it had 
to be something serious the matter, but at the time I was thinking ‘we’ll sort 
the bloods out, everything will be fine.’” CO10 
“But he was going to do us anyway within the two-week pathway in any case. 
But when you get it that quick you think oh does he think it’s something 
serious, because it was quick.” OG6 
A few patients in all procedure groups described cancellation and subsequent 
appointment rearrangement by the hospital. When this occurred, patients were sent 
a cancellation letter and an alternative appointment, which was usually at a later 
date: 
“I don’t know if it was one or two months before my appointment, and they 
said unfortunately due to circumstances it had been altered and, I don’t know 
if it was at least a month more I had to wait to have it done.” CO3 
The effect of appointment cancellation on patients appeared to be related to the 
impact on the waiting time for procedure. While most patients had no problem with 
the cancellation, a few felt it prolonged the waiting process and increased their 
anxiety.  
The convenience of the appointment for the procedure was also raised. Patients 
generally felt able to phone the department to rearrange their appointment if it didn’t 
suit, however; some patients were only able to rearrange it for the same day in a 
different week. For some this was problematic due to their own work or home 
commitments. For those undergoing OGD or colonoscopy, this brought up the issue 
of choice regarding appointment time versus having a specific endoscopist do the 
test. Some patients prioritised having the same endoscopist who they had seen in 




“I suppose in a way if there was another specialist that could have done it, 
rather than if there’s only, I mean I don’t know if there is but rather than just 
relying on Mr X to do it. So I suppose that would be a good thing from a 
patient’s point of view, if there’s another specialist that can do the same thing 
on another day.” CO2 
In terms of appointment time preference, most patients stated that they would prefer 
a morning appointment. The reasons for this included: a perception that it is easier to 
park at the hospital in the morning, fasting overnight is easier for a morning 
appointment, a perception that waiting time is likely to be shorter in the department 
(as there is little opportunity for the clinic to be running late) and less time to worry 
about the test on the day.  
4.4.2. Information before the test: information about the test 
All patients stated that they were given information about the test prior to the 
procedure, including; information about the test itself, the necessary pre-procedure 
preparation/diet and the risks of the test. Patients felt that being informed about the 
test reduced their anxiety prior to attending and on the day of the procedure. Most 
information was given in written form. Some patients were also given information by 
the person who referred them for the test. A few patients who had written information 
would have preferred a more detailed discussion with the person who referred them 
for the test, rather than in written form:  
“So I think… the doctor sending you for the referral should tell you why you’re 
going for it, and what it will entail, and then you’re in the loop sort of style… 
Instead of sitting there thinking what the hell’s the matter with us? You’re 
worried about it. You start worrying and you’re worried all the time, then you 
go down there so if you’re worried when you go you’ll tense up.” OG2 
 
“I think it's nice to speak to somebody personally… because a lot of people 
don't know what to expect and I think if you have someone talk to you 
beforehand, it [expectation of the test] would be fine.” CT6 
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Opinions on the written information about the test were varied. Most patients seemed 
satisfied with the written information they had been given, stating that it enabled 
them to prepare for the test.5 
“It was very, very good information. I'm glad I had a bit of paper to read on 
what was going to happen, what to expect when you come and what'll happen 
and they tell you all that's going to happen.” CT6 
Some patients noted that more information about what would actually happen during 
the test, how the test might feel and how they may feel in the days after the test, 
would have been useful. Others felt that the information sheets were conflicting or 
confusing and some thought too much irrelevant information was included. In 
particular, some patients felt that the CTC information did not explain the test fully 
and the test differed significantly from their expectations as a result: 
Int: “Do you think you had enough information before the test?”  
Pt: “No. Not for the CT no. I thought… I was just gonna go and stand in front 
of an x-ray machine, but once she said you’re taking your clothes off right 
down to your socks, and putting these two dressing gowns on, I knew I was in 
for something totally different! (chuckles) I didn’t expect the camera or 
anything at all for that fact.” CT3 
A few patients said that they did not read the information they were given, most 
commonly those who had previous experience of the procedure: 
“Because I've already done it, I felt I didn’t need to read it. And whatever was 
written there I had gone through and I knew why I was having it done.” OG15 
Another patient did not read the information as they felt it would put them off 
attending for the procedure and they ‘didn’t want to know.’ 
Pt: “I had all the information on the tests saying what was going to happen 
yes. To be honest with you I didn’t particularly read through it.”  
Int: “Why not?” 
                                            
5 Written information varies between hospitals: interviewees were from a single site 
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Pt: “I was just I’ve got to go, I’ve got to go, I’m not going to read this to put 
myself off. Aye and somebody says if you read that you’re going to put that 
down your throat. I would think I’m not going.” OG7 
In addition to information from the hospital, some patients sought information 
elsewhere. Of those undergoing OGD, several spoke to friends or family members 
who had undergone the procedure. The majority of these patients ‘wished they 
hadn’t listened’ to other people as they tended to tell ‘horror stories.’  
“You hear horror stories about people trying to rip the cord out but I’m sure 
they exaggerate. People like that exaggerate and I know that. I didn’t, I try not 
to take notice but, you do let the nerves build up on the day.” OG3 
“It’s not as bad as what people think. There’s always people that makes it out 
to be worse than it actually is.” OG1 
One patient felt less nervous about the test after speaking to others as they realised 
it was ‘just routine.’  A few patients turned to the internet for information and said this 
helped them know what to expect. Some patients described avoiding the internet as 
“sometimes you can Google it and you’ve got two weeks to live!” One patient looked 
at images of potential pathology and was reassured during the procedure when he 
did not see this on the monitor. 
4.4.3. Information before the test: alternatives to the test 
A few CTC and OGD patients were told of an alternative to the proposed test. For 
those who had CTC, some described choosing or being offered CTC instead of 
colonoscopy. For OGD, some patients were offered this via a transnasal route rather 
than the oral route. One patient described the reason for choosing CTC over 
colonoscopy because she “want[ed] the easiest one possible… I’m a coward!” One 
patient felt she was only offered CTC as an alternative to colonoscopy because she 
had expressed reluctance to undergo colonoscopy at the initial clinic appointment:  
“Well she [the doctor] was just starting to describe what a colonoscopy was 
and… I sort of interrupted and said well I’ve already had one a few years ago 
and I think she picked up on the fact that I was quite reluctant to have another 
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one unless it was absolutely necessary and that was when she explained that 
there was an alternative if I would prefer that.” CT8 
Similarly, two patients who had transnasal endoscopy described being given the 
option between this and OGD at an appointment with a hospital consultant. The 
choice was based on previous experience: 
“For me it [the OGD] was awful. So when they gave me the option of going 
through the nose, I thought well, the tube has to be smaller going through the 
nose than it does going straight down the throat… so I thought I've got to 
have it done... I'll try that [transnasal].” OG15 
Of the two patients who opted for transnasal endoscopy, they chose this as it was 
perceived to be easier, with a thinner camera: 
“I'd had a test previously, but 35 years previously, and that was the big tube 
down the throat. And that’s, whilst it was uncomfortable, it certainly wasn't 
terrible. But I expected this to be easier. And I was proved right, it was fine 
both times.” OG13 
Others were happy to proceed with what the doctor recommended as “doctor knows 
best.” One patient described being told that the “camera test” (i.e. colonoscopy) was 
always more accurate than CTC, but said that the referring doctor felt that CTC 
would be easier in her case: 
“I wouldn’t say I was given the option, but then again I didn't push for an 
option. I just took his word for it. He explained it to me. He said the camera is 
better. It's very accurate, but I think this would be less invasive for you. He 
said I can do it with you having a larger BMI, not a problem and I've never had 
a problem. But I think for you it might be easier. Because he knew I 
sometimes get problems with anaesthetic and things like that.” CT6 
Two OGD patients described being aware that there was choice to have the 
procedure done transnasally, but that this was either not made available to them or 
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they could not choose this on the day of the procedure6. One patient who had the 
test transnasally was referred by their GP and expected to have a standard OGD. 
When they phoned to make the appointment, the staff told them “they’re going to go 
down your nose and it’s not as invasive.” The patient was satisfied with this.  
4.4.4. Information before the test: risks 
Several patients described being made aware of the risks of the procedures both 
verbally by the referrer and in the information leaflets they were given prior to the 
procedure. The general attitude to this was that the test ‘had to be done’ which 
justified the risks: 
“And obviously I know there's radiation involved. My friend's got a thing about 
radiation killing you and things like that; whereas me, I've never had anything 
done. I've had a couple of chest X-rays and I think over your time of life 
sometimes you've just got to do it, haven't you? …. So I was just a case of OK 
this needs to be done. That was all how I felt about it, so I was all right with it.” 
CT6 
4.4.5 Preparation for the Test7 
One patient did not read the information for the test and therefore did not fast 
appropriately, meaning he was turned away on the day of the test. This patient felt ‘it 
was my fault’ and was impressed that the hospital rearranged the appointment for 
later in the same day.  
Patients referred for colonoscopy and CTC stated that they found the diet 
beforehand very restrictive and the information about this was sometimes conflicting 
or confusing in terms of what could be eaten. Some commented that recipes or meal 
plans would be helpful in planning their pre-procedure diet. Patients were often 
                                            
6 TNE is not available in all hospitals. At the site where the qualitative interviews 
were conducted this can only be undertaken by certain endoscopists. 
7 Pre-procedure preparation varies between tests. Patients undergoing OGD need to 
fast for a period of time, whereas those undergoing colonoscopy and CTC adhere to 
an altered diet followed by laxatives and a fasting period. 
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anxious that their bowel preparation wouldn’t work and as a result some patients 
commenced the diet earlier than required: 
“I probably started the dietary instructions maybe two days before their date 
because of…my same test five years previously [where preparation hadn’t 
worked properly] I thought oh I’ll give it an extra couple of days just in case.” 
CO9 
The laxative drinks before the test were described as ‘disgusting,’ ‘horrible’ and 
‘bitter.’8 Those undergoing colonoscopy in particular ‘struggled’ with the volume of 
liquid: 
“Oh, I didn’t want to look at another piece of liquid again! It was just one 
tumbler after another and you were clock watching because you’re thinking I 
should be drinking this, now I need to drink the water.”CO3 
Both colonoscopy and CTC patients described the effects of the laxative preparation 
as ‘severe.’ Some felt that neither the written nor verbal pre-procedure information 
prepared them for the extreme effects of the drinks:  
“When it said you may have diarrhoea, that is just not enough to tell people, 
because I had four sets of leggings on. All over my toilet, all over my floor, I 
had to wash everything – I was in a right mess with it. So I think they need to 
prepare people a lot more for that.” CT6 
Some patients found that the first dose of the laxative drink had no effect.  
“And when it came to taking the mixture for to get things going, you had two 
50ml glasses of stuff to take two days running, and the first day when I took it, 
nothing really happened. And I was getting a bit concerned because obviously 
your interest is as far as the clinical side is to have a real clear view of the 
bowel like to make sense of the thing.” CT10 
This caused anxiety in relation to affecting the quality of the examination.  
                                            
8 Less volume is required for the preparation before CTC than for colonoscopy  
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4.4.6. Anticipation of the procedure 
The most common topic when talking about before the test was anxiety. Patients 
were worried about the test itself, often because they didn’t know what to expect or 
were worried about discomfort. In general, those with previous experience were less 
anxious:  
“When I first started getting it [having regular colonoscopies], I was a bit 
apprehensive because it’s all new but after 20 years it’s just like water off a 
duck’s back to be quite honest. It doesn’t bother me whatsoever now.” CO4 
A patient who described a previous bad experience felt this made her more anxious 
about the procedure:  
“I was frantic, because I thought it would be no different. I thought it would be 
no different to what the first one was.” CT2 
OGD patients were concerned about swallowing the tube and feeling sick or retching 
during the test. Colonoscopy and CTC patients were worried that the preparation 
would not have worked correctly. For a few patients this was because they felt 
embarrassed at the thought and others were worried that the bowel may not be clear 
enough to allow the procedure to be completed.  
Other patients in the colonoscopy and CTC groups described feeling embarrassed in 
anticipation of the test. This related to the part of the body being examined: 
“I think basically it all boils down to that I’m slightly embarrassed. You know, 
it’s eh, private things getting poked about I suppose, you know?” CO1 
A few patients described feeling anxious about “following through,” during the test 
because of the preparation (i.e. opening their bowels).  
Some patients in each group described feeling anxious about the results even before 
they had attended for the procedure. One participant who had a non-GI cancer in the 
past said that they were frightened about the possibility of finding cancer:  
Int: “how did you feel when you were told you were going to have the scan?” 
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Pt: “A little bit, well frightened in case it had come back for the third time 
because, you know, you get people who get it once and twice, but three times 
I would’ve just given up then.” CT4 
4.4.7. Arriving at the hospital 
All patients arrived by car or public transport to the hospital, although some 
mentioned that patient transport was available had they needed it. Hospital parking 
was described as expensive and difficult to find a space. CTC and colonoscopy 
patients had concerns about getting to the hospital due to ongoing laxative effects. 
“I think I got halfway down the road and I knew I had to go back for a change, 
which wasn't pleasant. I know I was a bit concerned about the time.” CO8 
The staff in all areas were described as ‘welcoming’ and ‘friendly.’9  Patients said 
that staff guided them through each stage of the procedure whilst there: 
“It's really taken out of your hands because when you go to the reception 
they're there, they take the forms off you. They tell you where to go. They 
come and get you and everything's, it's just taken out of your hands really; 
you've got no worries as such. You just sit there and wait for them coming. So 
I think they're pretty good.” OG10 
4.4.8. Waiting in the department10 
Some CTC and colonoscopy patients were unhappy with the hospital-provided 
gowns as they did not close or cover them adequately: 
“Well, the CT scan, you're requested to go into a cubicle, get your kit off, put a 
gown on, which the gowns are hopeless – they're useless because half the 
strings are missing, so how do you fasten them?” CT5 
                                            
9 Patients who attend for OGD and colonoscopy have routine observations such as 
blood pressure and heart rate checked by a nurse. 
10 Colonoscopy and CTC patients were encouraged to bring their own dressing gown 
to wear over the hospital gown, whereas OGD patients did not need to get changed.  
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Two colonoscopy patients said they felt that someone could have walked in to the 
changing room, but all other patients said that the changing areas were sufficiently 
private.11   
Some patients were satisfied that the waiting areas were sufficiently private, but 
others who had to wait in gowns had concerns about privacy and dignity. Some 
patients described the waiting area as being on a public corridor. Others spoke about 
how one waiting area was mixed gender with family members and friends able to 
wait with patients. Some patients did not like this:  
Pt: “There are husbands and wives and you're sitting waiting with just your 
dressing gown on and this silly little Wee Willy Winky night gown on.” 
Int: “So what do you think about that?” 
Pt: “Well, I think I'm too old to be embarrassed, but the thing is I think other 
people can be embarrassed and so you have to be very careful for your 
dignity.” CT5 
Waiting with others made a couple of patients feel more anxious and these patients 
expressed a wish for more private waiting areas. A few patients indicated that they 
would have preferred to be taken straight to the procedure after changing to prevent 
having to wait in communal areas when wearing a gown. 
“What I found was a bit discomforting was… I’m very open, I’m very liberal 
minded, but it was the joint male-female waiting room. And people were, 
some people had like the gowns on. So that was a little bit off-putting.” CO9 
When it was time to move from the waiting area to the procedure room, some 
patients described having to walk through a busy public corridor to get there. Most of 
those wearing gowns found this embarrassing and expressed a preference for the 
procedure room to be beside the waiting area: 
Pt: “But the main thing I didn’t like was once you got changed into your gown, 
your surgical gown, then you had to walk along the public corridors to the 
                                            
11 CTC patients stated they got changed in a private cubicle, whereas colonoscopy 
patients were taken to a changing room which could be locked. 
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examination room. If anything you could change about that that would be 
better. I did find that a bit off-putting, a bit discomforting.”  
Int: “What about that was discomforting? “ 
Pt: “Just everybody could see you. You’re basically in a dressing gown 
walking down a corridor.”  
Int: “And what do you think could be done to, so what would your ideal 
situation for that be?” 
Pt: “Ideal situation would be if you could go into a changing room, get 
changed there and then you walk directly into a procedure room.” CO9 
Some patients described being unable to find a seat in the waiting room because it 
was too busy.  
“Well, to be honest with you, the worst thing about the whole thing was the 
waiting room's never got any seats in it. And that's the honest truth. So I had 
to stand in the corridor both times.” OG13 
Patients having endoscopic procedures said that they were given a locker to store 
their belongings, however, CTC patients had to carry their belongings. For some, 
they were unsure what to do with their things: 
“You get changed and you've got to carry your clothes around with you. There 
should be accommodation whereby…you’re taken and you get a locker and 
you put your stuff in the locker, then you’re escorted back to that locker and in 
that area; whereas, you haven't to carry – it's like the bag lady, you know, the 
bag woman on the streets. It's more archaic, as opposed to not being patient 
and area friendly.” CT5 
The waiting rooms were generally described as ‘functional’ and ‘pleasant’ with 
distractions including television and magazines. A few patients felt that the waiting 




Patients described anxiety whilst waiting for the test in the department, with one 
describing it as ‘like waiting for the firing squad.’  This was exacerbated in some 
cases by a longer waiting time than had been expected:  
“I did find I was getting more anxious in that waiting time…. yeah.  A bit 
anxious. Just wanted it to be over as quickly as possible. And I may have 
been in there for about an hour and a half, two hours or something. Again, it’s 
not a complaint, I wouldn’t complain about that. I just found I was getting a bit 
agitated waiting to go in. I wanted to be in and out, you see.” CO1 
While all CTC patients were satisfied with their waiting time (which did not exceed 20 
minutes) some of those who had OGD or colonoscopy waited for over two hours. 
Patients said that they expected long waits in the department. Some patients said 
that being updated by staff about delays was helpful. One patient was unhappy that 
they had not received an apology for the delay in their procedure:  
Interviewer: “What time was your appointment?” 
Pt: “It was about half past two and they called me down at half past four, 
quarter to five. And I hadn't had anything to eat since eight o'clock the 
following [previous] morning. And all you can have is water or clear liquids. 
And that wasn't very good. And I've never got an apology for that. Apparently, 
I mean they admitted there was an emergency, but surely they can do 
something?” CO7 
4.5. During the Test 
4.5.1. Medication12 
Some OGD and colonoscopy patients said they would have liked more written 
information about the effects of the medications and examples of situations where 
each option may be preferable. Patients said that they did not always know what to 
                                            
12 Patients undergoing CTC are sometimes given an injection to relax the bowel 
(Hyoscine butylbromide)- this is not a sedative and is not optional. Those undergoing 
OGD may have the option of no preparation, throat spray, sedation or both. 
Colonoscopy patients may choose sedation or use ‘gas and air’ (Entonox). 
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expect from sedation and a few asked acquaintances with experience before the day 
of the procedure.  
Patients who opted not to have sedation said they had done so because it was more 
convenient. They thought that the recovery would be easier and quicker; they would 
not need someone to stay with them after the procedure and they could drive 
afterwards. However, a few of these patients acknowledged that the procedure itself 
would have been easier had they had sedation:  
 
“It may have made it easier for the two minutes the camera was down but it 
wouldn’t have made it easier recovery for the rest of that day, so to speak. 
And with regards to having the spray, like I say, I was picked up from here 
and I was back to work within half an hour.” OG3 
 
Several patients said that having undergone OGD with throat spray, this was 
sufficient. Before having the procedure they expected that it would ‘numb the throat.’ 
Some described the taste as sickly and the effects varied between patients; some 
spoke about not being able to feel endoscope insertion but others could still feel this 
(described in section 4.5.3.) One patient with previous experience of the test opted 
against throat spray as it caused a choking sensation:  
 
“I didn’t want the spray down my throat. I’ve had experience and it’s the worst 
experience ever. You feel like you’re choking to death.” OG6 
 
Patients who chose sedation said they expected it to make the procedure easier but 
were unaware of what precisely to expect in terms of how they would feel. Patients 
hoped they could ‘float away’ and that it would ‘take the edge off’ or that they would 
not remember the procedure. One patient had hoped they would be ‘knocked out’ 
but understood that this was not possible.  Some patients saw sedation as the ‘easy 
option’ but some patients would do anything to make the procedure easier. Others 




Three OGD patients felt that staff would prefer them to have throat spray rather than 
sedation. This did not influence their choice. This impression was an inference rather 
than verbal instruction given by staff.  
 
“But obviously I know they don’t like to give you it [sedation] because 
obviously they’ve got to keep you in a bit longer and you’ve got to have 
somebody to look after you. I understand that, but if it makes my experience 
better I don’t care personally.” OG6 
 
One patient chose both throat spray and sedation for OGD. She felt that staff had 
seemed surprised by this and thought this dual option could be made clearer to all 
patients. Another patient who had opted for sedation was surprised to be given 
throat spray in addition. This patient would have preferred to have a discussion 
about this before proceeding:   
“The nurse said to him [endoscopist], she’s not having throat spray she’s 
having sedation, and he just said well she’s getting both. And I just thought 
well why? And by that time it was open your mouth and swallow… I still don’t 
know why I had to have both.” OG11 
The effects of sedation varied between patients and sometimes differed from their 
expectations, with some patients not remembering the procedure and others feeling 
they had not had enough sedation (‘I don’t think I was sedated at all… or very 
mildly’). One patient who had previously had a colonoscopy with sedation said that 
the sedative did not seem to work as well on their most recent test.   
4.5.2. In the procedure room 
Patients described the procedure rooms as ‘functional,’ with some feeling that the 
rooms could be made more relaxing with music or dimmed lights. A few patients 





4.5.3. Staff interactions 
Patients spoke about the atmosphere in the procedure room and how staff attitudes 
and actions made them feel. Patients described how a ‘jovial’ or ‘teamworking’ 
atmosphere put them at ease.  
“There was no I’m a doctor, you’re a nurse, you’re the patient- it was one 
family with him. He kept everybody going and everyone was relaxed. The 
nurses were relaxed, cos you were with a doctor who was relaxed. So nobody 
was nervous because no one was running around. It was a good atmosphere- 
that helps.” OG2 
Examples of poor communication included failure of staff to introduce themselves or 
provide any explanations of the procedure or what would happen and staff 
discussing unrelated topics. This made patients feel like “something else he’d [the 
endoscopist] got to get through in his working day.” An example of perceived poor 
communication clouded the entire impression of the experience for one patient: 
“And again when coming back the nursing staff were, they were lovely, all of 
them. There wasn’t one that I could say wasn’t. But my lasting impression 
from having this gastroscopy will be the consultant which is unfortunate.” 
OG11 
Patients stated that having the endoscopist (or radiographer) talk through what was 
happening during the procedure put them at ease. 
 “They know the situation. They know what they’re going to tell you is pretty 
accurate. They can foresee it before it happens so it's taking away the 
unknown from people and I just felt that that's what they did.” CT6 
Overall, nursing staff were described as ‘fantastic,’ ‘friendly,’ ‘professional’ and 
patients spoke about how they played a large part in ‘distracting’ them from the test. 
Several patients described how nursing staff ‘took care’ of them by reassuring them, 
giving tips on how to cope, helping them to change position and distracting them with 
jokes or conversation.  
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One patient said that nurses were important for monitoring comfort and reporting 
back to the endoscopist: 
“She [the nurse] could say excuse me, but can she have some more 
[sedation] because it's really hurting her.” CO7 
Nurses were also perceived as helping to protect patients’ dignity, for example, 
ensuring patients are ‘all covered up.’ The majority of patients described the positive 
effects of staff, however, one patient who struggled to retain air during a CTC13 
described how staff made them feel like they had been ‘bullied’: 
“And one of the nurses was shouting at us because I couldn’t hold the air in 
that they’d put in so she was shouting because the other nurse was saying it’s 
all right. But by this time I just wanted to go home. I wanted to get out.” P2 
Opinions on who should do the test were varied and one patient described their 
overall preference as someone who was ‘competent.’  One patient had expected a 
trainee but their procedure was done by a consultant; they were content with the 
prospect of having a trainee as they “have to learn.” One female patient worried that 
a male staff member would be doing her CTC. In both lower GI procedures sex was 
raised in relation to embarrassment; no patients described having had a choice of 
the sex of the endoscopist: 
“It would have been nice to have a female, yes, but I suppose it’s the same as 
a man going and he gets a female doctor when it’s his anatomy and he 
doesn’t want to show it to a female, he’s embarrassed. So it would have been 
nice if there had been a choice of a female specialist, so that would have 
definitely, I would have preferred that.” CO2 
Some patients said that they would have preferred to have the procedure conducted 
by the same endoscopist who had referred them for the test; they felt that this 
endoscopist would already be acquainted with their case and had built a rapport with 
them. In contrast, other patients said that they would prefer to have the procedure at 
                                            
13 Inflation of ‘air’ (carbon dioxide) is required for CTC to inflate the bowel and enable 
the lumen to be visualised 
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a day and time that suited them rather than wait until the endoscopist whom they had 
already met was available.  
4.5.4. The Test 
The experience of the test varied between procedures and patients described both 
temporal and physical aspects. Patients’ reports on the physical experience of the 
test differed across the three procedures (see 4.5.5 – 4.5.7). Some patients who had 
sedation could not remember anything about the procedure. Irrespective of 
procedure, patients were often unsure about how long the test would be likely to take 
and some, mainly in the colonoscopy group, spoke about how it seemed like it was 
“going on forever.” Others, particularly in the CTC and OGD groups, said the test 
was “over quickly.” These patients spoke about how inserting the camera was quick 
but that it took a longer time to remove it. Patients said that being told at the 
beginning how long the procedure would take made things more manageable for 
them: 
“She [radiographer] said the whole [procedure] will take about just under 
twenty minutes which it did. So I knew I just had to suffer for twenty minutes 
and that was it all done.” CT3 
Patients in all procedure groups described being embarrassed during the test. Some 
OGD patients described vomiting during the procedure and they spoke about how 
they were embarrassed about their lack of control over their reaction.  
“The water that comes up and everything it's embarrassing for me. I think 
that's the worst of it all for me. But it's part and parcel of it isn't it? If that bit 
didn't happen it would be great.” OG10 
In the CTC and colonoscopy groups, embarrassment was related to the nature of the 
procedure: 
“Em, it’s hard to put it into words, really. I think basically it all boils down to 
that I’m slightly embarrassed. You know, it’s eh, private things getting poked 
about I suppose, you know? Women might go through a lot more than men 
do, but I was a bit embarrassed like, you know? Might sound silly.” CO1 
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A few patients said that the sex of staff affected their embarrassment.  
Pt: “I’m saying that it’s embarrassing but these nurses have got to do it day in 
and day out so to them it’s nothing but to me it was, I felt embarrassed. I 
shouldn’t have been but I’m just stupid.” 
Interviewer: “What did you feel embarrassed about?” 
Pt: “About a young girl having to put her fingers into my bottom, that’s the only 
thing; it’s very embarrassing. I was thinking more embarrassed for her having 
to do it, but when you think about it it’s her job and they do it all the time.” P4 
Patients in the colonoscopy group described being given ‘dignity’ shorts to wear 
during the procedure, which they viewed positively:  
“I just had a gown on. You know, that was the first time I had it done. But the 
second time, they gave me these knickers with the slit up and I thought that's 
a lot of better. That's a lot more dignified.” CO7 
CTC patients were not given dignity shorts, but one patient who had undergone 
colonoscopy in the past thought that having dignity shorts for CTC would have 
reduced their embarrassment. 
Patient reports on the physical experience of the test differed across the three 
procedures. 
4.5.5. Sensory experience of the test: OGD 
Prior to endoscope insertion, OGD patients stated that a mouthguard or “dummy,” 
was inserted into their mouth if they were having the test orally; this was generally 
perceived as unpleasant.  
“And the clamp in the mouth, that's not very easy to deal with.” OG9 
OGD patients felt that “swallowing the camera” was the hardest part of the 
procedure. Some patients felt that it was their responsibility to ensure they 
swallowed the camera, rather than that of the operator:  
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“The camera was going down and you’ve got to swallow it- you’re dead dry, 
you know, trying to get this thing down. Once it’s in, honestly, if you breathe 
properly and do what you’re told you don’t feel it.” OG2 
Although patients undergoing transnasal OGD did not describe needing to swallow 
the camera, insertion of the camera by either route was portrayed as unpleasant, 
with common descriptions of “gagging,” “retching” and “choking.” Transnasal patients 
described a “strange” feeling in the nose. OGD patients described the test as “not 
pleasant,” and “uncomfortable.” 
“It just feels like you're swallowing a grape whole or something like that. Yeah, 
so like it's just like a grape or a cherry or something like that at first. But 
obviously it's not that size, it just feels like that.” OG10 
“it's just natural to try and get rid of whatever's stuck in your throat. And I know 
that you can't because it's there, but your body just automatically - and it's 
hard to try and stop it. So I'm trying to get it out, but trying to stop myself at 
the same time. And then the nurse is trying to keep your head straight and 
there's stuff coming out all over. But it's got to be done. It's got to be done. 
And I just kept thinking that. My eyes tight shut. It's got to be done. It's got to 
be done. And in a minute it'll be gone. And then it's finished.” OG15 
(transnasal) 
Some patients said that the discomfort they experienced was due to air being 
inserted. A few patients who underwent biopsies described feeling pain as the biopsy 
was taken. 
Some patients said that they knew the test could be stopped if needed, either by 
signalling to the staff or by the nursing staff picking up that they were not tolerating 
the procedure, and this made them feel reassured: 
“She’s (the nurse) there all the time and she says if you feel discomfort, put 
your hand up and I’ll stop it. And it’s her that reassures you and relaxes you, 
so when you’re on the table, the talk she’s just given you know she’s there to 
keep an eye on you.” OG2 
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Patients felt reassured by this.  
4.5.6. Sensory experience of the test: Colonoscopy 
Colonoscopy patients described how they had gel inserted rectally prior to 
colonoscope insertion, and that this was a “cold shock” and embarrassing to some. 
Some described discomfort as the colonoscope was inserted, while others felt 
nothing:  
“It’s just actually the penetration if that’s the word I’m looking for. It’s probably 
that but once it’s inside it’s great. He waxes it, what do you call it? He oils it, 
so it’s, you know, he’s very good and, as I say, you get a few twinges when 
it’s going in, I can feel it, but of course they fill you full of air so you get a feel 
of pains but that’s the air doing that to you.” CO4 
The physical feeling during the test ranged from “cramps” and “twinges” to “painful.” 
Patients who spoke about pain said that it tended to come and go throughout the 
procedure; they attributed the pain to air being pumped in and the camera going 
around bends. They described how nursing staff sometimes pressed on the 
stomach, which made pain worse.  
Patients in this group described being able to stop the test, with two patients doing 
so. Having the endoscopist talk during the procedure and prepare them for 
discomfort helped some patients to cope with more painful parts, with one patient 
also describing how the endoscopist checked that they were happy to continue the 
procedure:  
“He (the endoscopist) talked all the way through the procedure and he told us 
that it was going to be painful going round a bend. I found it uncomfortable 
and he says is that all right?  I says yes. Can I proceed? Yes. So everything 
was all explained, he even explained parts of the bowel and everything.” CO5 
Patients also spoke about how they found the procedure easier when staff pre-
empted possible discomfort and increased their sedation.  
“They give me some medication. It begins with ‘B’, I can’t remember what they 
call it, but anyway. He put some in but he knew I was in a little bit of pain. But 
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I didn’t even have to ask him, he knew and he just topped it up again a little bit 
and after that it was fine.” CO4 
Conversely, one patient described the endoscopist continuing despite her obvious 
discomfort and wish to stop, leaving her feeling like a “piece of meat on the bed.” 
 “He wasn't explaining he was going to have to go around a corner and it was 
going to hurt. He [was] just totally, get on with it, she's had one dose. Leave 
her to it; that should be enough. It wasn’t enough.” CO7 
Only one patient described being given gas and air (Entonox, nitrous oxide) during 
the procedure; they did not feel this helped with pain control. 
4.5.7. Sensory experience of the test: CTC 
CTC patients spoke about having “jelly” inserted rectally before a tube was inserted. 
Patients described gas being in “blown in” and described “severe cramps,” 
“discomfort” or a feeling “like a stitch.”  Gas insertion also made some patients feel 
they needed the toilet. One patient attributed their discomfort to dye being inserted 
intravenously, but most patients attributed this to air being inserted:  
“I felt bloated. Oh when the air, yes I felt it was very painful, but it were like 
bad wind, but because I get sort of twinges around the stomach area so I 
suppose it depends what’s that matter with you as to how you’re going to feel 
doesn’t it.” CT8 
Some patients spoke about how they had to change position and this was difficult for 
some because the bed was small; some described how nurses helped them with 






4.6. After the Test 
This stage of the process covered the time period from when the procedure was 
completed until after discharge. 
4.6.1. Recovery 
Following the test patients described returning to the waiting room or changing 
cubicle. Patients who had undergone CTC often described a feeling of needing to 
pass wind or use the toilet following the test. Some of these patients spoke about 
how the toilet that they could use after the test was immediately adjacent to a waiting 
room, which worsened their feelings of embarrassment: 
“They said just go in there and I’m thinking well I’m sitting and I thought God I 
can’t, there’s seats out there. What if somebody come and sat out there? 
Could you break wind when there’s people sitting out there and of course I’m 
sitting going, I panicked, get your clothes on there, go home.” CT2 
As a result of this, some patients waited until they got home to go to the toilet. Other 
patients described relief that they were taken to a private toilet away from other 
patients. A few patients didn’t feel the need to use the toilet or pass air until they left 
the department, whereas another few patients preferred to wait until they got home 
to use the toilet: 
“She said just take as long as you like. I think it was just in case this wind was 
going to come away from us. But it didn’t, it waited until I got all the way 
home! (laughs) And then I had to run upstairs to the toilet to get rid of it.” CT4 
Patients generally felt that the nurses “took care” of them while they were recovering. 
Aside from those who had throat spray, who were unable to eat or drink for a period 
after the test, all patients spoke about being offered a cup of tea after the procedure. 
For some this was the best part of the experience because they were thirsty and 
because it indicated that the procedure was over:  
Pt: “I'm impressed with the person that brings me a cup of tea afterwards 
because I'm so relieved, you know.”  
Int: “What is it about that cup of tea?” 
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Pt: “I'm going to start crying again. It's just the relief it's over.” CO7 
Some patients said they felt able to stay in the department for as long as was 
required to recover. Others noted that the recovery area was busy and, in some 
instances, felt pressure to leave: 
“Because I remember they knocked on the door and said are you finished? I 
went no, I'm not. And so therefore I think that time is enough, provided that it 
shouldn't be like a cattle market. It should be like if you say right, there's a 
benchmark for everything. If you say well OK then he's in there for half an 
hour, that's OK. So we can get the next patient in the time and just have a 
matrix, call it whatever you wish, and cross-check and just say OK, this one 
can go out now, instead of whoosh, whoosh, come on, out. At the end of the 
day, it's supposed to be patient care, isn't it?” CT5 
The physical after-effects of the test and sedation varied. While some patients said 
they felt back to normal almost immediately, others described feeling “wobbly” or 
“fragile”; and others spoke about ongoing cramps, wind, stomach discomfort or a 
sore throat. While most patients felt back to normal the following day, some 
described unexpected ongoing altered bowel habit and discomfort. This was 
unexpected and caused anxiety: 
“I expected to have diarrhoea for at least a day like, but not for about three or 
four or five days like. I don’t know if this might just have aggravated what 
problem I may have, I don’t know.” CT1 
A few patients who had undergone OGD spoke about discomfort in the throat for a 
day following the procedure. 
“It was like there was something lodged there and you got it free and it's a bit 
raw.” OG15 
A few patients who had throat spray also described a numb feeling in the throat for a 




4.6.2. Results and Follow-Up 
Patients spoke about how they preferred to have the results of their test immediately. 
Most who had undergone OGD or colonoscopy said they were told results either by 
the endoscopist after the test or by the nursing staff before they left the department. 
These ‘verbal’ results were not always detailed and some patients spoke about 
receiving a letter at a later date with more thorough results or biopsy results.  
Some CTC patients noted that the process by which they would receive results was 
not clear.14  
“They did say that I would get a copy of them, but I haven’t had that. So I’m a 
bit unsure whether I have to come back here for an appointment or whether 
I’d just be seeing my GP.” CT8 
These patients were often anxious about how they would get the result and what it 
might show: 
Interviewer: “How do you feel about that [waiting for the results]?” 
Pt: “Just a little bit worried: it could be something, it could be nothing. I think 
it’s just understandable to feel a little bit apprehensive.” CT4 
Pt: “I think obviously when you get tests like that and you’re waiting, you are 
tending to be a little bit apprehensive naturally. So that’s as far as it goes 
yeah.”  
Interviewer: “Apprehensive about what?” 
Pt: “Well just wondering if everything’s OK. And if it’s not what it’s [the result] 
going to be.” CT10 
Some patients in each procedure group, who hadn’t had results by the time of the 
interview felt that if something serious had been found then someone would have 
                                            
14 CTC patients never got their results on the day of the procedure. This is because 
following the procedure, the scan must be interpreted and reported by a radiologist. 
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contacted them. However, others felt they had to chase things in case they were 
“lost in the system.” 
Of those patients who had received their written results, some described these as 
confirming the verbal results, but a few wanted more information about their 
diagnosis and a follow up plan.  
4.6.3. Willingness to attend for future tests 
Most patients said they would have the test again if necessary, although a couple 
spoke about how they would prefer to change certain aspects (e.g. request another 
endoscopist, have sedation instead of throat spray). 
4.7. Discussion 
These interviews provided a detailed, descriptive account of aspects of the 
procedural pathway and revealed which aspects of the experience mattered to 
patients. This analysis did not set out to identify ‘factors’ that might influence 
experience since the primary purpose was to inform generation of topics and a 
question bank. Therefore, this is further research that could be undertaken.  
4.7.1. Key findings 
Six over-arching themes were identified; anxiety, expectations, choice & control, 
communication & information, comfort and dignity & embarrassment. These did not 
appear at every point in the procedure pathway; however, they were common across 
all procedures. This suggests it may be possible to develop a PREM that could be 
used for multiple procedures.  
Some sub-themes fell into more than one over-arching theme, suggesting that some 
of the over-arching themes were closely related. For example, the time from referral 
to the procedure date (subtheme: referral for the test) fell into ‘expectations’ and 
‘anxiety.’ Although a longer wait for the procedure appointment made patients feel 
more anxious, patients who received an appointment sooner than expected became 
anxious that this might reflect a potentially serious diagnosis. The subtheme 
preparing for the test fell into ‘expectations,’ ‘information’ and ‘anxiety.’ For example, 
when a CTC patient described that the laxative “mixture” didn’t work as he had 
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expected this caused anxiety that the procedure wouldn’t be able to go ahead. He 
noted that having appropriate information which managed his expectations could 
have prevented this anxiety. This has implications for questionnaire development, as 
basing questionnaire items purely on over-arching theme could result in questions 
being attributed to a single theme, where in fact they contribute to several.  
4.7.2. Strengths and limitations of phase 
This is the first time that patient perspectives across three different GI procedures 
have been explored using in-depth, qualitative methods. Qualitative interviews have 
been undertaken in GI procedures, however, these tend to focus on specific 
populations, such as Barrett’s oesophagus surveillance or colorectal cancer 
screening (von Wagner et al., 2009; Arney et al., 2014), or specific aspects of the 
procedure to enable comparison between procedure types, such as comfort in 
colonoscopy and colon capsule endoscopy (von Wagner et al., 2009; Thygesen et 
al., 2019). Furthermore, where more than one procedure type has been explored the 
results are analysed and described separately, rather than identifying themes 
common to all, for example; one study comparing colonoscopy, barium enema and 
CTC in a screening population (von Wagner et al., 2009). 
The qualitative interviews provided in-depth, descriptive accounts of the patient 
experience of GI procedures. Semi-structured interviews were used as this allowed a 
detailed description of the individual patient experience, where participants could 
speak more freely about sensitive areas. Indeed, patients did speak about sensitive 
issues, such as the insertion of the tube or camera, detailed descriptions of the 
effects of bowel preparation and discussion about particular issues which caused 
them embarrassment.  
Diversity was sought in several aspects, including; procedure, sex, age group, 
indication and outcome, in the anticipation that this would capture people who had a 
broad range of experiences.  Effort was made to ensure as full a range of eventual 
diagnoses were included, including those who received a cancer diagnosis, although 
only one patient with cancer was recruited. This was likely due to a combination of 
factors, including difficulty in scheduling an interview time when a new cancer was 
being assessed and the majority of participants were approached prior to their test, 
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meaning that the diagnosis was not known at the time of recruitment. Participants 
who had undergone transnasal endoscopy were also recruited to ensure the full 
breadth of OGD experience was explored, however, only three such participants 
were included. Most participants described a generally positive experience; however, 
two participants described a negative overall experience. This was despite effort to 
include participants who might have been more likely to have a negative experience, 
such as those with incomplete procedures. It may be that patients generally do have 
positive experiences, but the possibility cannot be excluded that those who were 
approached, or agreed to participate, were somewhat selected.  
A potentially significant limitation of this phase was that participants were recruited 
from a single site (STDH), and it is unknown as to whether additional issues may 
have been identified by including other sites. As noted above, participants in this 
phase were generally positive about their overall experience. It may be that this is a 
site-specific issue. The endoscopy unit from which participants were recruited is 
accredited with the Joint Advisory Group on GI endoscopy, meaning that it meets a 
number of standards across four domains: clinical quality, quality of the patient 
experience, workforce and training (Joint Advisory Group, 2016). 223 units (of 
approximately 454 in England) have full JAG accreditation, with a further 58 
assessed but requiring improvement in 2018 (Joint Advisory Group on GI 
Endoscopy, 2019). Some endoscopists in the unit also undertake NHS BCSP 
procedures and are as such required to demonstrate high quality colonoscopy, which 
could have a positive impact on experience. However, at the time of the interviews 
only two of twelve independent endoscopists were bowel cancer screeners and 
patients were recruited from all endoscopist lists (excluding BCSP lists). In terms of 
general experience, the hospital performs ‘about the same’ as other hospitals in 
England in the annual NHS inpatient survey, although this only addresses inpatient 
experience (Care Quality Commission, 2008). Potential differences between sites 
include pre-procedure information sheets, which are generally site-specific. Referral 
pathways may differ, for example, some sites may accept all endoscopy referrals as 
‘direct to test,’ whereas patients at other sites may be seen in outpatients first. At 
STDH there is a mixture of ‘direct to test’ and clinic referrals. Most endoscopy units 
give a written form of results when the patient leaves the department, although 
practice may vary. Furthermore, some units which operate ‘direct to test’ policies 
72 
 
may have pre-assessment for endoscopic procedures, which is where patients either 
attend an appointment with or are telephoned by a nurse to check they are fit for the 
procedure. This was not standard practice at STDH at the time of this study.   
The effect of recruiting from a single site was somewhat addressed by recruiting 
patients with prior experience of GI procedures at other hospitals, however, it is 
noted that while comparisons could be made, the interviews focused on the most 
recent test. 
All OGD and colonoscopy procedures in this study were undertaken by doctors, 
including gastroenterologists, surgeons and trainees. CTCs are undertaken by 
radiographers and nurses, usually without a doctor present. There are increasing 
numbers of nurse endoscopists both in the UK and internationally (Chapman et al., 
2009; Duncan et al., 2017). It would have been helpful to include patients who had 
procedures done by nurse endoscopists in the qualitative phase, however, there 
were no such endoscopists in the unit from which participants were recruited. 
Research in this area has shown that nurse endoscopists and doctors perform 
colonoscopies to an equal standard and a majority of patients have no specific 
preference for who performs the procedure (van Putten et al., 2012). No patients in 
this study brought up the grade or discipline of endoscopist as being important. 
Participants were approached by health professionals (research doctor or research 
nurse) and this may have affected selection or willingness to participate, for 
example, patients may have viewed participation as improving or adding to their 
management (although it was made clear that decision to participate would not affect 
clinical care). Participants who were especially pleased (or displeased) with their 
experience may have been more willing to participate, and this could have influenced 
the results. Staff were encouraged to approach all eligible patients on a consecutive 
basis, but this did not always occur. 
Using an inductive, data-driven analysis approach ensured that the themes were 
derived solely from the data. Review of the thematic analysis by the supervisory 
team and double-coding of a subset of interview transcripts strengthened the 
integrity of the analysis. The sub-themes that emerged from the qualitative interviews 
were presented chronologically as this was how most patients described their 
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experience. This order was then used as a template for the PREM in subsequent 
stages of the research.  
4.7.3. Discussion of findings in context of literature 
The findings of the qualitative interviews were reviewed within the context of the 
literature and current practice.  
4.7.4. Information  
The topic of ‘information’ arose several times across many sub-themes in the 
qualitative interviews. Participants described its effect on helping them to prepare for 
the test and knowing what to expect during the test. The British Society of 
Gastroenterology (BSG) guidelines emphasise the importance of written information 
prior to a procedure so that the patient is able to give informed consent (Beg et al., 
2017) In the current study, patients talked about the written information about the 
test and preparation, information given during the test verbally by staff and 
information after the test, for example, the results. Qualitative interviews comparing 
patient experiences of colonoscopy, barium enema and CTC corroborate that 
information provision is important to patients (von Wagner et al., 2009).  
4.7.5. Clarity and mode of information delivery 
A few patients in this study found that the written information leaflets were ‘confusing’ 
or contained either too much or too little information. All interviews were conducted 
at the same hospital in this study and therefore the patient information leaflets were 
standardised for each procedure, meaning that it is unclear to what extent the 
findings can be generalised to other sites. However, it was clear that patients had 
differing opinions on these standardised information leaflets, suggesting that patients 
have different requirements. Studies from both the UK and Ireland have shown 
significant variation in the amount of information contained in patient information 
leaflets for both colonoscopy and gastroscopy in different hospitals, and that the 
reading level often exceeds recommended reading age standards of 11- 12 years 
(Parahoo et al., 2003; Gargoum et al., 2014; Mason et al., 2018). Unclear or 
confusing information before colonoscopy is associated with increased anxiety (Luo, 
2013; Shafer et al., 2018). Approaches to improve pre-procedural information have 
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included written information interventions tailored to patient ‘coping’ style, web based 
interventions and videos explaining either the preparation or procedure (Morgan et 
al., 1998; van Vliet et al., 2004; Eberhardt et al., 2006; Bytzer et al., 2007), however, 
a combination of oral and written information appears to be preferable for pre-
procedural information when compared with oral information alone (Pearson et al., 
2005; Felley et al., 2008) but also for information about results following the 
procedure (Rubin et al., 2007). The results of the qualitative interviews in this study 
suggest that patients want different types of information and even different modes of 
delivery. The ideal would be to find a way to offer patients information which can be 
personalised to their needs in terms of what the information covers and how it is 
delivered. 
4.7.6. Information about sensory experience and effect on anxiety 
Some patients would have liked more information about how the test would feel (the 
sensory component of the test), how long the test would take, what exactly would 
happen during the test and more information about what the sedation would do. A 
previous study exploring OGD patients experience of written information suggested 
that such information should be expanded to cover what would happen during the 
procedure and sensory components of the procedure (Thompson et al., 2003). A 
further study showed that patients prefer to receive sensory information and in some 
cases this can reduce anxiety before the test (Liu et al., 2018). The concept of 
sensory experience is not limited to GI procedures and has been described, for 
example, in women attending for colposcopy who describe different aspects to the 
sensation of the test (O’Connor et al., 2016). This qualitative study also noted that a 
lack of sensory information affected women’s expectations and was linked with a 
negative sensory experience during the procedure. Therefore, providing information 
about what the test will feel like may play a role in letting patients know what to 
expect during their procedure.  
4.7.7. Alternative sources of information 
A few patients in this study said that they had looked online for information about the 
test. In general, this behaviour has risen over recent years with increased internet 
accessibility. Studies suggest that improvements in publicly available patient 
75 
 
resources are required (Koch-Weser et al., 2010; Amante et al., 2015). A study 
comparing information seeking behaviour between referral pathways and indications 
found that overall, 31% of patients with internet access searched for information 
about their procedure online (Silvester et al., 2016). In that study, patients with 
symptoms were more likely to seek information online than in screening patients. 
In this study, the qualitative interviews did not explore what sources of online 
information were accessed. One American study examining patients accessing 
healthcare noted that patients find accessing online information online frustrating and 
access a variety of sources, not all of which are credible (LaValley et al., 2017).  
Consistent with this, patients in the current study acknowledged that accessing 
online information was not always helpful and sometimes caused them to worry 
further about the outcome of the procedure. A study which administered a survey to 
haematology outpatients found that accessing internet information may increase 
anxiety in some patients (38%) but in others it can be reassuring (32%) and can 
improve coping (Laurent et al., 2012). This was not explored in such detail in the 
current study and may be an area for further exploration in patients undergoing GI 
investigations.  Regarding gastroenterology information online, a recent study 
assessing the quality of patient information leaflets on gastroenterology society 
websites (American College of Gastroenterology, American Gastroenterological 
Association, American Society of Gastrointestinal Endoscopy, British Society of 
Gastroenterology and National Institute of Diabetes and Digestive and Kidney 
Diseases) showed that no institute provided information at a suitable level for 
patients, in terms of reading level (Hansberry et al., 2017). In terms of endoscopy 
specific information on the internet, one study found that only three websites out of 
45 identified sites provided information of a satisfactory quality about OGD (Priyanka 
et al., 2018). Ensuring patients have access to adequate information is important, 
particularly given that the number of ‘open access’ referrals in the UK is rising, 
meaning that patients have their test without being seen by an endoscopist first in 
the outpatient department (Siau et al., 2017). Further areas of research may explore 
what patients see as trusted sources of online information and focusing on providing 




4.7.8. Communication  
Communication was very strongly linked with information in this study, and they were 
therefore incorporated into one over-arching theme. Patients described poor 
communication as having a negative effect on their experience, for example, staff 
failing to introduce themselves, not talking through the procedure or talking amongst 
themselves about unrelated topics. Furthermore, patients described staff attitudes as 
important. Staff could make the atmosphere in the room more relaxing and patients 
also gave examples of when staff negatively affected their experience. Several 
previous studies highlight the importance to patients of good staff communication, 
manner of staff and explanations by staff in OGD, colonoscopy and CTC (del Río et 
al., 2007; von Wagner et al., 2009; Sint Nicolaas et al., 2012; McEntire et al., 2013; 
Qureshi et al., 2013). 
4.7.9. Role of nursing staff 
The perceived role of nursing staff was commonly discussed by participants and was 
represented in four out of the six over-arching themes. In addition to giving 
information before the test, patients described nurses as having a role in protecting 
their dignity, distracting them during the procedure, helping them to cope with 
discomfort and monitoring them and feeding back to the endoscopist if they were 
finding the test too uncomfortable. Most of the literature describes the role of nurses 
as largely being about communicating and giving information to patients, and 
monitoring patients (Voynarovska et al., 2008). Nursing staff’s role in helping patients 
to manage pain using non-pharmacological methods has been described in 
colonoscopy (Ylinen et al., 2007). Outwith GI procedures, a UK study of patient 
experiences of prostate cancer care found that those who saw a specialist nurse had 
more positive experiences (Tarrant et al., 2008). Patients in that study felt that 
nurses had more time to explain results in a simplified way, were able to give more 
information and support and also had a role as the patient’s advocate. Although the 
latter was not described in the current study, patients did describe how nurses could 
intervene when they felt the patient was too uncomfortable, for example, and ask for 





Patients described anxiety about various stages of the procedures, for example, 
anxiety about what the test would involve, what the result of the test would be, how 
they would access their results and whether the bowel preparation would work 
properly (CTC and colonoscopy).  
In colonoscopy, one study examined specific aspects contributing to anxiety by 
asking patients to complete a survey in which they rated their levels of anxiety 
immediately prior to the colonoscopy appointment (Shafer et al., 2018). Patients 
were anxious about the bowel preparation, the procedure itself and the results. Since 
this was a quantitative study, the potential causes of anxiety were listed for patients 
to endorse and rate, rather than exploring patients’ anxieties in detail. The current 
study provided more detail about what aspects of the procedure caused anxiety and 
demonstrated that causes of anxiety were actually similar across all procedures 
(aside from concerns about the effects of bowel preparation, which were limited to 
those undergoing CTC and colonoscopy) and were evidenced across all phases. 
This means that questions within the PREM could examine anxiety in more detail, as 
described by patients. 
Within CTC, there is a relative paucity of literature exploring patient anxiety. One 
study asked patients undergoing CTC and colonoscopy as part of a randomised 
controlled trial to complete a diary, which included questions about anxiety. This 
found no significant difference in anxiety levels between procedures (van Dam et al., 
2013). The current study did not explore levels of anxiety but instead described 
several dimensions of anxiety which were common across all procedures.  
The role of information in reducing patient anxiety before the test has already been 
discussed, for example, information about the sensory experience of OGD has been 
shown to reduce pre-procedural anxiety (Liu et al., 2018). 
4.7.11. Effect of previous experience on anxiety 
In the current study, participants described two distinct reactions to previous 
experience and its effect on anxiety. A patient who underwent regular surveillance 
colonoscopies felt that the procedure was ‘routine’ and did not feel anxious, whereas 
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another patient who felt they had a previous bad experience of CTC described 
feeling ‘frantic’ before the procedure.  
Previous studies are inconsistent. One study that administered questionnaires to 
patients before and after colonoscopy found that previous colonoscopy experience 
had no effect on either pain during the current colonoscopy or anxiety prior to the 
procedure (Ylinen et al., 2009). Another study comparing the effects of video 
information on pre-procedure anxiety in patients undergoing colonoscopy 
administered Spielberger state trait anxiety inventory (STAI) questionnaires to 
patients a week prior to and immediately before the procedure (Luck et al., 1999). 
This found that patients who had not had a previous colonoscopy had significantly 
higher baseline anxiety scores than those with previous experience. A further 
qualitative study involving interviews with patients who were about to or who had 
recently undergone colonoscopy found that those with previous experience of the 
test described less anxiety as they knew what to expect from the procedure 
(Rollbusch et al., 2014). The current study identified this in patients who attended for 
the test regularly, but patients who had a perceived ‘bad’ experience previously were 
more anxious about the procedure.  
4.7.12. Reducing anxiety during the procedure 
A few patients in the current study mentioned that they would have liked to have 
music in the procedure room, or that they liked that music was playing. This has 
been well explored in patients undergoing colonoscopy, with studies finding that 
listening to music can reduce anxiety, reduce patient discomfort and reduce the 
amount of sedation required (Chlan et al., 2000; Lee et al., 2002; Binek et al., 2003; 
Ko et al., 2017). 
4.7.13. Anxiety about the test results 
Some patients in this study expressed anxiety about what the results may be after 
the test and how they might receive them, if they hadn’t already. A study randomised 
patients undergoing OGD or colonoscopy with sedation to receive standard verbal 
results or standard verbal results in addition to a copy of the endoscopy report 
(Spodik et al., 2008). The rationale for undertaking this study was that patients who 
received sedation may not remember being told the results. The study found that 
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patients who received written results reported significantly less anxiety (measured 
using the Beck Anxiety Inventory) than those who did not. This level of detail was not 
assessed within the current study’s qualitative interviews, but it is standard practice 
in the endoscopy unit where recruitment took place to give a written report after OGD 
and colonoscopy. For patients undergoing CTC, an immediate written report is not 
possible as the images need to be interpreted by a radiologist, which is time 
consuming.  
4.7.14. Embarrassment 
Patients in the current study described embarrassment at various stages of the 
procedure. For colonoscopy and CTC, embarrassment was reported when patients 
had to wait in public areas wearing gowns, during the procedure due to the private 
part of anatomy involved and after the procedure if they had to use toilets which 
were within earshot of the waiting area. Some patients felt the sex of the operator 
affected their embarrassment. 
Some work has been undertaken to compare embarrassment, associated with 
different procedures (e.g. CTC compared with colonoscopy) however, this work 
focused on overall embarrassment (Gareen et al., 2015). In the context of colorectal 
cancer screening, feelings of vulnerability and embarrassment in female patients 
were identified in a systematic review of the literature as a barrier to uptake 
(McLachlan et al., 2012). A further two questionnaire studies found that women were 
more likely than male patients to have a preference for an endoscopist of the same 
gender (Fidler et al., 2000; Shah et al., 2011). In the current study, men expressed 
embarrassment with regards female operators undertaking intimate procedures, 
suggesting this issue is not just limited to female patients. This appears to be a novel 
finding.  In order to explore this further in a PREM, questions about embarrassment 
and patient preference for endoscopist/ operator gender should be included.  
The literature focuses on embarrassment mainly with regards lower GI procedures, 
however, the current study demonstrated that patients undergoing OGD also 





4.7.15. Choice and control 
In this study, patients described having control over their choice when considering 
what test to undergo (e.g. colonoscopy or CTC) and what medication to have (e.g. 
sedation or throat spray for OGD). Control was also described in terms of being able 
to stop the test and the feeling that they were responsible for swallowing the 
endoscope (OGD). Although patient preferences have been investigated in patients 
undergoing GI procedures (for example, when comparing the acceptability between 
per-oral and transnasal endoscopy, Alexandridis et al., 2014),  patient perspectives 
of choice and control have not been explored in a detailed fashion. Involving patients 
in decisions about their clinical care and enabling patients to make choices relating 
to their management is a priority of the NHS in England (NHS England, 2017). The 
qualitative interviews highlight areas where patients describe the importance of 
choice related to GI procedures. 
4.8. Summary 
This phase of the study identified aspects of the experience that are important to 
patients and provided a structure for questionnaire item generation. Several themes 
emerged that are present in the literature; however, this phase provided more detail 
regarding aspects of these, such as anxiety and embarrassment. No themes were 





Chapter Five: Developing the ENDOPREM™ 
5.1. Aims of phase 
This second phase aimed to develop a pilot PREM. It involved two stages: a 
question bank was generated and initially refined by discussions within the study 
team, with areas of interest explored with a focused literature review; this was then 
further refined and finalised through cognitive testing with patients. 
5.2 Generating the Question Bank 
5.2.1. Determining question topics 
In order to generate a question bank, it was first necessary to determine what topics 
should be addressed in the questionnaire. The themes identified within the 
qualitative interviews were organised into chronological order according to stages of 
the patient ‘journey,’ as described during the patient interviews. Questions were 
derived according to the stage of the procedure. Review confirmed that the over-
arching themes were covered by questions within each procedure stage, further 
ensuring content validity. Focused literature review found no additional aspects of 
patient experience.  
The first iteration of the question topics is shown in table 5.1. The wider study team 
agreed on these areas broadly, however, question phrasing and some topics for 
inclusion/exclusion were debated in the review and revision rounds. Some 
explanatory questions were added as they were factors that might influence 
experience, for example: my appointment was cancelled or changed by the hospital 
(Yes/ No/ Not sure or can’t remember) and the person doing the test was 
male/female. In the early iterations, discussion centred mainly on phrasing of 
questions to ensure they encapsulated the patient experience as described by the 
qualitative interviews, rather than asking questions about service delivery. An 
example of this relates to the waiting room. An early draft of the question asked 
about patient satisfaction of the waiting area. The question was intended to ask 
whether patients felt comfortable whilst waiting. However, it could be interpreted as a 
question about the facilities rather than experience, and as such, didn’t fall within any 
82 
 
of the over-arching themes. It was therefore rephrased to ask about the extent to 
which patients felt comfortable whilst waiting.15 
                                            








Suggested Question/ Topic 
Participant 
Characteristics 
- - Age 
Education level 
Ethnicity 
Number of previous GI procedures 






- Expectations Experience of referral mode- e.g. referred directly or appointment 
with doctor in outpatients first 
 Information 
before the test 
- Information & 
Communication 
Was there enough opportunity to discuss the test before the day of 
the test? 
Were you able to discuss the test prior to the day of the procedure? 













- Choice & Control Were you able to change the appointment if it didn’t suit? 
 Alternatives - Information & 
Communication 
Were you told of any alternatives to the test? 
 Information 
about the test 
- Information & 
Communication 
- Expectations 
Did you receive enough written information before the test about: 
1. What would actually happen on the day 
2. What the procedure would involve 
3. How you may feel after the test 
Did you feel the information prepared you for the test? 
 Clarity of 
information 
before the test 
- Information & 
Communication 
Was the information before the test easy to read? 
Did you understand it? 
 Other sources 
of information 
- Information & 
Communication 
Did you talk to others about the test? 









Prior to the test, were you worried about what it might entail? 





- Information & 
Communication 
Was the information regarding the diet clear? 
Did you need any further information? 
 Taste of bowel 
preparation 
- Comfort The bowel preparation tasted acceptable/ was manageable 





Was the volume of bowel preparation more than you expected? 
 Effects of 
bowel 
preparation 
- Expectations Did the laxative drinks work as well as you expected? 
 Trouble-
shooting 
- Information & 
communication 
If you had problems with the drinks did you know where to find help/ 
advice? 
Arriving at the 
hospital 
Parking  If you drove, how easy was it to get parked at the hospital? 
Waiting in the 
hospital 
Getting 
changed at the 
hospital 
- Embarrassment & 
dignity 
Was the dressing area private enough? 
 Waiting in the 
department 
- Embarrassment & 
dignity 
Was the waiting area private enough? 
 Waiting areas - Comfort How satisfied with the waiting area were you? 




Did you wait in the department for longer than you expected? 
During the test Choice of pre-
medication 
- Choice & Control 
- Information & 
Communication 
- Expectations 
Were you pressured into taking a particular pre-medication option? 
 




How satisfied were you with the effect of the pre-medication 
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 The procedure 
room 
- Comfort  
 






- Information & 
Communication 
How satisfied were you with the atmosphere? 
 Staff attitudes - Information & 
communication 
How satisfied were you with: 
1. Attitude of nursing staff 
2. Attitude of the Endoscopist 
3. Communication skills of the nursing staff 
4. Communication skills of the endoscopist 
 Discussion 
before the test 
- Information & 
Communication 
Were you given adequate time to discuss the test before it started? 
 Staff 
reassuring 
- Information & 
Communication 
- Anxiety 
Did staff put you at ease? 
 Maintaining 
dignity 
- Embarrassment & 
dignity 
Did you find the procedure embarrassing? 
Did staff protect your dignity during the test? 
 Ability to stop 
the test 
- Choice & Control 
- Comfort 
Did you feel able to stop the test if it became too uncomfortable? 
 Endoscopist 
gender 
- Choice & Control 
-Embarrassment & 
dignity 
Were you given the option of Endoscopist gender? 
Options to include no but it didn’t matter to me, yes and this mattered 




- Information & 
Communication 
Were you happy with the explanation/ discussion with the 
Endoscopist during the test? 
 Feeling of the 
test 
- Comfort How unpleasant/ uncomfortable was the procedure? 
After the test Comfort after - Comfort Following the test how uncomfortable were you? 
                                            
16 This question was reviewed and refined. It was decided to add a question regarding gender to enable its association with 
embarrassment to be assessed 
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the test 1. Immediately after 
2. Before leaving the department 
3. In the days following the test 
 After-effects of 
test 
- Expectations In the days following the test, did you continue to have diarrhoea? 
 Results - Expectations Were you satisfied with how you were given results? 
If you were not given results at the time of the test, did you know 
when you would get them? 
How satisfied were you with the waiting time for results? 
Were you given enough information after the test about 
1. Results and explanation 
2. Follow up plan 
 - - Refreshments after the test 
Table 5.1: Initial question bank 
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Ten rounds of review and revision within the study team were conducted. This 
involved circulating questionnaire drafts via email and inviting group members to 
comment, and several teleconference discussions. Those discussions and decisions 
taken are summarised in the sections below.  
5.2.2. Before the Test 
The qualitative interviews found that referral for the test or initial outpatient 
appointment by primary care, and patient expectations around this, was an important 
aspect of patient experience (e.g. patients believing they had been referred for an 
OGD but instead being seen in clinic first for a discussion with the procedure being 
undertaken in a subsequent appointment). The study team agreed that consultations 
and decisions made in primary care were beyond the remit of this PREM, but that 
inclusion of a question assessing satisfaction with the referral process could be 
useful in assessing experience; therefore a question addressing this was added (I 
was happy with the way I was referred for the test- Likert response options). 
5.2.3. Preparing for the Test 
This section centred on questions about bowel preparation for colonoscopy and CTC 
patients. First drafts of questions asked about the taste of the preparation, but review 
by the team concluded this did not capture all of the over-arching themes associated 
with the bowel preparation. Further questions were developed relating to the taste 
and volume of the preparation compared to patient expectations and anxiety 
associated with whether the preparation worked properly.  
5.2.4. At the Hospital, before the Test 
Some questions in this section asked about experience of waiting in the department. 
The first iteration of questions asked about cleanliness and adequacy of the waiting 
areas. As discussed above, this addressed the facilities rather than patient 
experience. Questions considered to better address the themes in this phase were 
developed. These focused on the waiting time in the department compared with 





5.2.5. During the Test 
The items which generated the most discussion within the team in this section were 
related to pain and discomfort. Debate centred on defining pain and discomfort, 
whether these terms were interchangeable and the presence of pain across different 
stages of the procedure. Three approaches were undertaken to review this. Firstly, 
the qualitative interviews were revisited, specifically looking at times when pain or 
discomfort were mentioned. This clarified that patients described three aspects to 
pain/discomfort: intensity, duration and number of times pain/discomfort was 
experienced. Secondly, a focused literature review was conducted to identify 
descriptions of pain and discomfort and potential differences between the two and 
how they are measured (Appendix I). This showed that the majority of studies used 
the terminology ‘discomfort’ rather than ‘pain.’ Pain and discomfort were measured in 
a variety of ways, including numbered response scales (NRS), verbal response 
scales (VRS) and visual analogue scales (VAS). Thirdly, pain and discomfort were 
explored further in the cognitive interviews (section 5.3.6). 
For the purposes of the PREM, the study team decided that different approaches to 
pain and discomfort measurement should be explored within the cognitive interviews, 
including VAS, VRS and NRS. The concepts of pain and discomfort were also 
explored in more detail.  
5.2.6. After the Test 
Discussion in this section centred mostly on the results of the procedure. Although 
the question domains here were clear from the qualitative analysis (namely anxiety 
about what the results would show, uncertainty about how they would get their 
results and uncertainty about next steps in terms of management), discussion 
centred on how to best assess these areas, given variation in practice about how and 
when results are received. There was concern within the team that reporting of 
aspects of patient experience could be affected by whether someone had received 
their results. A question to determine whether and how results had been received 
was therefore added with multiple response options. Where questions asked about 
results, an extra option was added allowing participants to declare that they hadn’t 
yet received their results.  
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One question which wasn’t covered by any of the over-arching themes was included 
in this section: I was pleased with the refreshments offered. In the qualitative 
interviews, this was seen as a ‘marker’ of the end of most procedures and patients 
described its importance as a signal at the end of the test.  
5.3. Cognitive Testing 
Five rounds of cognitive testing were undertaken, with three participants in each 
round. Four participants had taken part in the qualitative interviews and 11 had not 
been interviewed before. Table 5.2 shows participants’ characteristics.  
Variable Number of participants (%) 
Gender Male 6 (30.0%) 
 Female 9 (60.0%) 
 
Age ≤54 5 (33.3%) 
 55-64 5 (33.3%) 
 65-74 3 (20.0%) 
 ≥75 2 (13.3%) 
 
Procedure OGD (including 
transnasal endoscopy) 
7 (46.7%) 
 Colonoscopy 7 (46.7%) 




High School 9 (60.0%) 
 College 4 (26.7%) 
 Higher education 2 (13.3%) 
Table 5.2: Cognitive Interviewee Characteristics 
Issues identified in these interviews are described according to procedural stage in 
the following subsections.  
5.3.1. Patient Information 
In the questionnaire drafts used in the first three rounds, three boxes were provided 
for participants to enter their age in single digits. The rationale for this was that 
patients could have been 100 years old or over. 5 out of 9 participants found this 
format confusing and hesitated over which boxes to use. This issue was in the 
formatting response stage and was a computational problem. Subsequently, this was 
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changed to a large box for participants to write their age; this caused no problems in 
subsequent rounds. 
In terms of the procedures participants had had, three participants who had 
undergone colonoscopy were confused by the descriptions of colonoscopy and CTC 
(lexical problem, understanding response stage). The wording of the descriptions of 
both colonoscopy and CTC were refined and found to be acceptable in further 
cognitive rounds. 
Participants were asked to record how many procedures they had undergone 
previously. Understanding of this question was variable in terms of whether the 
current test should be included (omission/inclusion problem). The question was 
reworded to clarify that this included the current test. A summary of the questions 
amended in this section, the response stage and type of problem they represented is 
shown in table 5.3. 





Please fill in your 
age (in years): 
Response options 
three boxes 
Formatting Computational Response option 
changed to one large 
box 
Which test did you 
have on this 
occasion? 
Colonoscopy 
:(Camera or tube 
inserted through 
the back passage)  
CT Colonoscopy/ 
pneumocolon: 
(Scan where air is 
passed into the 
bowel through a 
small tube) 
Understanding Lexical Response options 
changed: 
Colonoscopy: Camera or 
tube inserted through the 
back passage 
CT Colonoscopy/ 
pneumocolon: CT scan 
where a short tube is 
inserted into the back 
passage- done in the x-
ray department 
Please indicate 
which test and how 
many you have had 
Understanding Omission/ 
inclusion 
Including your most 
recent test, please 
indicate which tests and 
how many you have had 
Table 5.3: Patient characteristic question development 
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5.3.2. Cognitive Interviews: Before coming for the test 
 “I was able to choose a time that was convenient for me to have the test” 
This question posed a problem in the performance response stage as participants 
noted that they didn’t actually choose the appointment slot. Participants pointed out 
that they didn’t have choice over the time, but this didn’t necessarily adversely affect 
them (logical problem). The wording of the question was changed to “I felt able to 
change the appointment if it didn’t suit me,” and was considered acceptable in further 
cognitive rounds. 
“I was given enough information before the test about what it would involve” 
This question was designed to assess whether patients had enough information prior 
to the day of the test. In the first round, 2 out of 3 participants answered this question 
based on the information given in the department on the day of the test 
(understanding response phase, temporal issue). The question was reworded and 
headings indicating the stage of the test were inserted in all sections of the 
questionnaire. No issues were identified in subsequent questionnaire rounds with this 
question. 
“I had enough time to discuss the test” 
This question was intended to ask participants if they had adequate opportunity to 
discuss the test with the referring clinician prior to the day of the test. In the first and 
second round of interviews, one participant was not sure who they could have 
discussed the test with (computational problem) and two participants answered the 
question for the wrong time stage of the test (temporal problem). Section headers 
stating ‘Before the test’ were placed at the top of each new page. The question was 
also restructured to state that it was referring to having time to discuss the test with 
the referring clinician. No further issues with this question were identified in 
subsequent rounds. 
“I felt anxious about the results of the test” 
One participant in the first round of cognitive interviews and another in the fourth 
round answered this question in relation to how they felt after the test, whilst awaiting 
the results (understanding, temporal problem). To address this, sections of the 
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questionnaire were labelled according to the stage of the procedure they related to. 
Where a section stretched across pages the section header was repeated at the top 
of the page.  
The issues arising in this section, the response type and problem stage, are 
summarised in table 5.4. 





I was able to 
choose a time that 
was convenient for 
me to have the test 
Performance Logical I felt able to change the 
appointment if it didn’t 
suit me 
I was given enough 
information before 
the test about what 
it would involve 
Understanding Temporal Before coming for the 
test, I was given 
enough information 
about what the test 
would involve 
I had enough time 
to discuss the test 
Understanding Temporal 
Computational 
I had enough time to 
discuss the test with 
the person who 
referred me 
I felt anxious about 
the results of the 
test 
Understanding Temporal Before coming for the 
test I felt anxious about 
the results of the test 
Table 5.4: Before the test question development 
5.3.3. Cognitive Interviews: Preparing for the test 
No problems with specific questions were identified for this section of the 
questionnaire, which applied only to those undergoing CTC and colonoscopy. One 
interviewee (in round 1) of the seven who had undergone OGD started to complete 
this section. On further questioning, they had understood that it wasn’t relevant to 
them but stated that they wanted to be helpful and so had answered the questions 
based on a relative’s experience. A large text box stating that the section should only 
be answered by those undergoing colonoscopy and CTC was inserted. No further 





5.3.4. Cognitive Interviews: At the hospital, before the test 
“I felt able to ask any questions I had before the test” 
In the first round of interviews, one participant understood the question and said they 
felt able to ask questions, but felt embarrassed about asking questions. They 
therefore found difficulty formatting their response. A further participant in the second 
round felt able to ask questions but didn’t have any (logical, formatting problem). The 
question was intended to ask whether participants felt that staff could be asked 
questions and address any concerns they had. This centred on communication but 
also on information. The question was reworded and a further question added to 
assess whether all questions had been answered. No further issues were identified in 
subsequent testing.  
“I had enough privacy when getting ready for/ waiting for the test” 
These two questions- one which referred to privacy when getting ready for the test 
and the other whilst waiting- were initially in the same section. Patients undergoing 
OGD (round three) pointed out that they did not need to get changed for the test and 
therefore the question relating to privacy when getting ready was moved to the 
section about preparing for the test in the department. One participant undergoing 
OGD (round three) didn’t feel that they needed privacy whilst waiting for the test and 
was not sure how to answer. This was a performance problem and related to an 
logical issue. 
The issues arising in this section are summarised in table 5.5.  





I felt able to ask any 
questions I had 
before the test 
Formatting  Logical I felt able to ask the 
staff any questions 
before the test 
I had no unanswered 
questions before the 
test 
I had enough privacy 
when getting ready 
for/ waiting for the 
test 
Performance Logical Question moved to 
colonoscopy/ CTC 
specific section 
Table 5.5: At the hospital, before the test question development 
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5.3.5. Cognitive Interviews: During the test 
“I was able to choose what medication (e.g. throat spray, sedative), if any, to 
take without feeling pressurised by staff” 
An interviewee in the first round who underwent CTC could not answer this question 
as they were not offered any medication (performance stage, logical issue). A further 
OGD participant had the same issue as they did not realise there was a choice 
(round three). After discussion within the research team, the response options were 
not altered; had an option of ‘no choice was provided’ been added, the team felt this 
could cause further confusion for those undergoing OGD/colonoscopy/CTC who did 
have a choice but didn’t feel free to choose. The question was simplified and 
reworded, with no problems in subsequent rounds.  
“It was important that I was able to choose the gender of the person doing the 
test” 
Participants in the first and second cognitive interview rounds demonstrated logical 
performance problems with this response as they were not given a choice in the sex 
of the person doing the test. Revisiting the qualitative interview data indicated that 
not all participants expressed a preference for operator sex, but that some found that 
operator sex affected whether they felt embarrassed. A separate question with Likert 
response options to the ‘Before coming to the hospital for your test’ section was 
added, which asked (I hoped the person doing the test would be the same sex as 
me) and a question asking the sex of the person doing the test was added. No further 
problems were identified in subsequent rounds.  
“The atmosphere in the test room put me at ease” 
This question had been intended to assess communication between staff and staff 
behaviour in the procedure room. In the first and second cognitive interview rounds 4 
out of 6 participants were confused and did not understand the wording of the 
question (lexical issue). One participant suggested this meant the equipment, and 
another explained:  
Researcher: “What do you think that question means- the atmosphere in the 
test room put me at ease?” 
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Pt: “When I was in there… the nurse was talking to us, the doctor was talking 
to us all the time. You know I just felt like I was just having a chat with them. It 
doesn’t really bother us at all.” 
Researcher: “Does that question seem different to E7 and E8, the person 
doing the test and the other staff in the test room, are they asking the same 
thing or…?” 
Pt: “they constantly asked us if you ok? Yes, fine. And they were calling us by 
name. It was just general chat and familiar with you. They were friendly and I 
didn’t feel threatened in any way, there wasn’t any embarrassment or anything 
like that even though I knew what was going to happen. It’s not pleasant or 
something that’s done every day really but I felt really at ease with them.” 
(COG4) 
This question was removed as there were already two other questions asking about 
staff behaviour and communication in the procedure room. 
A summary of the above issues is shown in table 5.6. 
Question Response  
Stage 
Problem Type Final Question 
I was able to choose 
what medication (eg 
throat spray, 
sedative), if any, to 
take without feeling 
pressurised by staff 
Performance Logical I felt free to choose 
what medication to 
take (e.g. throat spray, 
sedative, no 
medication) 
It was important that 
I was able to choose 
the gender of the 
person doing the 
test 
Formatting Logical The person doing the 
test was: male/female 
Additional question 
added:  
I hoped the person 
doing the test would be 
the same sex as me 
The atmosphere in 
the test room put 
me at ease 
Understanding Lexical Question removed 





5.3.6. Cognitive Interviews: Pain and Discomfort 
The decision was taken to include pain and discomfort questions in this phase to 
investigate whether people complete these in the same way or differently. In the first 
cognitive interview round, 10 questions about pain and discomfort were included: two 
VAS each for pain and discomfort regarding the overall and worst pain/discomfort 
experienced; one VRS relating to the number of pain/discomfort episodes and two 
VRS relating to the length of time the pain/discomfort was experienced both overall 
and at its worst (Appendix I). The anchors used in the VAS were ‘no discomfort’ to 
‘worst discomfort imaginable’ and ‘no pain’ to ‘worst pain imaginable.’ No problems 
with understanding the anchors arose within the cognitive interviews. The first 
iteration of the VAS more closely related an NRS, as shown in Figure 5.1. 
 
Figure 5.1: First iteration VAS 
 
Participants found this format difficult to complete and were not sure where to put the 
cross. The final iteration is shown in Figure 5.2. All participants completed this 
correctly within the third to fifth cognitive interview rounds.  
 
 
Figure 5.2: Final VAS 
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Participants in earlier rounds felt that there were too many questions and that the 
questions repeated themselves. One participant felt like they were being ‘caught out.’   
Pain and discomfort were explored further in the cognitive interviews and it was clear 
that the meaning of these terms varied between participants. Some equated the two, 
whereas others described pain as more severe than discomfort: 
“Now me, I never got any pain. There was discomfort but I wouldn’t have 
classed it as pain. Potentially some people might get pain.” (COG5) 
“Well if I’m not comfortable I’ll say I just don’t feel right but that’s as far as it 
goes. Oh I feel awful today, it’s an everyday phrase that people use. And to 
me it’s just that, you’re not 100% yourself, you’re out of kilter. That’s all it 
means to me. But pain is an entirely different thing. Pain to me is something 
which is unbearable; you just can’t wait for it to go away. It drives you crazy 
and drives you insane when you’ve got real pain.” (COG12) 
It also became clear that participants could not differentiate between the overall 
length of pain/discomfort experienced and the time that the worst pain/discomfort 
lasted. These questions were therefore changed and instead participants were asked 
how long the pain/discomfort lasted during the test. Instead of asking about overall 
compared to worst pain/discomfort, participants were instead asked to rate the level 
of pain/discomfort experienced during the test using a VAS.  
No problems with the pain/discomfort questions were identified in the final round of 
cognitive interviews.  
 
5.3.7. Cognitive Interviews: After the Test 
 “I was pleased with the refreshments offered” 
Participants who had throat spray were unable to eat and drink following the test. An 
OGD participant in the first round therefore encountered a logical problem with the 
response formatting for this question. A further response option was added to 
account for those not offered refreshments. No further issues with this question were 
raised in subsequent rounds of testing.  
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“I felt uncomfortable before/after I left the hospital/ clinic” 
One participant in the first round, two in the second round and one in the fourth round 
had difficulty answering this question as they were unsure about the time period that 
was being referred to (understanding, temporal problem). The questions were 
reworded to include an example of the time period referred to. No further problems 
with the questions were identified following this.  
“When I left the hospital, I was unsure of how I would get the results of my 
test” 
Two participants in the second round noted that there were sometimes two parts to 
the results for endoscopy patients: the findings of the test (which they may have been 
told on the day of the procedure) and the results of any biopsies taken, which usually 
followed later. Some participants were not sure which result the question related to. 
An additional question asking how participants received their results was inserted, 
asking participants to tick one of seven response options to indicate whether they did 
not have any results, had some of their results and had all of their results.  A further 
response option was added to the question above (When I left the hospital, I was 
unsure of how I would get the results of my test) for those who already had results. 
No further issues were identified in later cognitive interview rounds.  
The issues raised in this round of cognitive interviews are summarised in table 5.7. 
Question Response  
Stage 
Problem Type Final Question 
I was pleased with 
the refreshments 
offered 
Performing Logical Additional response 
option entered 
I felt uncomfortable 
before/after I left the 
hospital/ clinic 
Understanding Temporal I had discomfort before 
I left the hospital/clinic 
 
I had discomfort after I 
left the hospital/ clinic 
(e.g. when I got home) 
When I left the 
hospital, I was 
unsure of how I 
would get the results 
of my test 
Formatting  Computational Additional response 
option entered 
Table 5.7: After the test question development 
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5.3.8. Cognitive Interviews: Overall Experience 
Three questions on the overall experience were tested in the first three cognitive 
interview rounds; 
1. Overall I was happy with my experience of the test 
2. Overall the experience was better than I expected 
3. I would recommend this test to a friend or relative if they required it 
The wording of the first question was changed from happy to satisfied, after feedback 
from participants. The final question regarding recommending the test was removed 
as participants noted that they wouldn’t advise relatives against procedures 
recommended by clinicians. No further issues were identified in subsequent rounds 
of testing.  
5.4. Discussion 
5.4.1. Key findings 
This phase of the study generated an initial question bank which was refined through 
multiple rounds of revision and review within the study team, followed by cognitive 
pretesting. The most common issues arising in the cognitive interviews were logical 
problems, which were refined in subsequent interview rounds. The pilot PREM is 
shown in Appendix F. 
5.4.2. Strengths of phase 
The strengths of this phase lay in the multiple rounds of revision and review within 
the wider study team, supplemented with cognitive interviews with patients who had 
undergone GI procedures. Circulation of the qualitative analysis to the study team 
alongside the questionnaire iterations helped ensure all aspects of the patient 
experience were covered and facilitated expert consensus on question wording and 
response options. This also helped to refine and remove questions which did not 
assess patient experience according to the over-arching themes but instead covered 
service delivery issues (for example, satisfaction with the waiting area). Where there 
were areas of disagreement or uncertainty, such as the measurement of pain and 




The aim of cognitive pre-testing is to ensure that intended recipients correctly 
understand and respond to questionnaire items (Willis, 2004). Analysis was 
undertaken using a framework proposed by Conrad and Blair (1996), enabling 
problems to be identified according to their response stage and further broken down 
to problem type. This standardised approach was useful in identifying patterns of 
problems but also facilitated improvement of problem questions by easily identifying 
the underlying issues. There is no agreed optimal number of participants for cognitive 
testing of questionnaires, however, undertaking ‘rounds’ of cognitive interviewing with 
refinement of questions and subsequent retesting is recommended (Beatty et al., 
2007); the current study involved five rounds, by which point all issues were resolved.  
A further strength of this work was the inclusion of previous qualitative interview 
participants (n=4) in the early rounds of cognitive pre-testing. This provided content 
validity as the participants agreed that the questionnaire represented their 
experience, with no suggested additions. These four participants were supplemented 
by new participants who had no prior contact with the researcher or knowledge of the 
study. This helped to provide confidence that patients that were ‘new’ to the topic/ 
study could understand and complete the questionnaire. Moreover, they did not 
suggest any additions to the content.  
5.4.3. Limitations of phase 
A limitation of this phase is that only one CTC patient was included in the cognitive 
pre-testing. This was partly because recruitment from this group was more difficult 
due to the relatively low numbers of these procedures at the research site and also 
that CTC is often used for patients deemed too frail for colonoscopy, meaning that re-
attendance was not always easy. An alternative to this could have been telephone 
interviews; however, it was felt that this would be difficult as the researcher would not 
be able to see participant’s reactions or identify hesitation to enable probing. 
A further limitation was that participants were only included from one hospital site, 
meaning that some aspects of experience could be specific to that site. This is a 
particular risk because the qualitative interviews used to generate the items were 
undertaken at the same site. 
Another limitation is that health professionals approached people to ask them if they 
were potentially willing to take part (researcher, research nurses). It is therefore 
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possible that this emphasised recruitment of health literate or more highly educated 
participants who might be expected to be better able to complete a questionnaire, 
however, this was difficult to mitigate. Purposive sampling was used to ensure a 
range of education levels were included, to try and limit this effect. Nine participants 
had not undertaken any further or higher education.  
The researcher leading questionnaire development and undertaking the cognitive 
interviews (LN, student) was a gastroenterology research fellow with a dual role as 
an endoscopist. This could potentially have influenced interpretation of the cognitive 
interviews and questionnaire development. The effect of this was somewhat 
mitigated through supervision by non-GI supervisors, and multiple rounds of review 
and revision within the team who were mainly non-gastroenterologists or clinicians 
(Appendix E).  
5.4.4. Pain and discomfort 
The main area of discussion in both the initial review and revision rounds and the 
subsequent cognitive testing was pain and discomfort. Literature review, described in 
Appendix I, revealed heterogeneity between methods to assess pain and discomfort 
in endoscopy and CTC studies, with VAS and VRS being the most commonly used. 
A literature review examining response scale selection in pain measures has recently 
been published and concludes that 11-point NRS demonstrates slight superiority in 
terms of reliability, validity and responsiveness compared to other measures 
(Safikhani et al., 2018). However, the authors are clear that pain/discomfort 
measurement tools should be tailored to the context in which they are being used. 
The difficulty with designing the pain/discomfort measure in this study lay in the 
diversity of patient descriptions across and even within procedural groups in the 
qualitative interview phase and in the cognitive testing.  
The first draft of questions presented in cognitive testing contained several detailed 
questions about pain/discomfort at various stages of the test, but participants found 
this confusing and repetitive (Appendix J). The questions were therefore refined and 
focused to cover three broad categories; intensity, duration and frequency, which had 
emerged from the qualitative interviews. This description aligns with that used in a 
nurse- reported measure of comfort in colonoscopy (Rostom et al., 2013) and also a 
patient-reported measure in the Norwegian colorectal screening population (Hoff et 
al., 2006). In some cases, qualitative interview participants attributed their 
102 
 
pain/discomfort to certain stages or circumstances of the test, for example, air/gas 
insufflation, biopsies, bend negotiation in colonoscopy and camera/tube insertion 
(see sections 4.5.5-7). Including every eventuality described in the qualitative 
interviews would have resulted in a lengthy, and potentially confusing, questionnaire, 
the detail of which may have been difficult for participants to discriminate.  
A further problem with these questions was the meaning of pain and discomfort. The 
qualitative work elicited that some patients perceived pain as a more severe form of 
discomfort, whereas others equated the two. This was clear in the cognitive 
interviews also, as some participants answered the same for pain and discomfort, 
whereas others scored discomfort higher than pain. A literature review revealed that 
exploration of this is lacking with regards GI procedures, however irritable bowel 
syndrome (IBS) qualitative work has noted that most patients describe pain and 
discomfort as two different entities (Spiegel et al., 2010). Further study described that 
discomfort can be non-painful in this setting (Sach et al., 2002). Bearing this in mind, 
the study team agreed that asking the same questions for pain and discomfort in the 
pilot PREM was the most pragmatic approach and would enable further investigation 
and analysis in phase 3 (chapter 6). 
  
5.4.5. Summary  
In summary, this stage of question development including multiple rounds of expert 
revision and review, followed by cognitive pre-testing, resulted in a pilot PREM 
(ENDOPREM™) comprising 59 questions encompassing patient experience, in 
addition to a section addressing participant characteristics (Appendix F). The 
questions were divided into seven sections, namely; Section A- Completing this 
survey, Section B- Before coming to hospital for your test, Section C- Preparing for 
your test, Section D- At the hospital, before the test, Section E- During the test, 
Section F- After the test and Section G- Overall experience. 
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Chapter Six: Piloting the ENDOPREM™ 
6.1. Introduction 
This phase of the study investigated the psychometric properties of the pilot 
ENDOPREM™ (Appendix F). The statistical analysis focuses on the following areas: 
• Patterns of response 
• Respondents’ characteristics 
• Distributions of responses  
• Levels and patterns of missingness 
• Completion of pain and discomfort questions 
• Exploratory factor analysis and internal consistency 
6.2. Patterns of Response 
6.2.1. Response rate 
Questionnaires were distributed from October 2017 to September 2018. Participants 
were asked to return their questionnaire using a pre-paid envelope using the freepost 
address of the host organisation. Due to an issue with the freepost license from 
March 2018 to mid-May 2018, recruitment had to be paused and therefore the total 
recruitment time was 9.5 months. 1651 questionnaires were distributed and 802 were 
returned. Two of these questionnaires were blank and another had been distributed 
in error (patient had undergone a procedure not covered by the study). Thus, the 
overall response was 799 out of 1650 eligible participants, a rate of 48.4%.  
6.2.2. Comparison of respondents vs non-respondents 
Of the 851 patients given questionnaires who didn’t respond (including the two blank 
questionnaires), 350 (41.2%) were male. Non-respondent’s ages ranged from 18-89 
with mean of 58.6 (SD 15.7). Table 6.1 compares respondents and non-respondents 
by sex, age, procedure type and recruitment site. There was no significant effect of 
sex on response (χ21=0.91, p = 0.342), however age (χ21= 94.45, p <0.001), 
procedure (χ21= 18.31, p <0.001) and site (χ21= 8.04, p = 0.045) were all significantly 







p value  
Sex Male 346 (49.7%) 350 (50.3%) p = 0.342 
 Female 444 (47.3%) 494 (52.7%) 
 
Age ≤54 142 (30.4%) 325 (69.6%)  p < 0.001 
 55-64 191 (48.7%) 201 (51.3%) 
 65-74 271 (60.4%) 178 (39.6%) 
 ≥75 181 (56.4%) 140 (43.6%) 
 
Procedure OGD 328 (45.6%) 392 (54.4%) p < 0.001 
 Colonoscopy 346 (54.3%) 291 (45.7%) 
 CTC 115 (55.0%) 94 (45.0%) 
 OGD and 
Colonoscopy 
10 (29.4%) 24 (70.6%) 
 
Site A  98 (43.9%) 125 (56.1%) p = 0.045 
 B  193 (53.8%) 166 (46.2%) 
 C 220 (50.1%) 219 (49.9%) 
 D  288 (45.7%) 342 (54.3%) 
Table 6.1: Characteristics of respondents vs non-respondents 
6.3. Response distributions 
6.3.1. Content of questionnaire and questions included in analyses 
73 questions were included in the questionnaire booklet (Appendix F). The ten 
questions in Section A (socio-demographics and previous endoscopy experience) 
were included to enable comparison between groups in further analyses beyond this 
thesis. A summary of the responses to these questions is shown in table 6.2 













A4. Gender Male: 43.3% 
Female: 55.6% 
Missing: 1.1% 




A6. Ethnicity White: 98.4% 
Asian/ British Asian: 0.3% 
Black/ African/ Caribbean/ Black British: 0.1% 
Other: 0.1% 
Missing: 1.1% 
A7. Is someone helping you 








OGD and colonoscopy: 5.1% 
Colonoscopy and CTC: 0.5% 
Not sure: 0.3% 
Missing: 1.0% 
A9. Have you had another 




A10. How were you referred for 
your most recent test?  
GP: 45.3% 
Hospital doctor: 38.8% 
Regular monitoring tests: 6.8% 
Regular tests because of family history: 2.3% 
Other: 0.9% 
Missing: 6.0% 
Table 6.2: Responses to Section A 
A free text box was provided for completion by participants who stated that they were 
referred in a way not listed in A10. Of the seven participants who selected ‘other,’ 
one did not complete the free text box, three stated they had been referred by 
‘endoscopy’ and one was referred by a nurse. Two participants reported that they 
were referred through the Bowel Cancer Screening Programme. When this was 
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queried with the site it transpired that both patients had had OGDs, therefore this 
referral mode was not possible. 
Three questions were included as potential ‘explanatory’ questions for future 
analyses beyond this thesis: 
• B4: My appointment was cancelled or changed by the hospital (Yes/ No/ Not 
sure or can’t remember) 
• E4: The person doing the test (inserting the tube or camera) was: Male/ 
Female 
• F7: How did you receive the results of your test? (various options offered) 
A free text question was included at the end of the questionnaire for participants to 
complete if they wished to provide any further information, however; this was not 
analysed in this thesis.  
Section B contained 15 questions which covered various aspects of the experience 
before arriving at the hospital for the test. 
Section C included six questions which were only relevant to participants who had 
undergone colonoscopy or CTC and are therefore described separately. Questions 
E13 and E16 were visual analogue scales (VAS) where respondents were asked to 
rate their discomfort and pain respectively. Questions E14 (how long did the 
discomfort last during the test), E15 (how many times did you experience discomfort 
during the test), E17 (how long did the pain last during the test) and E18 (how many 
times did you experience pain during the test) followed the VAS questions and, in 
order for the response options to make sense, used different Likert scales from the 
remainder of the questionnaire.  As such, the questions designed to assess 
discomfort and pain are analysed separately in section 6.6.  The final list of 







B1 I was happy with the way I was referred for the test Referral Happy 
B2 The time from first being referred to having the test 
done was satisfactory 
Referral Wait 
B3 I felt able to change the appointment if it didn’t suit 
me 
Apt Change 
B5 Before coming for the test, I was given enough 
information about what the test would involve 
Info 
B6 The information I received before the test was 
easy to understand 
Info easy 
B7 After reading the information, I did not have any 
questions about the test 
Info questions 
B8 The instructions on what I needed to do before the 
test were easy to follow 
Instructions 
B9 I had enough time to discuss the test with the 
person who referred me 
Discuss referrer 
B10 I felt anxious about what the test would involve Anxious involve 
B11 I was made anxious by talking to other people who 
had previously had the test 
Other people 
B12 I felt anxious about the results of the test Anxious results 
B13 I expected the test to be uncomfortable Expect Uncomf 
B14 I expected the test to be painful Expect Pain 
B15 I was worried that inserting the tube/camera would 
be uncomfortable 
Expect insert 
B16 I hoped the person doing the test would be the 
same sex as me 
Same sex 
C1 The bowel preparation had an unpleasant taste Prep taste 
C2 The bowel preparation tasted better than I 
expected 
Taste better 
C3  The volume (amount) of the bowel preparation 
was more than I expected 
Prep volume 
C4 The amount of bowel preparation I had to drink 
was manageable 
Prep manage 
C5 I was worried that the bowel preparation would not 
clear my bowel properly 
Prep work 
C6 I had enough privacy when getting ready for the 
test 
Change privacy 
D1 I waited longer in the department than I expected Dept wait 
D2 I was comfortable while sitting in the waiting area Comf wait 
D3 I felt able to ask the staff any questions before the 
test 
Ask staff 
D4 I had no unanswered questions before the test No questions 
D5 I had enough privacy when waiting for the test Privacy wait 
E1 During the test my dignity was maintained at all 
times 
Dignity 
                                            
17 This is how questions are referred to in subsequent tables in this chapter 
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E2 I felt free to choose what medication to take Choose meds 
E3 The medication worked as well as I expected Meds work 
E5 I felt confident that the person doing the test what 
they were doing 
Confident 
E6 The person doing the test did their best to put me 
at ease 
Ease endoscopist 
E7 The other staff in the test room did their best to put 
me at ease 
Ease other 
E8 I was satisfied with the explanation given to me 
about the test 
Explanation 
E9 The person doing the test addressed any concerns 
I had 
Concerns add 
E10 I felt I could stop the test if it became too 
uncomfortable 
Could stop 
E11 I felt embarrassed during the test Embarrassed 
during 
E12 The test took longer than I expected Test duration 
E14 How long did the discomfort last during the test? Discomfort last 
E15 How many times did you experience discomfort 
during the test? 
Discomfort 
number 
E17 How long did the pain last during the test? Pain last 
E18 How many times did you experience pain during 
the test? 
Pain number 
E19 Overall, the test was more uncomfortable than I 
expected 
Overall comf 
E20 Overall, the test was more painful than I expected Overall pain 
E21 I felt embarrassed by the discomfort I experienced Discomf emb 
E22 I felt embarrassed by the pain I experienced Pain emb 
F1 I was satisfied by the explanation given to me by 
the person doing the test 
Explan after 
F2 I was pleased with the refreshments offered Refreshments 
F3 I had discomfort before I left the hospital/clinic Discomf hosp 
F4 I had discomfort after I left the hospital/clinic Discomf home 
F5 It took longer than I expected to recover from the 
test 
Recovery 
F6 I was worried about the test results Results worry 
F8 When I left the hospital, I was unsure of how I 
would get my test results 
Unsure results 
F9 I was happy with the way I received the results of 
my test 
Happy results 
F10 I received the results of my test sooner than I 
expected 
Results sooner 
F11 I know what the next steps are going to be Next steps 
G1 Overall I was satisfied with my experience of the 
test 
Satisfied 
G2 Overall the experience was better than I expected Better expected 




6.3.2. Respondents’ characteristics 
Respondents’ ages ranged from 18-95, with a mean age of 65.3 (SD 12.6).  43.3% of 
respondents were male and the majority (99.5%) were of white British ethnicity. 
According to procedure, documented by research staff, 41.1% of respondents 
underwent OGD (including 0.8% who underwent transnasal endoscopy), 43.3% 
underwent colonoscopy, 1.3% underwent both OGD and colonoscopy on the same 
day (referred to as ‘OGD & colonoscopy’ henceforth) and 14.4% underwent CTC.  
There was sometimes a discrepancy between the procedure documented in the site-
completed additional information sheet and that reported by the patient. All 
discrepancies were firstly queried with sites to confirm the actual procedure. Of the 
328 participants who underwent OGD, 298 (90.8%) self-reported as having an OGD, 
4 (1.2%) as having a colonoscopy and 23 (7.0%) reported having OGD & 
colonoscopy. Of the 346 participants who underwent colonoscopy, 326 (94.2%) 
agreed with this, 1 (0.3%) reported CTC, 3 (0.9%) reported OGD and 13 (3.8%) 
reported having both procedures. 115 participants underwent CTC, of whom 102 
(88.7%) reported CTC, 5 (4.3%) reported colonoscopy and 4 (3.5%) reported both 
colonoscopy and CTC.  
Table 6.4 shows respondents’ characteristics according to procedure. Mean age was 
similar across all procedures with the exception of CTC, who were older, on average. 
The percentage of male participants was similar across all groups except OGD & 
colonoscopy, however; there were comparatively fewer overall participants in this 
group.  
Table 6.4: Respondents’ characteristics according to procedure 
The demographic characteristics of participants by recruitment site are shown in 
Table 6.5. This shows variation in the numbers of respondents across sites, ranging 





Mean age SD 
OGD 328 (41.1%) 40.6% 64.3 12.7 
Colonoscopy 346 (43.3%) 48.3% 64.0 12.6 
OGD and 
Colonoscopy 
10 (1.3%) 20.0% 64.2 9.5 
CTC 115 (14.4%) 39.5% 72.2 10.4 
     
Overall 799 (100%) 43.3% 65.3 12.6 
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from 98 to 288. Aside from site A (52.1%) the percentage of male respondents was 
similar across sites (39.4- 44.6%). The mean age was similar across sites (63.8 - 
66.2). 





Mean age SD 
A  98 52.1% 63.8 13.40 
B  193 43.5% 66.1 11.65 
C  220 39.4% 64.3 12.25 
D  288 44.6% 66.2 13.14 
Overall 799 43.3% 65.3 12.60 
Table 6.5: Respondent demographics according to site 
6.3.3. Response distributions 
Table 6.6 shows the response distribution for the questions listed in table 6.3 (with 
the exception of section C, which is reported in section 6.3.9); ‘conditional’ indicates 
that the question had a ‘not applicable’ response option (e.g. in question E3 
participants were given the option of ticking ‘I did not have any medication’ instead of 
completing the Likert scale).  


















B1 797 0.3 68.8 27.0 2.5 1.5 0.3  
B2 791 1.0 63.8 30.7 3.2 1.6 0.6  
B3 771 3.5 57.7 34.2 6.1 1.7 0.3  
B5 796 0.4 70.8 26.9 0.8 0.9 0.3  
B6 795 0.5 69.1 27.8 1.6 0.9 0.3  
B7 794 0.6 63.3 28.3 3.3 3.8 0.8  
B8 798 0.1 66.3 31.1 1.1 1.1 0.4  
B9 788 1.4 50.9 32.2 11.0 4.9 0.9  
B10 788 1.4 16.0 34.4 19.3 19.0 11.3  
B11 781 2.3 6.5 13.3 18.2 33.4 28.6  
B12 789 1.3 21.9 44.6 18.5 9.8 5.2  
B13 794 0.6 28.6 55.8 8.7 4.9 2.0  
B14 793 0.8 13.4 29.9 28.2 23.1 5.4  
B15 793 0.8 21.6 43.8 16.4 14.5 3.8  
B16 791 1.0 7.5 7.1 41.3 20.7 23.4  
D1 759 5.0 8.0 10.7 17.0 36.4 27.9  
D2 760 4.9 36.8 50.8 5.4 4.2 2.8  
D3 758 5.1 50.0 45.0 3.2 1.2 0.7  
D4 759 5.0 52.0 40.6 3.6 2.5 1.3  
D5 760 4.9 49.7 43.6 3.6 1.8 1.3  
111 
 
E1 792 0.9 70.8 27.5 1.0 0.4 0.3  
E2 769 3.8 65.8 26.5 5.3 1.8 0.5  
E3 774 3.1 42.2 31.1 5.3 5.6 1.8 14.0 
E5 791 1.0 75.6 22.6 0.9 0.6 0.3  
E6 791 1.0 74.3 22.3 2.1 0.9 0.4  
E7 792 0.9 77.8 20.1 1.6 0.3 0.3  
E8 794 0.6 70.4 28.0 0.9 0.6 0.1  
E9 792 0.9 64.0 29.3 5.6 0.9 0.3  
E10 793 0.8 53.6 32.7 9.5 3.2 1.1  
E11 791 1.0 4.3 8.0 16.1 37.0 34.6  
E12 793 0.8 3.8 9.7 23.7 36.7 26.1  
E19 789 1.3 7.4 16.5 20.3 35.9 20.0  
E20 789 1.3 4.9 12.4 17.4 39.8 25.5  
E21 789 1.3 2.5 7.0 15.5 42.2 32.8  
E22 789 1.3 2.0 5.2 15.2 41.7 35.9  
F1 784 1.9 61.5 33.3 2.7 1.9 0.6  
F2 783 2.0 45.7 29.9 5.0 1.1 0.3 18.0 
F3 778 2.6 5.3 14.5 11.4 37.0 31.7  
F4 783 2.0 5.2 21.2 10.3 33.0 30.3  
F5 782 2.1 4.7 7.9 13.9 40.9 32.5  
F6 778 2.6 10.2 33.0 24.2 19.4 13.2  
F8 731 8.5 3.7 9.4 7.8 30.1 19.4 29.5 
F9 760 4.9 32.1 30.4 3.7 1.8 1.2 30.8 
F10 743 7.0 22.2 23.8 14.5 3.0 1.6 34.9 
F11 730 8.6 35.9 39.6 9.7 9.2 5.6  
G1 791 1.0 55.6 37.4 4.2 2.3 0.5  
G2 784 1.9 45.8 32.4 14.5 5.9 1.4  
Table 6.6: Response patterns by question 
6.3.4. ‘Floor’ and ‘ceiling’ effects 
24 items within the questionnaire showed evidence of a ‘ceiling’ effect:18 
• B1, B2, B3, B5, B6, B7, B8, B9 
• D3, D4, D5 
• E1, E2, E3, E5, E6, E7, E8, E9, E10 
• F1, F2 
• G1, G2 
The remainder of questions showed a more even distribution of responses. 
Response patterns were similar according to sex, age, procedure and age (not 
shown); some subtle differences are described in the following sections.  
                                            




6.3.5. Response patterns by sex 
Response patterns by sex were similar to the overall response pattern. The ‘ceiling’ 
effect in question E3 (medication worked as well as I expected) was more marked for 
men (43.7%) than for women (37.6%). 
6.3.6. Response patterns by age 
Response patterns by age were similar to the overall response patterns. The ‘ceiling’ 
effect regarding question E3 was less marked in the 65-74 (39.9%) and 75+ (34.8%) 
age groups than in those ≤ 54 years (43.0%) and those aged 55-64 (47.1%). This 
may reflect larger proportions of respondents who did not have medication in the 
upper two age groups (14.9% and 20.0%, respectively) compared with the lower two 
age groups (7.1% and 12.8%, respectively).  
6.3.7. Response patterns by procedure 
Response patterns by procedure were similar to the overall data and ‘ceiling’ effects 
were observed in the same questions as the overall data. Of interest, there was a 
‘ceiling’ effect in F2 for patients who had undergone OGD (I was pleased with the 
refreshments offered). The ‘ceiling’ effect in question E3 (medication worked as well 
as I expected) was 35.0% in participants undergoing colonoscopy and 13.9% of 
participants undergoing CTC. In both groups, the majority of respondents agreed or 
strongly agreed (colonoscopy: 63.3%; CTC: 47.8%- 33.9% in this group had no 
medication) with the statement.  
6.3.8. Response patterns by site 
Ceiling effects were observed in the same questions as the overall data, with the 
exception that centre D showed a ‘ceiling’ effect of only 39.8% for question G2 
(Overall the experience was better than I expected). In addition, centres B and C 
showed a mild ‘ceiling’ effect in question D2 (41.3% and 42.8%, respectively) (I was 
comfortable while sitting in the waiting area). No ‘floor’ effects were observed.  
6.3.9. Section C response patterns: overall 
Only respondents who underwent colonoscopy or CTC were asked to complete 
section C, as this focused on questions related to the preparation (oral contrast or 
laxatives) required prior to the test. The number of correct respondents for whom this 
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section was relevant was, therefore, 471 (colonoscopy, 346; OGD & colonoscopy, 
10; CTC, 115). Table 6.7 shows, by procedure, the number and percentage of 
participants who responded to each question in section C. Fifty-nine participants 
(18.0%) who underwent OGD responded to these questions. These responses are 










C1 59 (18.0) 338 (97.7%) 8 (80.0%) 111 (96.5%) 
C2 56 (17.1%) 337 (97.4%) 8 (80.0%) 112 (97.4%) 
C3 57 (17.4%) 340 (98.3%) 8 (80.0%) 111 (96.5%) 
C4 58 (17.7%) 340 (98.3%) 8 (80.0%) 111 (96.5%) 
C5 58 (17.7%) 338 (97.7%) 8 (80.0%) 111 (96.5%) 
C6 57 (17.4%) 340 (98.3%) 8 (80.0%) 112 (97.4%) 
Table 6.7: Section C number of responses according to procedure 
The overall response patterns for section C, for those who underwent colonoscopy, 
CTC or OGD & colonoscopy are shown in table 6.8. There were no floor effects. 
Question C6 (I had enough privacy when getting ready for the test) demonstrated a 
ceiling effect of 65.5%.  
















C1 457 3.0 30.1 26.5 21.2 15.5 3.6 
C2 457 3.0 9.3 34.4 18.0 21.9 13.4 
C3 459 2.5 21.7 26.5 28.7 16.6 4.0 
C4 459 2.5 14.4 54.6 12.1 10.8 5.5 
C5 457 3.0 10.2 32.7 21.4 25.5 7.2 
C6 460 2.3 64.3 29.9 1.7 1.1 0.6 
Table 6.8: Section C responses (excluding OGD) 
When broken down by procedure (colonoscopy and CTC as only 10 respondents in 
OGD & colonoscopy group), response patterns were similar to those seen for all 
procedures combined (tables 6.9 and 6.10). Although the ‘ceiling’ effect of question 
C6 was less marked in the CTC group, this was still above 50% in both groups. No 





















C1 338 2.3 31.7 27.2 21.6 15.4 4.1 
C2 337 2.6 9.5 34.7 19.0 22.8 13.9 
C3 340 1.7 25.6 28.5 28.5 13.8 3.5 
C4 340 1.7 11.5 54.7 14.1 13.8 5.9 
C5 338 2.3 9.2 30.8 24.0 29.3 6.8 
C6 340 1.7 68.2 30.3 1.2 0.3 0.0 
Table 6.9: Colonoscopy group responses to section C 
















C1 111 3.5 28.8 26.1 23.4 18.9 2.7 
C2 112 2.6 9.8 38.4 17.0 21.4 13.4 
C3 111 3.5 12.6 23.4 30.6 27.0 6.3 
C4 111 3.5 25.2 61.3 6.3 2.7 4.5 
C5 111 3.5 14.4 42.3 17.1 16.2 9.9 
C6 112 2.6 57.1 33.0 3.6 3.6 2.7 
Table 6.10: CTC group responses to section C 
6.3.10. Section C response patterns: by sex, age group and site 
The response patterns by age-group, sex and site were similar to those seen overall 
and no new ceiling or floor effects were observed (not shown). The ‘ceiling’ effect 
observed in question C6 was 67.5% in females and 62.8% in males. The ‘ceiling’ 
effect of C6 was much higher in those aged 55-64 (74.8%) compared to the 
remaining groups (range 60.5-62.8%). 
6.4. Missing Responses 
Patterns of missing values were described firstly according to the questionnaire items 
themselves and secondly on a respondent basis.  
6.4.1. Missing entries per question 
Descriptive analyses of missing items for pain and discomfort questions (E13, E14, 
E15, E16, E17 and E18) are described in section 6.5. The overall rate of missing 
responses for each of the remaining questions was low, as shown in table 6.6 
(section 6.3.3.) and table 6.8 (section 6.3.9), meaning that completion rates on a per 
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question basis were high. Missingness was over 5% for only three questions (F8, 
F10, F11); F11 had the highest rate of non-completion (8.6%).  
6.4.2. Number of questions missed per participant 
Excluding section C, 274 (34.3%) respondents failed to complete one or more 
questions. The mean number of items missed in all participants was 1.2 (range 0-28, 
SD 2.79); the maximum was 28. The distribution of number of questions missed per 
participant (where at least one question was missed, mean 3.4) is shown in figure 
6.1.  
  
Figure 6.1: Distribution of number of questions missed per participant 
6.4.3. Missing responses according to sex 
The mean number of missing responses was less in male than female respondents 
(1.0 vs 1.23) but this difference was not significant (t=-1.318, df=788, p=0.188). 
6.4.4. Missing entries according to age 
The mean number of missing responses increased by age and was considerably 
higher (2.4) for the oldest group than the others (0.5, 0.7, 0.9) (Table 6.11). The 
mean number of missing responses for those aged 75 and older was 2.4. 
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Group N Mean Std 
Deviation 
95% CI for Mean Minimum Maximum 
Lower Upper 
≤ 54 142 0.5 1.3 0.3 0.7 0 7 
55-64 191 0.7 1.6 0.5 1.0 0 8 
65-74 271 0.9 2.6 0.6 1.3 0 26 
≥ 75 181 2.4 4.2 1.8 3.0 0 28 
Total 785 1.2 2.8 1.0 1.4 0 28 
Table 6.11: Missing entries according to age group 
The one-way ANOVA indicated a significant effect of age on the mean number of 
missing responses (F(3,781)=17.98, p<0.001). The Games-Howell post-hoc test 
indicated the mean number of missing responses in the 75+ group was significantly 
different from each of the other groups.   
6.4.5. Missing responses according to procedure 
There was no statistically significant association between procedure and mean 
number of missing responses (F(2,786)=2.931, p=0.054). 
6.4.6. Missing responses according to site 
There was no difference in mean number of missing questions by site (F(3,795)= 
0.768, p=0.512). 
6.5. Missing responses: Section C 
The mean number of missing responses among the 471 who should have completed 
section C was 0.2 (range 0-6, SD 0.9). 451 (95.8%) participants answered all 
questions; six participants missed one questions, five missed 2-5 questions and nine 
did not answer any questions in this section.  
There was no significant difference in mean number of missing responses in section 
C by sex (males: 0.14, [SD= 0.9]; females:0.16 [SD 0.8]; t=-0.226, df=463, p=0.821). 
Mean number of missing questions varied significantly by age-group (ANOVA 
F(3,458)=3.411, p=0.017), with post-hoc testing indicating that the mean number of 





Group N Mean Std 
Deviation 




≤ 54 78 0.15 0.96 -0.06 0.37 0 6 
55-64 111 0.17 0.98 -0.01 0.36 0 6 
65-74 158 0.01 0.08 -0.01 0.02 0 1 
≥ 75 115 0.35 1.23 0.12 0.57 0 6 
Total 462 0.16 0.88 0.08 0.24 0 6 
Table 6.12: Section C Mean number of missing responses overall and according to 
age 
There was no significant difference in the mean number of missing responses in 
section C for those who underwent colonoscopy (0.12, SD 0.8) and CTC (0.2, SD 
0.9; t=-0.756, df= 459, p=0.450).  
One-way in-between ANOVA showed a statistically significant difference in mean 
number of missing responses to section C between sites (F(3,467)= 3.389, p=0.018). 
Post-hoc tests indicated that the mean number of missing responses per participant 
in site B (0.0) was statistically significantly less than those in site C (0.4; p=0.013). 
Differences between the means in other centres did not reach statistical significance. 
6.6. Pain and Discomfort 
The analysis of the questions on pain and discomfort was focused on determining the 
relationship between responses to the pain and discomfort questions, with a view to 
reducing the number of items within the questionnaire.   
6.6.1 Visual Analogue Scale: Method of Response 
9 (1.1%) participants failed to complete the VAS for discomfort (E13) and 16 (2.0%) 
failed to complete the VAS for pain (E16). 780 respondents completed both the pain 
and discomfort VAS. 
Of those who completed E13 and/or E16, 55.2% and 60.3% correctly followed the 






 Question E13 
(discomfort) 
Question E16 (pain) 
Correct method used19 441 (55.8%) 482 (61.6%) 
Number circled 260 (32.9%) 237 (30.3%) 
Cross under/above line 41 (5.2%) 44 (5.6%) 
Number written 8 (1.0%) 7 (0.9%) 
Cross on line and 
number circled 
37 (4.7%) 8 (1.0%) 
Anchor circled 1 (0.1%) 4 (0.5%) 
Range indicated 2 (0.3%) 1 (0.1%) 
Table 6.13 Response modes to VAS questions 
6.6.2. Visual Analogue Scale: All Responses 
The mean discomfort score was 41.3 (SD 25.9) and the mean pain score was 27.0 
(SD 26.3). Figures 6.2 and 6.3 show the distribution of discomfort and pain scores, 
respectively. A higher percentage of respondents reported a score of zero for pain 
than did for discomfort (12.0% vs 4.7%). Responses tended to crowd around ‘whole’ 
numbers in each question, rather than being normally distributed. 
 
Figure 6.2: E13 (discomfort) Response Distribution 
 
                                            




Figure 6.3: E16 (pain) Response Distribution 
Figure 6.4 shows the scattergram produced when questions E13 (discomfort) and 
E16 (pain) are cross-tabulated. Spearman’s rank correlation test showed a 
statistically significant positive correlation between responses to E13 and E16 (rs= 
0.667, N=777, p<0.001). However, the scattergram line does not cross zero and 





Figure 6.4: Correlation between E13 and E16.  
In a paired analysis (n=777), the mean difference in self-reported discomfort and pain 
was 14.3 (SD 20.14). The distribution of differences is shown in figure 5.5. 12.1% of 
participants had a difference of less than zero (i.e. pain score was higher than 
discomfort score), 23.3% had a difference of zero and 64.6% had a difference over 
zero. 
The main difference in (paired) scores was significantly different from zero and the 
size of the effect was moderate. A paired t-test showed that the difference between 





Figure 6.5: Difference in discomfort and pain scores.  
There was no significant effect of gender (t= 0.786, df=767, p=0.432), age (F (4,772) 
= 1.19, p=0.310) or site (F (3,773) = 1.22, p=0.301) on the mean difference in scores 
(Table 5.14). 
There was a significant difference in mean scores according to procedure type (F 
(3,773) = 36.2, p<0.001). OGD scores were significantly different from those for other 
procedures (p≤0.05). There was no significant difference between colonoscopy and 
CTC (p=0.638), colonoscopy and OGD & colonoscopy (p=1.000) or CTC and ‘OGD 













p value  
Sex Male 13.7 20.0 0.432 
 Female 14.9 20.1 
     
Age Group ≤54 16.5 21.2 0.310 
 55-64 15.9 20.5 
 65-74 13.1 19.8 
 ≥75 12.8 19.1 
     
Procedure OGD 21.9 22.6 <0.001 
 Colonoscopy 8.4 15.4 
 OGD and 
Colonoscopy 
8.4 12.9 
 CTC 10.7 18.3 
     
Site A 12.4 23.4 0.301 
 B 12.7 18.6 
 C 14.7 19.7 
 D 15.8 20.2 
Table 6.14: Effect of sex, age, procedure and site on pain and discomfort  
6.6.3. Visual Analogue Scale: Score according to response mode 
The analyses described in section 5.5.2 were repeated to compare those who used 
different response modes. Participants (n=2) who indicated a range were excluded 














































Table 6.15: Comparison of mean scores according to VAS response mode 
                                            
20 ‘Cross’ response mode included: those who placed a cross on, above or under the 
line, or who both placed a cross on the line and circled a number.  
‘Number’ response mode included: those who circled or wrote a number or who 
circled an anchor. 
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6.6.4. Duration of Discomfort and Pain 
Questions E14 and E17 asked respondents to rate how long the discomfort or pain 
lasted during the test, respectively, according to the following responses: 
• I didn’t have pain/ discomfort 
• A short time 
• A moderate time 
• A long time 
The distribution of responses to each question is shown in table 6.16. No floor or 
ceiling effects were demonstrated and the percentage of missing responses was low.  
A similar proportion of participants chose ‘a long time’ for both pain and discomfort, 
however, a higher proportion of participants indicated that they had no pain (34.5%) 
than had no discomfort (10.9%). 
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Table 6.16: Response distributions to E14 and E17 
Comparison of the questions (Table 6.17) indicated reasonable consistency in 









































































Table 6.17: Crosstabulation of duration of pain and discomfort (E14 and E17) 
6.6.5. Frequency of Discomfort and Pain 
Questions E15 and E18 asked respondents to rate the number of times they 
experienced discomfort or pain, respectively, during the test: 
• None 
• 1 or 2 times 
• 3 or 4 times 
• More than 4 
• Constantly 
The distribution of responses is shown in table 6.18. No floor or ceiling effects were 
demonstrated. The percentage of patients who indicated they had constant pain 
(3.5%) was lower than those with constant discomfort (8.1%). Fewer participants 
indicated that they had no discomfort (11.8%) than no pain (35.6%). 
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Table 6.18: Response distributions to E15 and E18 
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Comparison of the questions (Table 6.19) indicated reasonable consistency in 
responses (Spearman’s rank correlation: rs=0.617, N=775, p<0.001). Only 41.3% of 
participants who had zero episodes of discomfort indicated they had zero episodes of 
pain, with 33.3% selecting ‘constant’ pain.  
 






































































































Table 6.19: Correlation of number of episodes of pain and discomfort 
 
6.6.6. Comparison between the duration and frequency of discomfort 
Responses to E14 (how long did the discomfort last during the test) and E15 (how 
many times did you experience discomfort during the test) were cross-tabulated 
(table 6.20). and were correlated (rs 0.744, p<0.0001). The majority of participants 
who chose the lowest score for discomfort duration (zero) also chose this response 
for the number of episodes of discomfort (zero; 97.6%). Participants who chose the 
highest score for discomfort duration (long time) chose one of the two highest 
response options for number of discomfort episodes (more than 4 and constantly; 
97.3%). Participants choosing the lowest scores for one question never chose the 
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Long time 0  
(0%) 
0 (0%) 1  
(2.7%) 














Table 6.20: Correspondence between the duration and number of episodes of 
discomfort 
 
6.6.7. Comparison between the length and number of episodes of pain 
Responses to E17 (how long did the pain last during the test) and E18 (how many 
times did you experience pain during the test) were very highly correlated (rs =0.909, 
p<0.001) (Table 5.21).  















































Long time 0 (0.0%) 0 (0.0%) 1  
(4.2%) 


















6.6.8. Discomfort and pain compared to expectations 
Responses to questions E19 and E20 (Overall, the test was more uncomfortable/ 
painful than I expected) were cross-tabulated (table 6.22). Responses were 
significantly positively correlated (rs=0.769, N=789, p=<0.001). 

































5 (8.6%) 2 (3.4%) 8 (13.8%) 12 (20.7%) 58 (100%) 

















5 (3.1%) 160 
(100%) 
Disagree 2 (0.7%) 2 (0.7%) 6 (2.1%) 246 
(86.9%) 




















Table 6.22: Comparison of E19 and E20 
6.7. Correlations 
In this section the pain and discomfort VAS questions were excluded, partly due to 
the reverse scoring nature of the responses and also because the type of question 
varied significantly. Furthermore, the previous section identified that these questions 
were correlated with one another. The final PREM may include only discomfort or 
only pain and it was not appropriate to include questions that may be omitted in a 
factor analysis, therefore, the pain questions were excluded. Questions from Section 
C were excluded as they were only answered by participants undergoing lower GI 
examinations and therefore would only produce factors, if relevant, for a subset of 
patients. Questions included within the questionnaire as ‘explanatory’ questions were 
excluded from the factor analysis. The overall satisfaction questions in section G 




6.7.1. Inter-item correlations 
When responses to pairs of questions were correlated, two pairs of questions 
emerged as strongly correlated (rs >0.8): 
• B5 and B6 (Before coming for the test, I was given enough information about 
what the test would involve and the information I received before the test was 
easy to understand) 
• F3 and F4 (I had discomfort before I left the hospital/ clinic and I had 
discomfort after I left the hospital/ clinic) 
Although all questions had some degree of correlation with at least one other 
question, one question correlated relatively weakly (rs <0.35) with only one other 
question and a further three questions correlated weakly with only two other 
questions: 
• B16 (I hoped the person doing the test would be the same sex as me) 
• D1 (I waited longer in the department than I expected) 
• F2 (I was pleased with the refreshments offered)  
• F8 (When I left the hospital, I was unsure of how I would get the results of my 
test) 
Inter-item correlations are shown in Appendix K.  
6.7.2. Item total correlations 
Corrected item total correlations were calculated for the same questions included in 
section 6.7.121. The ITCs are shown in table 6.23. Eight items showed poor corrected 
item-total correlation, i.e. ITC <0.3: 
• B11, I was made anxious by talking to other people who had previously had 
the test (ITC 0.292) 
• B13, I expected the test to be uncomfortable (ITC 0.196) 
• B16, I hoped the person doing the test would be the same sex as me (ITC 
0.281) 
                                            
21 Questions included: B1, B2, B3, B5, B6, B7, B8, B9, B10, B11, B12, B13, B14, 
B15, B16, D1, D2, D3, D4, D5, E1, E2, E3, E5, E6, E7, E8, E9, E10, E11, E12, E14, 
E15, E19, E21, F1, F2, F3, F4, F5, F6, F8, F9, F10, F11 
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• D1, I waited longer in the department than I expected (ITC 0.225) 
• F2, I was pleased with the refreshments offered (ITC 0.175) 
• F8, When I left the hospital, I was unsure of how I would get my test results 
(ITC 0.165) 
• F9, I was happy with the way I received the results of my test (ITC 0.081) 
• F10, I received the results of my test sooner than I expected (ITC -0.006) 
Item Item 
Number 
Scale mean if 
item deleted 





Referral Happy B1 176.79 320.54 0.441 
Referral wait B2 176.86 321.01 0.376 
Apt change B3 176.97 321.03 0.354 
Info B5 176.74 319.70 0.525 
Info Easy B6 176.76 319.35 0.525 
Info Questions B7 176.91 317.67 0.446 
Instructions B8 176.80 318.44 0.531 
Discuss 
Referrer 
B9 177.17 315.39 0.439 
Anxious 
Involve 
B10 178.62 311.34 0.402 
Other People B11 177.72 317.23 0.292 
Anxious 
Results 
B12 179.08 317.68 0.305 
Expect Uncomf B13 179.45 323.93 0.196 
Expect Pain B14 178.58 317.40 0.309 
Expect Insert B15 179.07 317.32 0.323 
Same Sex B16 177.91 318.12 0.281 
Dept Wait D1 177.74 319.68 0.225 
Comf Wait D2 177.27 316.56 0.424 
Ask staff D3 176.97 317.64 0.530 
No questions D4 176.99 317.39 0.480 
Privacy wait D5 177.05 316.74 0.484 
Dignity E1 176.74 319.69 0.547 
Choose meds E2 176.83 319.56 0.430 
Meds Work E3 176.68 310.07 0.333 
Confident E5 176.69 320.68 0.504 
Ease 
endoscopist 
E6 176.74 318.50 0.533 
Ease other E7 176.67 320.21 0.544 
Explanation E8 176.72 319.83 0.571 
Concerns add E9 176.84 317.39 0.549 
Could stop E10 177.07 315.07 0.492 
Embarrassed 
During 
E11 177.52 313.08 0.426 
Test Duration E12 177.69 314.40 0.405 





E15 178.98 316.49 0.355 
Overall Comf E19 177.94 310.44 0.460 
Discomf Emb E21 177.44 313.98 0.457 
Explan after F1 176.88 317.44 0.504 
Refreshments F2 176.31 319.06 0.175 
Discomf hosp F3 177.66 312.51 0.404 
Discomf home F4 177.81 310.73 0.419 
Recovery F5 177.53 313.74 0.416 
Results worry F6 178.46 315.43 0.333 
Unsure 
Results 
F8 176.34 313.71 0.165 
Happy Results F9 176.06 322.42 0.081 
Results sooner F10 176.20 326.93 -0.006 
Next steps F11 177.52 314.84 0.357 
Table 6.23: Item total correlations 
6.8. Exploratory Factor Analysis 
6.8.1. Questions included in factor analysis  
The questions with few or weak inter-item correlations (B16, D1, F2, F8) and those 
with ITC <0.3 (B11, B13, B16, D1, F2, F8, F9, F10) were not included in the factor 
analysis. Of the questions asked for both pain and discomfort, only the discomfort 
questions were retained.  
The questions included in the factor analysis are listed below: 
B1, B2, B3, B5, B6, B7, B8, B9, B10, B12, B14, B15 
D2, D3, D4, D5 
E1, E2, E3, E5, E6, E7, E8, E9, E10, E11, E12, E14, E15, E19, E21 
F1, F3, F4, F5, F6, F11 
A second correlation matrix for these 37 remaining questions was produced (not 
shown). The determinant for this correlation matrix was 1.550E-9.  
6.8.2. Sampling adequacy 
The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.904 
(‘meritorious’ according to Kaiser et al, 1974, or ‘superb’ according to Hutcheson & 
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Sofroniou, 1999), suggesting sample size was adequate for factor analysis. On 
inspection of the anti-image correlation matrix, all KMO statistics were above 0.5, 
again indicating acceptable sampling (not shown). Bartlett’s test of sphericity (χ2 
(666) = 12005.5, p<0.001) indicated that relations between items were sufficiently 
large for principal component analysis. 
6.8.3. Principal components analysis  
The Scree plot (figure 6.6) shows one obvious point of inflection, suggesting that 
three factors could be retained. The three-factor solution explained only 44.8% of the 
variation.  
Principal components analysis (PCA) revealed seven potential factors with 
eigenvalues over 1. The average communality after extraction was 0.615, which 
suggests that all factors could be retained. The seven-factor solution was settled 
upon as this explained 61.5% of the variance.  
 
Figure 6.6: Scree plot for principal components analysis 
The pattern matrix for the seven factors is shown in table 6.2422 
                                            
22 Values under 0.4 have been suppressed 
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Item  Abbreviation Component 
1 2 3 4 5 6 7 
E6 Ease endoscopist .893       
E5 confident .881       
E9 Concerns add .813       
E8 Explanation .800       
E7 Ease other .790       
F1 Explan after .657       
E1 Dignity .568       
E10 could stop .547       
E2 Choose meds .410       
E3 Meds Work        
E15 Discomfort 
number 
 .877      
E14 Discomf last  .839      
E19 Overall Comf  .706      
E12 Test Duration        
B12 Anxious Results   .815     
B10 Anxious Involve   .776     
B15 Expect Insert   .746     
B14 Expect Pain   .650     
F6 Results worry   .617     
B7 Info Questions    .828    
B6 Info Easy    .818    
B5 Info    .758    
B8 Instructions    .748    
B9 Discuss Referrer    .740    
B1 Referral Happy    .661    
B2 Referral wait    .601    
B3 Apt change        
D5 Privacy wait     .800   
D3 Ask staff     .775   
D2 Comf Wait     .774   
D4 No questions     .765   
F11 Next steps        
F4 Discomf home      .939  
F3 Discomf hosp      .884  
F5 Recovery      .803  
E11 Embarrassed 
During 
      -.688 
E21 Discomf Emb       -.558 
Table 6.24: Pattern matrix for seven components 






Overall theme Included items 
1 The test itself E1. During the test my dignity was maintained at all 
times 
E2. I felt free to choose what medication to take 
E5. I felt confident that the person doing the test 
knew what they were doing 
E6. The person doing the test did their best to put 
me at ease 
E7. The other staff in the test room did their best to 
put me at ease 
E8. I was satisfied with the explanation given to me 
about the test 
E9. The person doing the test addressed any 
concerns I had 
E10. I felt I could stop the test if it became too 
uncomfortable 
F1. I was satisfied by the explanation given to me by 
the person doing the test 
2 Discomfort 
during the test 
E14. How long did the discomfort last during the 
test? 
E15. How many times did you experience discomfort 
during the test? 
E19. Overall, the test was more uncomfortable than 
I expected 
3 Anxiety and 
expectations 
about the test 
and results 
B10.I felt anxious about what the test would involve 
B12. I felt anxious about the results of the test 
B14. I expected the test to be painful 
B15. I was worried that inserting the tube/ camera 
would be uncomfortable 
F6. I was worried about the test results 
4 Before coming 
for the test 
B1. I was happy with the way I was referred for the 
test 
B2. The time from first being referred to having the 
test done was satisfactory 
B5. Before coming for the test, I was given enough 
information about what the test would involved 
B6. The information I received before the test was 
easy to understand 
B7. After reading the information, I did not have any 
questions about the test 
B8. The instructions on what I needed to do before 
the test were easy to follow 
B9. I had enough time to discuss the test with the 
person who referred me 
5 At the hospital, 
before the test 
D2. I was comfortable while sitting in the waiting 
area 
D3. I felt able to ask the staff any questions before 
the test 
D4. I had no unanswered questions before the test 
D5. I had enough privacy when waiting for the test 
6 Recovering F3. I had discomfort before I left the hospital/ clinic 
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from the test F4. I had discomfort after I left the hospital/ clinic 
F5. It took longer than I expected to recover from the 
test 
7 Embarrassme
nt during the 
test 
E11. I felt embarrassed during the test 
E21. I felt embarrassed by the discomfort I 
experienced 
Table 6.25: List of principal components and descriptions 
 
Inspection of the component matrix (table 6.26) indicated that component 1 (the test 
itself) correlated with component 4 (before coming for the test) and component 5 (at 
the hospital, before the test). All other relationships between components were 
relatively small.   
 
Component Correlation Matrix 
Component 1 2 3 4 5 6 7 
The test 
itself 



















.448 .057 .112 .378 1.000 .242 -.115 
Recovering 
from the test 




-.093 -.090 -.121 -.007 -.115 -.109 1.000 




6.9. Reliability of Scale 
The Cronbach’s α score for all seven components was >0.6 with six over 0.7. This 
suggests good internal consistency (Table 6.27). The overall reliability was 0.897. 
Component α 
The test itself 0.904 
Discomfort during the test 0.791 
Anxiety and expectations about the 
test and results 
0.773 
Before coming for the test 0.879 
At the hospital, before the test 0.811 
Recovering from the test 0.866 
Embarrassment during the test 0.622 
Overall 0.897 
Table 6.27: Internal consistency of scales 
6.10. Reliability of Section C 
Cronbach’s alpha was 0.592 when all six questions in section C were included in a 
reliability analysis. Corrected item-total correlations suggested that two questions 
correlated poorly with the overall total: C5 (I was worried that the bowel preparation 
would not clear my bowel properly, ITC 0.021) and C6 (I had enough privacy when 
getting ready for the test, ITC -0.011). When these two items were removed, the 
overall reliability of the scale improved to 0.693, indicating reasonable reliability.  
6.11. Discussion 
6.11.1. Key Findings 
The response rate was 48.5%, with a mean respondent age of 58.6. The response 
rate did not vary by sex; however, it was lower in those aged ≤54 years (30.4%) and 
in patients undergoing ‘OGD& colonoscopy’ (29.4%); however, only 34 individuals 
who had both OGD and colonoscopy were approached to take part in the study. 
There was a discrepancy between the patient reported procedure and the procedure 
confirmed by the research team in 53 cases (6.6%).   
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Section C, which should have been completed by those undergoing colonoscopy and 
CTC only, was completed by 96.1% of participants to whom it applied and 18.0% of 
those to whom it did not.  
Completion rates of individual questions were high, with only three questions 
showing missingness of over 5%, and none over 10%. Excluding section C, one third 
of participants (34.3%) failed to complete one or more questions, and the oldest age 
group (>75 years) were significantly more likely to miss questions. 3.9% of 
participants to whom Section C applied missed questions within this section, with 
patients in the oldest age group significantly more likely to miss questions. 
For the two VAS questions, the responses were formatted correctly by only 55.2% 
(E13, discomfort) and 60.3% (E16, pain) of respondents. Analysis showed these 
scores were correlated but responses for pain were systematically lower than for 
discomfort.  
Two pairs of questions correlated strongly (rs >0.8) and four questions poorly 
correlated with any others (rs <0.3). Eight questions (including the four with poor 
inter-item correlations) had poor corrected item-total correlation (ITC <0.3). Some 
questions with poor correlation also had higher missingness, i.e. D1 (I waited longer 
in the department than I expected); F8 (When I left the hospital, I was unsure of how I 
would get the results of my test); F9 (I was happy with the way I received the results 
of my test); F10 (I received the results of my test sooner than I expected).  
Principal components analysis identified seven components (The test itself; 
Discomfort during the test; Anxiety and expectations about the test and results; 
Before coming for the test; At the hospital, before the test; Recovering from the test; 
Embarrassment during the test), all of which had Cronbach’s alpha of >0.6. 
6.11.2. Strengths and limitations of this phase 
This phase of the project was undertaken across four different sites in order to 
increase diversity of patients and experiences. A good range of participants were 
included. There was notable variation in the numbers of participants recruited per 
procedure type; only ten patients who had OGD & colonoscopy responded to the 
questionnaire (of 34 invited) and 115 CTC participants (of 209 invited). Far fewer 
137 
 
CTCs are done at each of the sites than OGD and colonoscopies and this was 
reflected in the number of participants recruited in this group.  
In terms of limitations, there was little diversity in ethnicity amongst respondents, with 
98.4% self-reporting as White British. This is in keeping with ethnicity data for the 
region, which indicates that the North East has the highest percentage of White 
British residents (93.6%) within England and Wales (Office for National Statistics, 
2011). This may also indicate that non-White British groups are less likely to respond 
to the questionnaire and translation of the questionnaire could be considered. The 
small percentage of non-White British ethnicity means that the performance and 
properties of the questionnaire are not known in this group.  
A recruitment log was kept in order to monitor characteristics of respondents and 
non-respondents. However, patients who were approached but who declined to 
participate in the study were not reliably recorded by the research teams, in part 
because they had not been asked to consent to their details being logged. It was not 
possible to be certain that every eligible patient was systematically invited to take 
part. There are significant differences between respondents and non-respondents in 
terms of age and the procedure undertaken, which is indicative of non-response bias; 
this may have implications if the data was used subsequently to measure experience. 
Non-response bias has been studied elsewhere, with lower age groups and females 
less likely to respond (Etter et al., 1997). In this study, only the former was observed. 
6.11.3. Timing of questionnaire 
Participants were asked to post the completed questionnaire back to the research 
team, rather than complete it on the day of the test. This was in part due to the fact 
that participants who had sedation may have impaired capacity to consent to 
research as a result. 8.3% (n=66) of respondents indicated that they completed the 
questionnaire on the day of the procedure. A priori two options were identified for 
timing questionnaire distribution by the study team: giving patients the questionnaire 
pack on the day of their test or posting it at a later date. It was considered possible 
that having the results may influence how participants would respond to the PREM. 
This has been shown in a study investigating PROMs in the setting of men 
undergoing prostate biopsies (Sharp et al., 2018). Biopsy-related distress was higher 
in those with a biopsy indicating cancer or those awaiting results than those with a 
normal result. An advantage of posting the questionnaire to participants was that 
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distribution could be delayed for a period to allow them to receive the results of their 
test, if they hadn’t already received them. However, participants in the qualitative 
interviews described varying methods and timescales of receiving their test results so 
this would not have ensured that all participants had their results. Giving the 
questionnaire pack on the day of the test allowed the procedure to be relatively fresh 
in participants’ minds. The outcome of the method used was that participants varied 
in terms of whether they had had their results; some had all results (31.5%), some 
had partial results (37.8%) and some had no results (23.7%). Further analysis 
(beyond this thesis) would be valuable to explore whether experience varies in these 
groups. In retrospect, an alternative approach would be to administer the 
questionnaire at two points and ask participants to indicate whether they had their 
results at each time point. This would have enabled test-retest reliability and 
responsiveness and whether responses are impacted by receipt (or not) of results, 
and what those results show, to be assessed. 
6.11.4. Ceiling effects 
Twenty-five items within the whole questionnaire showed a ceiling effect. No floor 
effects were found. This may suggest that participants viewed their experience 
positively in these domains. However, it could also indicate that those with positive 
experiences are more likely to respond.  
In terms of performance of the questionnaire, a high number of ceiling effects may 
mean that the questionnaire is not able to discriminate between levels of positive 
experiences. Similarly, a high number of floor effects (had that been observed) would 
suggest the same for the ‘low’ end of the scale (Dean et al., 2018). Traditionally, floor 
and ceiling effects are described in relation to questionnaire scales (rather than in 
relation to individual questions) and defined, in that context, as over 15% of 
participants endorsing the highest (‘ceiling’) or lowest (‘floor’) response option 
(Terwee et al., 2007; Wamper et al., 2010). Within the field of patient-reported 
measures, a proportion of less than 40% of respondents choosing the highest or 
lowest ordinal response score to an individual item may be taken to indicate the 
absence of a significant ceiling or floor effect (Dean et al., 2018). In this study, the 
ceiling effects were broadly similar across gender, age, procedure and site, with the 
exception of question E3 (the medication worked as well as I expected), which had 
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no ceiling effect in women. Furthermore, there was no ceiling effect for this question 
in the older two age groups.  
Previous studies have indicated that positive wording can affect how questions are 
answered (McColl et al., 2001; Locker et al., 2007; Jaensson et al., 2017). This was 
the rationale for using a mixture of positive and negative wording in this 
questionnaire. It was interesting, therefore, that ceiling effects were only present in 
questions that were worded in a positive way, e.g. during the test my dignity was 
maintained at all times.  
A possible solution to the issue of ceiling effects would be to increase the number of 
Likert response options to seven. Alternatively, the wording of some of the questions 
with ceiling effects could be changed to being negatively framed. 
6.11.5. Missingness 
On an individual question basis, missing responses were low (all < 10%), suggesting 
that the questions were acceptable to participants. The rate of item non-response 
was higher among participants >75 years old. In a study of patient reported outcome 
measures (PROMs) in patients with prostate cancer, older age was also associated 
with increased missingness (Drummond et al., 2015). Previous work has suggested 
that this observation could, in part, be due to reluctance in older patient age groups 
to report poorer experience and they therefore may instead leave responses blank  
(Voutilainen et al., 2014).  
6.11.6. Pain and discomfort 
Three questions were asked about both pain and discomfort, with the objective of 
refining and reducing the number of items in the questionnaire and, specifically, 
determining in future versions whether to ask about pain or discomfort. Comparisons 
between each of the questions indicated that the paired answers were well 
correlated, but discomfort tended to be scored more highly than pain. This could be 
because either pain is seen as a more severe form of discomfort or they are 
measuring different things. This quantitative assessment does not give insight into 
the difference between pain and discomfort as perceived by patients. Therefore, it is 
not possible to discriminate whether these questions are different descriptors of a 
similar entity or whether they describe separate entities altogether, although the 
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qualitative work suggested that individuals had one of these viewpoints.  Tian et al 
describe comfort as “not only a state of peace and serenity but also relief, ease or 
transcendence from the discomfort,” and that pain is a contributor to discomfort (Tian 
et al., 2019). Using this definition and noting that discomfort appears to be rated 
higher than pain in this population, retaining questions which focus on discomfort 
rather than pain might be a pragmatic approach. Alternatively, in terms of experience, 
it may be that some discomfort during the procedure is acceptable from a patient 
experience, but pain is not, and removing these questions may not fully address this 
aspect of experience. This could be explored in future research. 
The VAS questions for discomfort and pain (E13 and E16, respectively) were 
answered by a majority of respondents (98.9% and 98.0%, respectively), however, 
only 55.8% and 61.6% of respondents, respectively, answered these in accordance 
with the instructions. This problem was not identified in cognitive pretesting. In 
addition, there was a problem with data entry- both VAS on every questionnaire had 
to be measured (by LN) and the data re-entered. This was a laborious process and 
raised questions about the practicality of using a VAS in the questionnaire going 
forward. A solution to these problems could be to alter the VAS to make it clearer, 
remove the numbers from the ‘line’ or to change the scale to a numerical rating scale. 
Another approach could be to categorise responses into four or five groups, however, 
given the variable response modes even this could prove cumbersome in a practical 
setting. The final option would be to remove the VAS questions from the 
questionnaire and retain the other Likert response questions.  
6.11.7. Exploratory factor analysis 
There was not an intention from the outset to create a questionnaire with subscales. 
Principal components analysis suggested seven factors which accounted for 61.5% 
of the variation in the data. Evaluation of the scree plot indicated that three factors 
could be retained, however, the three-factor solution only explained 44.8% of the 
variation. Seven factors had eigenvalues >1 and explained 61.5% of the variation. 
Four of the factors appeared to be related to stages of the procedure (experience 
before coming for the test; at the hospital, before the test; the test itself; recovering 
from the test), whereas the remainder seemed to cover some aspects of the over-
arching themes identified in the qualitative interviews (discomfort during the test; 
anxiety and expectations about the test and results; embarrassment during the test). 
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Cronbach’s alpha was over 0.7 in all components aside from embarrassment, which 
was comparatively low at 0.622. Kline (2000) and Field (2018) suggest that α >0.7 
indicates good reliability. Whilst the embarrassment component had a relatively low 
reliability, this could in part be explained by the fact that the scale only comprised two 
questions (which had a correlation of 0.454). 
6.12. Summary 
In summary, psychometric testing of the PREM identified low rates of missingness 
and 25 questions with a ceiling effect. Pain and discomfort were correlated, but pain 
was given a lower score than discomfort. Seven factors were identified which explain 




Chapter Seven: Discussion  
7.1. Summary of work 
The preceding chapters have described the rationale for and the methodological 
approach to developing the Newcastle ENDOPREM™. Phase one described the 
patient experience of GI procedures and six over-arching themes were identified 
stretching across six procedure stages. Phase two involved item generation and 
refinement followed by cognitive pre-testing with patients who had recently 
undergone GI procedures. This phase resulted in a pilot PREM. The psychometric 
properties of the questionnaire were investigated in phase three.  
The key findings, strengths, limitations and discussion of each phase in the context of 
the literature are described in the discussion at the end of each chapter. This final 
discussion aims to discuss the ENDOPREM™ in the context of patient experience of 
GI procedures, make suggestions about further refinements and future research and 
to discuss the potential future uses of the ENDOPREM™.  
7.1.1. Domains of patient centred care 
The over-arching themes which emerged from the phase one qualitative interviews 
were: anxiety, expectations, choice & control, information & communication, dignity & 
embarrassment and comfort. The Picker Institute has defined eight principles of 
patient centred care; respect for patients’ preferences; coordination and integration of 
care; information, communication and education; physical comfort, emotional support 
and alleviation of fear and anxiety; involvement of family and friends; continuity and 
transition; access to care (Picker Institute Europe, 2019). There is some overlap 
between the themes identified in the current study and the Picker dimensions. 
Information & communication in the current study is broadly related to information, 
communication and education. Physical comfort is addressed by both the current 
study and the Picker domains. The themes of anxiety and expectations which 
emerged from the current study are covered partly by ‘emotional support and 
alleviation of fear and anxiety’ in the Picker domains, however, emotional support did 
not emerge during the qualitative interviews. This could be that emotional support is 
not required for these procedures, whereas it may be important to patients 
undergoing treatment for cancer, for example. The domains of continuity and 
transition and access to care did not emerge as over-arching themes from the current 
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study. However, some participants did express a preference for continuity of 
endoscopist rather than convenience of appointment, for example. This was included 
in the ‘choice & control’ theme. The differences between the themes identified in the 
current study and the domains of patient centred care may partially be explained by 
the fact that the ENDOPREM™ focuses on the experience of a specific (usually one-
off) procedure after the patient has been referred, meaning that items such as 
continuity of care and involvement of family and friends may be less relevant.  
7.2. Refining the questionnaire 
7.2.1. Item reduction 
Question B16 (I hoped the person doing the test would be the same sex as me) 
correlated weakly with other questions. It had been designed to identify patients’ 
preference for endoscopist gender and to enable comparison with embarrassment in 
further analyses (out with the remit of this thesis). In retrospect, the question did not 
require the Likert responses ‘strongly agree’ to ‘strongly disagree’ as it was an 
explanatory question, rather than a question about experience. Furthermore, the 
wording of the question was complex, in that it asked participants about their ‘hopes’ 
for the person doing the test. For future versions of the ENDOPREM™ this question 
could be removed and replaced with a simpler question, for example: I would prefer 
the person doing the test to be the same sex as me (response options: yes/ no/ I 
don’t mind).  
Question F2 (I was pleased with the refreshments offered) did not fit in to any of the 
over-arching themes identified in the qualitative interviews but had been included as 
several participants described the importance of a ‘cup of tea’ and its’ significance in 
representing the end of the procedure. The question did not correlate strongly with 
any others and 75.6% either agreed or strongly agreed with the statement (bearing in 
mind that 18.0% stated they were not offered a refreshment as they had throat 
spray). This question should be removed from future versions of the questionnaire.  
Question D1 (I waited longer in the department than I expected) correlated poorly 
with other items. The question was worded in terms of expectations because 
participants in the qualitative interviews described waiting longer than expected as 
having an impact on anxiety. In the pilot questionnaire, participants could have 
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waited for several hours in the department but if this is what they expected then they 
would disagree with the statement. This means that negative experiences could be 
missed. Given the poor correlation with other items, this question could be removed 
from future questionnaire versions. An alternative would be to reword the question to 
something more direct, for example: I waited too long in the department before the 
test.  
Question F8 (When I left the hospital, I was unsure of how I would get my test 
results) was another item that correlated poorly with any others. This was one of four 
questions addressing the results of the test and followed an ‘explanatory’ question 
which asked participants to identify how they received their results. The question was 
reasonably complex; however, no problems were identified with it in cognitive pre-
testing of the questionnaire. Given the poor correlation with others, and relatively 
high missingness, this item could be removed from the questionnaire.  
Responses to questions F3 (I had discomfort before I left the hospital/ clinic) and F4 
(I had discomfort after I left the hospital/ clinic, eg when I got home) had a similar 
distribution of responses and correlated highly with one another. This could be 
because patients who had discomfort at home were more likely to have had this in 
the hospital/clinic, or it may be that participants are unable to discriminate between 
the two. The questions could be refined into one question, for example, I had 
discomfort after the test. 
Several items were included for both pain and discomfort, as described in chapters 4 
and 5. The VAS questions were answered using an incorrect response format by 
44.8% (E13, discomfort) and 39.7% (E16, pain) of respondents. The question could 
be restructured by removing the numbers from below the line, therefore removing the 
ability to circle a response. Alternatively, a numerical rating scale could be used. Due 
to the high number of questions assessing both pain and discomfort, removing the 
VAS and instead keeping the other two questions would be an alternative option. 
Aside from the two VAS questions, a further six questions address pain and 
discomfort: E14 and E17 (How long did the discomfort/pain last during the test?); E15 
and E18 (How many times did you experience discomfort/pain during the test?); E19 
and E20 (Overall, the test was more uncomfortable/ painful than I expected). Both 
sets of questions were included to identify whether participants answered differently 
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for discomfort and pain, with the goal of removing one set of questions. When the 
pain and discomfort responses were cross-tabulated for each of these questions, the 
responses were well correlated, and pain tended to be scored less highly than 
discomfort. This could indicate that pain is a more severe form of discomfort, but also 
the two could represent different concepts. More missing responses were observed 
for pain than discomfort. If the discomfort questions are removed, patients who 
experience non-painful discomfort may not be identified. Another option would be to 
remove the questions about pain. It could be argued however, that some non-painful 
discomfort may be acceptable, but pain is not. Therefore, both sets of questions, 
excluding the VAS, have been retained for the next iteration of the ENDOPREM™. 
Further analysis could be undertaken to better understand what is associated with 
pain and discomfort and this could shed further light on these concepts. 
7.2.2. Item rewording or restructuring 
Ceiling effects were present in 25 questions, all of which were positively worded. It 
may be that this patient population genuinely had ‘positive’ experience of these 
items. Although some questions in the pilot PREM were negatively worded, the 
majority were positive. One solution would be to restructure some of these questions 
to be negatively worded.  
Questions F8 – F10 all addressed how or whether participants had received their 
results (When I left the hospital, I was unsure of how I would get my test results; I 
was happy with the way I received the results of my test; I received the results of my 
test sooner than I expected) and were situated in a ‘cluster’ within Section F of the 
questionnaire. Additional responses were included to allow participants to indicate if 
they already had their results (F8) or did not yet have their results (F9, F10). A similar 
percentage of respondents used the additional response option in each question 
(29.5%, 30.8% and 34.9%, respectively); in addition, 23.7% of participants had 
reported in a previous question that they did not yet have their results. This suggests 
an issue with the consistency of the additional response option and suggests that 
one of the additional response options (F8) has been misread. The questions should 
be reworded to ensure the same response options are offered for each question.  
Question F7 was used as an ‘explanatory’ question to identify whether patients had 
received all, some or none of their results. Several response options were provided, 
including; I do not have my results, I was told some results but have to wait for a 
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biopsy/tissue sample, I was told all of the results before I left the hospital, the results 
were posted to me, I received a written copy of all of the results before I left the 
hospital, I received a written copy of some of the results before I left the hospital but 
have to wait for a biopsy/tissue sample, I received my results in a different way (free 
text). Participants were asked to indicate all responses that applied to them. No 
problems with this question were identified in the cognitive pre-testing. The response 
options are long and as participants can choose more than one option, this could 
make identifying who actually had their results and who didn’t difficult. Simplifying the 
question in future versions would overcome this, for example: Have you received the 
results of your test? Response options: I have received all of the results; I have 
received some of the results; I have not received any results. 
Questions B5 (Before coming for the test, I was given enough information about what 
the test would involve) and B6 (The information I received before the test was easy to 
understand) were strongly correlated (rs >0.8). This may indicate that participants 
perceived these questions to be addressing the same issue. For future versions of 
the final questionnaire, B6 could be removed. The rationale for this is that if 
participants agree that they have been given enough information, this implies that 
they understood it.  
7.3. Using the questionnaire in practice 
7.3.1. Potential uses 
There are two broad potential uses for the ENDOPREM™; to assess patient 
experience in routine practice or as a research tool. For the former, ENDOPREM™ 
could be used as a tool to assess patient experience of OGD, colonoscopy and CTC. 
This could be used either within a single site to monitor care over time or in multiple 
sites to compare care across sites. This could identify areas where patient 
experience is negative and enable aspects to be targeted to improve the overall 
patient experience. The Global Rating Scale (GRS) in the UK is not prescriptive 
about how patient experience should be measured (Joint Advisory Group on 
Gastrointestinal Endoscopy, 2016a). Potentially, the ENDOPREM™ could be 
introduced as part of the Joint Advisory Group on Gastrointestinal Endoscopy (JAG) 
accreditation process to standardise reporting of experience between units. This 
would also be useful to benchmark quality of care.  
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The ENDOPREM™ could also be used as a research tool, for example, to compare 
patient experience between procedures. Its use could also be extended to assessing 
patient experience where new interventions or processes are introduced to GI 
procedures, for example, in studies assessing interventions to improve pathology 
detection, the ENDOPREM™ could be used to identify if such interventions impact 
patient experience. A specific example of this is the ADENOMA study, which 
investigated adenoma detection rate in patients undergoing colonoscopy with a 
device attached to the colonoscope compared to those undergoing standard 
colonoscopy (Ngu et al., 2018). A secondary outcome of the study was to 
demonstrate non-inferiority in terms of comfort and patient experience. This was 
measured using a nurse-reported comfort score and patient reported comfort specific 
to endoscope insertion. Potentially, ENDOPREM™ could be used to assess the 
impact of such interventions on patient experience.  
The ENDOPREM™ was developed to measure patient experience of endoscopy 
procedures (OGD and colonoscopy) and the most common alternative, CTC. 
Transnasal endoscopy is an increasingly popular approach to OGD and therefore 
participants who had undergone this procedure were included within the OGD 
recruitment to all stages of the study. For example, video-capsule endoscopy (VCE) 
has been developed as a means of imaging the small bowel. This involves 
swallowing a pill-shaped capsule containing a camera, which takes pictures through 
the GI tract and transmits this to an external data recorder (McAlindon et al., 2016). 
VCE is also being used to assess the colon and stomach, meaning that this may 
become more commonplace (Parker et al., 2015). Future use of the ENDOPREM™ 
could be to compare patient experience of capsule endoscopy with optical 
endoscopy, however, this would require validation of the ENDOPREM™ in a capsule 
population.  
7.3.2. Self-report of procedure undertaken 
7.1% of participants reported that they had undergone a different procedure from the 
actual procedure recorded by the research team. Participants may have had another 
test in the recent past which could partially explain this. This raises the issue as to 
whether patient self-reporting is reliable enough for future use. The procedure 
descriptions used in the pilot questionnaire did not raise any issues in the cognitive 
pretesting. A solution to this may be to add visual guides, for example, to aid 
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participants in reporting their procedure. This would not combat the issue of patients 
who have had multiple recent procedures but could help with those who are 
uncertain from the text descriptions about which procedure they had. A more 
accurate approach would be for staff issuing the questionnaire to mark the procedure 
undertaken. This could take the form of a sticker or letter printed on the inside cover 
but would be labour intensive and may not be possible in a non-research setting.  
7.3.3. Questionnaire length 
The pilot PREM was a fifteen-page booklet with 73 questions (including patient 
characteristics, ‘explanatory’ questions and section C). The number of missing 
responses did not systematically decrease as the questionnaire progressed, 
suggesting that length was not an issue for patients who responded to the 
questionnaire. Other studies comparing long and short versions of questionnaires 
have shown no significant effect of questionnaire length on response rate (Mond et 
al., 2004; Robb et al., 2017; Koitsalu et al., 2018). As a result, item reduction- here 
and in the future- should concentrate on removing questions that did/do not perform 
well and allow retention of most questions to address the whole patient experience, 
as described in the qualitative interviews.  
7.3.4. Questionnaire versions 
In order to reduce the effect of patients reporting the incorrect procedure, different 
paper versions of the questionnaire could be used, for example, creating procedure-
specific questionnaires with the procedure printed on the questionnaire. This could 
also include colour coding questionnaires according to procedure and removing 
section C (Preparing for the test) from questionnaires given to OGD patients.  
An alternative to paper questionnaires could be converting the PREM to an online 
questionnaire. This would result in a lower price per respondent, as physical copies 
of the questionnaire, postage and return envelopes would not be required. 
Consideration would need to be given to the issue of online data security and how 
much potentially identifiable information is collected, in addition to the acceptability of 
an online questionnaire in specific patient groups, for example, older age or those 
without internet access. A study in Poland investigated the difference in asking 
patients to complete a paper based questionnaire (asking questions about comfort 
and complications) following screening colonoscopy, compared with an intervention 
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group who were given the choice of paper, telephone or an online version of the 
questionnaire (Bugajski et al., 2019). This found no difference in the overall response 
rate, but significantly improved response rate of patients <60 years old in the 
intervention group. The response rate in the current study was lowest in patients 
aged <55 years. A digital version of the questionnaire may increase response in this 
group but would require further validation and testing of acceptability.  
7.3.5. Timing of questionnaire 
The timing of questionnaire distribution has been discussed elsewhere in this thesis 
(sections 3.2.3, 3.3.4, 6.11.3). In this study, the questionnaire was handed to patients 
in the endoscopy/ radiology department and they were asked to return it within two 
weeks. There was variation in the time taken to return the questionnaire, with 
evidence that some respondents completed it on the day of the procedure. Further 
study is suggested in which the questionnaire is administered at different time points, 
for example, in the department and two weeks following the procedure. This would 
provide further information about the reliability of the PREM but also about whether 
patients report their experience differently at varying stages of the procedure 
process.  
7.4. Future Research 
In addition to the psychometric properties and refinements discussed in this thesis 
(chapter six and seven), further analysis is suggested prior to use of the 
ENDOPREM™.  
Further research could focus on administering the questionnaire at different time 
points and comparing the responses, for example, on the day of the procedure and 
two weeks later. Comparison of the results would identify whether the measurement 
is stable over time (test-retest reliability) and whether the instrument responds to 
changes over time, for example before and after the patient receives results 
(responsiveness) (Streiner et al., 2008).  
A measure of depression, anxiety and stress (DASS 21) and a quality of life measure 
(EQ5D) were included in the pilot questionnaire booklet. The ENDOPREM™ was 
designed to measure patient experience of GI procedures and not solely state 
anxiety or quality of life. Further analysis could focus on whether these measures 
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correlate with the ENDOPREM™, to ensure discriminant validity, i.e. whether 
ENDOPREM™ measures different aspects from the quality of life measure (Streiner 
et al., 2008). As anxiety was an over-arching theme identified in the qualitative 
interviews, the DASS 21 may correlate to some extent with the ENDOPREM™. 
Further analysis could therefore assess the convergent validity of the PREM. In 
addition to this, comparison of different anxiety states and patient reported quality of 
life could be undertaken to identify their effect, if any, on patient experience of GI 
procedures.  
Analysis could be undertaken to describe the patient experience in the pilot study. 
This could include comparison of different groups (for example, sex, age groups, 
procedure) and use of the ‘explanatory’ questions to identify whether endoscopist/ 
operator gender or cancellation of the initial appointment affects experience.  
Although individuals who had undergone transnasal endoscopy were included in the 
pilot questionnaire phase, they only accounted for 0.8% of participants. Further 
research could be undertaken in this patient group to identify how the questionnaire 
performs in this group. Additional groups in whom the ENDOPREM™ could be tested 
include those undergoing video capsule endoscopy. 
The ENDOPREM™ was only tested in English in this pilot work. Future research 
could include translation of the questionnaire with subsequent validation studies. The 
benefits of this could include improved uptake of non-White British participants, for 
example, or use of the ENDOPREM™ in different countries. 
7.5. Summary 
In summary, this thesis has described the stages of the ENDOPREM™ questionnaire 
development and its psychometric properties. Further analysis of responsiveness 
and test-retest reliability are recommended prior to use. Future potential uses include 
comparing patient experience in single units over time, across multiple sites or within 




Chapter Eight: Student Reflection 
 
Undertaking this research project has been an informative experience. The mixed 
methods approach has enabled me to learn and develop skills in different research 
areas. I have developed skills in qualitative interviewing and analysis. Exploring in-
depth experiences of GI procedures with participants challenged my own practice as 
an endoscopist, and really impressed upon me the importance of good 
communication with patients during these procedures. A key challenge within the 
qualitative phase (both the qualitative interviews and later the cognitive interviews) 
was my dual role as an endoscopist and researcher. I learned the importance of 
maintaining an impartial, academic approach to the interviews and analysis. This was 
mitigated somewhat by having a non-GI supervisory team and wider study team.  
Item generation for the questionnaire involved several team members, detailed in the 
methods chapter. Working in a team can be challenging in terms of bridging different 
views and opinions. Despite being familiar with working in and leading a clinical 
team, I developed teamworking and leadership skills throughout this project within a 
completely different team dynamic.  
I generated the initial items and coordinated circulation of the question bank, 
teleconferences and refinement of the final questionnaire. I realised the importance 
of cognitive pre-testing with a range of patients and its role in identifying ‘problem’ 
questions. Prior to this study I had some experience of statistical analysis, having 
undertaken a Postgraduate Diploma in Clinical Research at Newcastle University. 
Investigating the psychometric properties of the questionnaire allowed me to build on 
this knowledge, assess the appropriateness of various statistical techniques and 
evaluate the results. I am now much more confident with statistics and SPSS® as a 
result. Completing this thesis has further developed my skills in academic writing and 
reporting results. 
Managing a multi-phase study across several sites allowed me to further develop 
skills in organisation, team-working, time management and problem-solving, all of 
which are transferable skills useful for future practice.  
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A personal challenge in completing this thesis was doing so while working in a busy 
clinical role, completing clinical training and commencing a consultant post.  This has 
required good time management and organisational skills. The importance of 
enjoying life away from work has become clear to me in terms of relaxation and 
improving productivity when working to a long-term deadline.  
I hope to continue to use and build on the skills learned during this project in future 




















































Appendix D: Interview Topic Guide 
SCOPE ME Interview Schedule 
 This interview schedule is intended to be a guide for the researcher conducting the 
interviews. Not all of the questions listed will be asked, and the order of the questions may 
vary; this will depend on the participants’ responses. 
Introduction 
The purpose of this interview study is to explore your experience of gastrointestinal 
procedures, in order to develop a questionnaire which can be used to assess patient 
experience. To do this, I will ask you questions regarding your recent test. Please go into as 
much detail as you can, what you have to say is very valuable information. 
The interview will last approximately 30 minutes. Everything you say is strictly confidential 
and anonymous, and you don’t have to talk about anything that you find uncomfortable. 
This is not a test so there are no wrong answers, so please be as honest as you can. 
Remember, you are free to withdraw at any time and do not need to give a reason for 
withdrawal. A decision not to take part or to withdraw your consent will not affect any of 
your future treatments within the NHS. 
Do you mind if I tape record our interview? 
Are you happy to continue? 
General Background 
• Could you start off by telling me a little bit about yourself please? 
• So to begin with, is this the first time you’ve had the test? 
o Any previous endoscopies? 
The Procedural Experience 
• Please can you tell me about your experience of the test? We’re thinking about the 
process as a whole- from the time you were referred to the results. Tell me about the 
events and experiences which were important for you. 
o Pre-test 
§ How did you come to be referred for the test?  
• Did you understand why you were having the test? Did you have a 
choice? 
§ How did you feel about having the test? 
• Did you know what to expect? How long did you have to wait?  
• Did you have enough information about the test, pros and cons? 
§ How did you get on with the preparation?  
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§ How did you get on when you arrived at the hospital to have your test? 
• Any problems with arriving at the hospital? 
• Was there anything that made waiting for your appointment easier or 
more difficult? 
o Eg appointment times, choice, availability 
• How did you feel about getting ready to have the test? Was there 
anything that made getting ready for the test easier or more difficult? 
o Did you need to do anything specific before the test? (eg 
change clothes, decide about sedation)  
o What are your views on the hospital facilities? 
o During the test 
§ How did you feel while you were having the test? 
• How did the procedure go? Some people say they don’t feel a thing, 
some say it’s uncomfortable and some say it’s painful to various 
degrees. What would you say? 
• Was there anything that made having the test easier or more difficult? 
• Did you have sedation? How did you decide on this? Choice? 
• Was there anything that stuck out about the various members of staff 
that you met during the process? How did the staff treat you? 
o If satisfied with staff, ask if there was anyone they were not 
impressed with or less impressed with  
o After the test 
§ How did you feel immediately after having the test? 
• Was there anything that made the recovery process easier or more 
difficult? 
§ How did you feel in the days following the test? 
• Was there anything that made the recovery process easier or more 
difficult? 
• Did you know what was going to happen next? 
§ How do you feel now about having had the test? 
• How would you feel if you had to have the test again? 
§ Were the test results explained to you? Have you received the results of your 
test?  
 
o What advice would you give to someone having the test? 
Summary 
• What things do you think are important in making sure patients have a good 
experience of the process? 




• What part of the procedure were you most satisfied with? 
• What part of the process did you find most difficult? 
 
Closing the Interview 
• Is there anything about your experience I haven’t asked that you would like to talk 
about? 
 
We will transcribe this interview and once all of the interviews we are conducting are 
transcribed, we will begin to analyse them. Any identifiable information about you (eg your 
name) will be kept separate from the data file so that you cannot be recognised from it. Any 
names that you have mentioned during the interview will also be changed in order to ensure 
anonymity and confidentiality. The results will be presented at medical conferences and 
published in academic journals. You will not be identified in any publication. Unless there is 




Appendix E: Study Team 
This appendix describes the members of the wider study team and their roles within 
this study (supervisory roles are not described in detail here): 
• Laura Neilson, LN (student): Gastroenterology research fellow 
• Contributed to methodological approach. Undertook qualitative interviews, 
qualitative analysis and focused literature review to identify initial topics. 
Generated initial question bank and led review and revision process within 
wider team. Worked with graphic designer to design questionnaire layout 
and appearance. Undertook cognitive interviews and analysis, with revision 
of questions and review with team where needed. Developed additional 
information sheets and led questionnaire phase. Cleaned questionnaire 
data and performed statistical analysis. 
• Colin Rees, CR (clinical supervisor): Professor of Gastroenterology/ 
Consultant Gastroenterologist 
• Chief investigator. Devised idea and methodology. Oversaw all phases of 
project. Participated in review and revision of questions. 
• Linda Sharp, LS (academic supervisor): Professor of Cancer Epidemiology 
with an interest in patient experience measures and patient reported outcomes 
(LS) 
• Contributed to methodological approach. Reviewed qualitative interview 
transcripts and supervised qualitative analysis. Advised on cognitive 
interviewing techniques, supervised analysis of cognitive interviews. 
Supervised statistical analysis.  
• Joanne Patterson, JP (academic supervisor): Clinical Academic Speech & 
Language Therapist and Clinical Lecturer with an interest in patient reported 
outcome and experience measures 
• Contributed to methodological approach. Reviewed qualitative interview 
transcripts and supervised qualitative analysis. Advised on cognitive 
interviewing techniques, supervised analysis of cognitive interviews. 
• Christian von Wagner, CW: Reader in Behavioural Science in Health with an 
interest in the acceptability and patient experience of participation in colorectal 
cancer screening  
• Participated in review and revision of questionnaire items 
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• Paul Hewitson, PH: Senior Research Officer with an interest in the design 
and construction of questionnaires, development and evaluation of PROMs 
and PREMs 
• Participated in review and revision of questionnaire items 
• Lesley McGregor, LM: Academic Psychologist with an interest in qualitative 
methodology and PREMs  
• Advised on qualitative interview technique. Double coded three qualitative 
interview transcripts  
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SCOPE-ME Pilot Questionnaire Phase Outcome Information 
The following questionnaires have now been returned. Please fill in the missing data from the patient record/ recruitment log and 
send back to the research team at South Tyneside (key below). Boxes with a * will be completed by the South Tyneside Research 






























          
          
          
          
          
          
          
          
          




Outcome Information Key 
Procedure Undertaken 
1 OGD 
2 Transnasal endoscopy 
3 Colonoscopy 
4 CT Pneumocolon/ CT Colonoscopy 
 
Indication 
OGD and TNE Colonoscopy and CTC 
1 Dysphagia 20 Diarrhoea (looser 
stools/ more 
frequent) 
2 Weight loss 21 Constipation 
3 Dyspepsia (inc 
heartburn, reflux, 
epigastric pain) 
22 Rectal bleeding 
4 Persistent 
nausea/vomiting 
23 Iron deficiency 
anaemia 
5 Upper abdominal 
mass 
24 Family history of 
colorectal cancer 
6 Iron deficiency 
anaemia 
25 Polyp surveillance 
7 Abnormal imaging 26 Abdominal pain 
8 Confirm ulcer 
healing 
27 Abnormal imaging 
9 Coeliac disease 
diagnosis/ Positive 
TTG or anti EMA 




29 Surveillance after 
colorectal cancer 
resection 
11 Varices surveillance 30 Planned 
polypectomy 
12 Suspected GI 
bleeding 





14 Other   
 
Medication given (excluding buscopan) 
 
 
Primary Diagnosis (main diagnosis) 
OGD and TNE Colonoscopy and CTC 
1 Normal 20 Normal 
2 Upper GI Cancer 21 Lower GI Cancer 




23 Diverticular disease 
5 Peptic Ulcer (any 
site) 
24 Inflammatory Bowel 
Disease 
6 Varices 25 Angiodysplasia 
7 Other  26 Other  
 
Endoscopist Grade 
1 Consultant Surgeon 
2 Consultant Gastroenterologist 
3 Trainee (supervised) 
4 Trainee (unsupervised) 
5 Staff Grade/ Associate Specialist (supervised) 
6 Staff Grade/ Associate Specialist 
(unsupervised) 
7 Nurse endoscopist (supervised) 
8 Nurse endoscopist (unsupervised) 
9 Other 
10 CTC so no endoscopist 
 
Complications 
1 Bleeding requiring admission/transfusion 
2 Perforation 
3 Hospital admission 
4 Reversal of sedation 
5 No complication 
 
1 Midazolam only 
2 Midazolam and Pethidine/Fentanyl 
3 Midazolam, Pethidine/Fentanyl and Entonox 
4 Pethidine/Fentanyl only 
5 Pethidine/Fentanyl and Entonox 
6 Midazolam and Entonox 
7 Entonox only 
8 No medication 
9 Other analgesia/sedative 
200 
 
Appendix I: Pain and discomfort review 
For patients undergoing colonoscopy, some described pain or discomfort at very 
distinct stages of the procedure, for example, when the camera was ‘going round a 
bend’ or inserting the camera. Others felt the whole procedure was painful or 
uncomfortable and others felt no pain or discomfort. For CTC patients who 
experienced pain or discomfort, the majority did not associate this with a specific 
stage of the procedure. Two patients attributed their discomfort to air being inserted. 
There was variation in OGD patient’s description of discomfort. Some felt that 
insertion of the camera was the most uncomfortable part, whereas others described 
general discomfort. Compared to the CTC and colonoscopy groups, these patients 
tended to use the words ‘uncomfortable’ or ‘discomfort’ rather than pain. Some 
participants described nausea and retching as contributing to their discomfort. One 
participant described a difference between pain and discomfort:  
“When I say it wasn’t painful, it wasn’t as though somebody was sticking a 
knife in you, it was just uncomfortable.” G4 
Following review of the qualitative data, a focused literature review was conducted to 
identify descriptions of pain and discomfort and the potential differences between the 
two. Jensen et al (1986) compared six different methods of measuring the intensity 
of clinical pain in patients with chronic pain. The study found similar performance of 
visual analogue scales (VAS), numerical rating scales (NRS), verbal rating scales 
(VRS), behaviour rating scales (BRS) and box scales. A more recent systematic 
review concluded that NRS tended to have high compliance rates and were easy to 
use compared to VRS and VAS, but corresponded well with VAS scores (Hjermstad 
et al., 2011). Various tools to measure pain and discomfort already exist, for 
example, the McGill Pain Questionnaire. This is a multidimensional tool which 
assesses pain using different scales and descriptors, however, the language and 
detail within this tool did not reflect the experience detailed in our qualitative analysis 
(Melzack, 1975). 
Specific to GI procedures, a four point Likert scale was developed in the UK to 
enable nursing assessment of patient discomfort during colonoscopy using four 
descriptors: no discomfort, mild discomfort, moderate discomfort and severe 
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discomfort (Rostom et al, 2013). This score correlated moderately well with the 
patient’s recalled comfort score on discharge. A Norwegian group designed a post-
procedure questionnaire for colonoscopy, asking patients if the examination was 
painful, in addition to whether ‘colicky’ pain or other discomfort was experienced 
during the procedure (Hoff et al., 2006). A four-point VRS was used, in addition to a 
similar question format asking how long the pain or discomfort lasted. This was 
validated in the screening colonoscopy population and later used in observational 
studies (Bugajski et al., 2018). A different approach using a 100mm VAS assessed 
real-time insertion pain during colonoscopy when comparing water exchange 
colonoscopy with water immersion (Cadoni et al., 2015). This score significantly 
correlated with patient-reported recalled pain using the same tool on discharge from 
the endoscopy unit. Similar VAS tools have been used to assess discomfort in 
patients undergoing OGD, colonoscopy and CTC (Bretthauer et al., 2002; Cheung et 
al., 2008; De Silva et al., 2009). In the United Kingdom and Ireland, it is 
recommended that the modified Gloucester comfort score is used to assess patient 
discomfort (NHS Bowel Cancer Screening Programme, 2011; Conjoined Board in 
Ireland of the Royal College of Physicians and Royal College of Surgeons, 2016). 
This non-validated tool consists of a 5-point scale with descriptors including: 1= no 
discomfort, 2=minimal discomfort, 3= mild discomfort, 4= moderate discomfort, 5= 
severe discomfort (Ekkelenkamp et al, 2011). Other studies report using similar 
Likert-style response options to the Gloucester comfort score (Bretthauer et al, 2016; 
Ngu et al, 2019). Ngu et al, 2019, broke down discomfort according to intensity, 
number of episodes, length of each episode and at specific time points in the 
procedure, using Likert style responses. This study assessed the use of a device 
placed on the end of the colonoscope and specifically asked patients about camera 
insertion to determine whether use of the device increased the discomfort of 
colonoscope insertion. Those with the device found insertion more uncomfortable, 
whereas all other comfort domains were comparable (Ngu et al, 2019). The majority 






Appendix J: Initial questions addressing comfort 
 
E15. Overall, the test was more uncomfortable than I had expected 
Strongly agree   o     Agree   o     Neither agree nor disagree   o     Disagree   o     
Strongly disagree   o 
E16. Overall, the test was more painful than I had expected 
Strongly agree   o     Agree   o     Neither agree nor disagree   o     Disagree   o     
Strongly disagree   o 
E17. How would you rate the overall level of discomfort you experienced during the 
test?  
   
E18. How would you rate the overall level of pain you experienced during the test?
   
E19. At its worst, how would you rate the intensity of discomfort you experienced 




E20. At its worst, how would you rate the intensity of pain you experienced during 
the test? 
   
E21. How many times did you experience discomfort during the test? 
None   o      1 or 2 times   o     3 or 4 times   o     More than 4 times   o     Constantly   o 
E22. How many times did you experience pain during the test? 
None   o      1 or 2 times   o     3 or 4 times   o     More than 4 times   o     Constantly   o 
E23. At its worst, how long did the discomfort last during the test? 
I didn’t have discomfort   o     A short time   o     A moderate time   o     A long time   o 
E24. At its worst, how long did the pain last during the test? 
I didn’t have pain   o     A short time   o     A moderate time   o     A long time   o 
E25. Overall, how long did the discomfort last during the test? 
I didn’t have discomfort   o     A short time   o     A moderate time   o     A long time   o 
E26. Overall, how long did the pain last during the test? 




Appendix K: Inter-item correlations 
 
  B1 B2 B3 B5 B6 B7 B8 B9 B10 B11 B12 B13 B15 B16 
B1 1.000 0.634 0.409 0.510 0.491 0.428 0.479 0.495 0.057 0.072 -0.016 -0.046 0.016 0.074 
B2 0.634 1.000 0.359 0.475 0.464 0.338 0.428 0.409 0.049 0.075 0.002 -0.042 0.007 0.054 
B3 0.409 0.359 1.000 0.281 0.299 0.277 0.335 0.353 0.065 0.071 0.065 0.038 0.052 0.070 
B5 0.510 0.475 0.281 1.000 0.825 0.645 0.660 0.531 0.205 0.133 0.072 -0.069 0.029 0.073 
B6 0.491 0.464 0.299 0.825 1.000 0.669 0.772 0.513 0.177 0.115 0.071 -0.061 0.047 0.060 
B7 0.428 0.338 0.277 0.645 0.669 1.000 0.584 0.543 0.180 0.153 0.065 -0.021 0.048 0.045 
B8 0.479 0.428 0.335 0.660 0.772 0.584 1.000 0.555 0.186 0.125 0.101 -0.036 0.020 0.064 
B9 0.495 0.409 0.353 0.531 0.513 0.543 0.555 1.000 0.168 0.070 0.069 0.035 0.046 0.059 
B10 0.057 0.049 0.065 0.205 0.177 0.180 0.186 0.168 1.000 0.522 0.519 0.345 0.532 0.258 
B11 0.072 0.075 0.071 0.133 0.115 0.153 0.125 0.070 0.522 1.000 0.353 0.154 0.345 0.223 
B12 -0.016 0.002 0.065 0.072 0.071 0.065 0.101 0.069 0.519 0.353 1.000 0.338 0.443 0.232 
B13 -0.046 -0.042 0.038 -0.069 -0.061 -0.021 -0.036 0.035 0.345 0.154 0.338 1.000 0.547 0.133 
B15 0.016 0.007 0.052 0.029 0.047 0.048 0.020 0.046 0.532 0.345 0.443 0.547 1.000 0.268 
B16 0.074 0.054 0.070 0.073 0.060 0.045 0.064 0.059 0.258 0.223 0.232 0.133 0.268 1.000 
D1 0.116 0.129 0.119 0.090 0.097 0.089 0.108 0.017 0.070 0.100 0.078 0.087 0.138 0.092 
D2 0.188 0.192 0.210 0.241 0.256 0.164 0.268 0.167 0.136 0.133 0.127 0.077 0.082 0.107 
D3 0.341 0.308 0.297 0.386 0.386 0.273 0.381 0.295 0.117 0.099 0.040 -0.056 -0.013 0.078 
D4 0.317 0.262 0.259 0.369 0.351 0.314 0.368 0.246 0.103 0.098 0.056 -0.040 0.029 0.082 
D5 0.288 0.247 0.265 0.331 0.331 0.245 0.380 0.248 0.152 0.074 0.087 0.002 0.075 0.066 
E1 0.404 0.338 0.254 0.490 0.480 0.350 0.457 0.309 0.057 0.036 0.005 -0.098 -0.029 0.086 




Continued from page 223 (Inter-item correlations) 
 D1 D2 D3 D4 D5 E1 E2 E3 E5 E6 E7 E8 E9 E10 
B1 0.116 0.188 0.341 0.317 0.288 0.404 0.334 0.165 0.377 0.372 0.424 0.410 0.425 0.331 
B2 0.129 0.192 0.308 0.262 0.247 0.338 0.309 0.158 0.316 0.318 0.386 0.359 0.386 0.282 
B3 0.119 0.210 0.297 0.259 0.265 0.254 0.304 0.140 0.227 0.233 0.302 0.284 0.311 0.274 
B5 0.090 0.241 0.386 0.369 0.331 0.490 0.446 0.226 0.447 0.449 0.497 0.526 0.452 0.348 
B6 0.097 0.256 0.386 0.351 0.331 0.480 0.432 0.217 0.441 0.396 0.462 0.522 0.423 0.318 
B7 0.089 0.164 0.273 0.314 0.245 0.350 0.291 0.188 0.303 0.333 0.325 0.395 0.334 0.259 
B8 0.108 0.268 0.381 0.368 0.380 0.457 0.385 0.201 0.427 0.408 0.433 0.532 0.435 0.269 
B9 0.017 0.167 0.295 0.246 0.248 0.309 0.257 0.160 0.272 0.292 0.333 0.363 0.336 0.293 
B10 0.070 0.136 0.117 0.103 0.152 0.057 0.077 0.176 0.032 0.080 0.088 0.128 0.071 0.121 
B11 0.100 0.133 0.099 0.098 0.074 0.036 0.042 0.094 0.020 0.021 0.026 0.063 0.012 0.043 
B12 0.078 0.127 0.040 0.056 0.087 0.005 0.017 0.078 -0.028 0.009 -0.014 0.029 0.044 0.037 
B13 0.087 0.077 -0.056 -0.040 0.002 -0.098 -0.100 0.051 -0.069 -0.033 -0.097 -0.066 -0.037 0.003 
B15 0.138 0.082 -0.013 0.029 0.075 -0.029 -0.040 0.144 -0.001 0.015 0.004 0.039 0.023 0.095 
B16 0.092 0.107 0.078 0.082 0.066 0.086 0.128 0.067 0.116 0.059 0.094 0.105 0.090 0.023 
D1 1.000 0.259 0.171 0.138 0.266 0.109 0.050 0.094 0.096 0.134 0.076 0.106 0.141 0.092 
D2 0.259 1.000 0.472 0.469 0.530 0.267 0.262 0.122 0.230 0.205 0.258 0.281 0.265 0.253 
D3 0.171 0.472 1.000 0.677 0.619 0.502 0.458 0.172 0.412 0.362 0.488 0.490 0.448 0.379 
D4 0.138 0.469 0.677 1.000 0.567 0.478 0.409 0.125 0.370 0.357 0.434 0.461 0.436 0.305 
D5 0.266 0.530 0.619 0.567 1.000 0.410 0.403 0.169 0.341 0.321 0.379 0.384 0.429 0.350 
E1 0.109 0.267 0.502 0.478 0.410 1.000 0.591 0.256 0.613 0.566 0.662 0.589 0.560 0.422 




Continued from page 224 (Inter-item correlations) 
 E12 E14 E15 E19 E21 F1 F2 F3 F4 F5 F6 F8 F9 F10 F11 
B1 0.119 0.042 0.039 0.105 0.107 0.390 0.126 0.118 0.115 0.154 0.048 0.021 0.059 0.002 0.247 
B2 0.076 0.047 0.072 0.154 0.116 0.305 0.114 0.092 0.090 0.103 0.038 0.002 0.024 -0.002 0.209 
B3 0.119 0.014 0.027 0.059 0.081 0.279 0.104 0.101 0.155 0.144 0.053 0.007 0.038 0.025 0.163 
B5 0.146 0.054 0.025 0.146 0.167 0.462 0.157 0.080 0.099 0.092 0.088 0.035 0.031 0.007 0.205 
B6 0.168 0.047 0.016 0.129 0.123 0.428 0.146 0.094 0.098 0.126 0.131 0.069 0.050 0.009 0.231 
B7 0.135 0.034 0.039 0.130 0.091 0.379 0.165 0.079 0.080 0.107 0.070 0.043 0.080 0.040 0.208 
B8 0.156 0.039 0.053 0.120 0.161 0.438 0.205 0.142 0.154 0.135 0.115 0.054 0.036 0.021 0.248 
B9 0.170 0.115 0.111 0.135 0.051 0.338 0.194 0.196 0.168 0.129 0.076 0.048 0.055 0.036 0.191 
B10 0.153 0.127 0.118 0.167 0.172 0.095 0.097 0.045 0.100 0.084 0.382 0.015 0.074 -0.003 0.069 
B11 0.098 0.013 0.007 0.111 0.101 0.070 0.109 -0.010 0.015 0.034 0.262 0.011 0.156 0.104 0.056 
B12 0.160 0.128 0.139 0.151 0.136 0.003 0.071 0.019 0.078 0.030 0.567 0.009 0.056 -0.001 0.064 
B13 0.107 0.258 0.279 0.173 0.096 -0.033 -0.036 0.063 0.130 0.061 0.202 -0.016 -0.007 -0.048 0.037 
B15 0.136 0.241 0.281 0.240 0.162 -0.023 0.005 0.067 0.096 0.071 0.284 0.005 0.051 -0.001 0.004 
B16 0.170 0.087 0.066 0.125 0.220 0.049 0.199 0.148 0.167 0.116 0.206 0.070 -0.030 -0.048 0.106 
D1 0.099 0.147 0.116 0.155 0.106 0.134 -0.091 0.071 0.124 0.139 0.072 0.035 0.053 0.008 0.070 
D2 0.203 0.121 0.112 0.146 0.254 0.251 -0.013 0.152 0.168 0.175 0.188 0.079 0.043 0.031 0.209 
D3 0.171 0.101 0.075 0.143 0.191 0.394 0.052 0.200 0.179 0.179 0.129 0.155 0.084 0.039 0.343 
D4 0.178 0.068 0.060 0.152 0.237 0.363 0.022 0.129 0.123 0.126 0.123 0.144 0.040 0.012 0.324 
D5 0.124 0.170 0.149 0.118 0.165 0.322 0.012 0.172 0.191 0.189 0.187 0.082 0.021 -0.006 0.263 
E1 0.185 0.136 0.131 0.210 0.314 0.491 0.182 0.207 0.179 0.222 0.080 0.150 -0.037 -0.033 0.285 




Continued from page 225 (Inter-item correlations) 
 B1 B2 B3 B5 B6 B7 B8 B9 B10 B11 B12 B13 B15 B16 
E3 0.165 0.158 0.140 0.226 0.217 0.188 0.201 0.160 0.176 0.094 0.078 0.051 0.144 0.067 
E5 0.377 0.316 0.227 0.447 0.441 0.303 0.427 0.272 0.032 0.020 -0.028 -0.069 -0.001 0.116 
E6 0.372 0.318 0.233 0.449 0.396 0.333 0.408 0.292 0.080 0.021 0.009 -0.033 0.015 0.059 
E7 0.424 0.386 0.302 0.497 0.462 0.325 0.433 0.333 0.088 0.026 -0.014 -0.097 0.004 0.094 
E8 0.410 0.359 0.284 0.526 0.522 0.395 0.532 0.363 0.128 0.063 0.029 -0.066 0.039 0.105 
E9 0.425 0.386 0.311 0.452 0.423 0.334 0.435 0.336 0.071 0.012 0.044 -0.037 0.023 0.090 
E10 0.331 0.282 0.274 0.348 0.318 0.259 0.269 0.293 0.121 0.043 0.037 0.003 0.095 0.023 
E11 0.131 0.072 0.070 0.255 0.202 0.199 0.188 0.086 0.321 0.188 0.156 0.099 0.169 0.291 
E12 0.119 0.076 0.119 0.146 0.168 0.135 0.156 0.170 0.153 0.098 0.160 0.107 0.136 0.170 
E14 0.042 0.047 0.014 0.054 0.047 0.034 0.039 0.115 0.127 0.013 0.128 0.258 0.241 0.087 
E15 0.039 0.072 0.027 0.025 0.016 0.039 0.053 0.111 0.118 0.007 0.139 0.279 0.281 0.066 
E19 0.105 0.154 0.059 0.146 0.129 0.130 0.120 0.135 0.167 0.111 0.151 0.173 0.240 0.125 
E21 0.107 0.116 0.081 0.167 0.123 0.091 0.161 0.051 0.172 0.101 0.136 0.096 0.162 0.220 
F1 0.390 0.305 0.279 0.462 0.428 0.379 0.438 0.338 0.095 0.070 0.003 -0.033 -0.023 0.049 
F2 0.126 0.114 0.104 0.157 0.146 0.165 0.205 0.194 0.097 0.109 0.071 -0.036 0.005 0.199 
F3 0.118 0.092 0.101 0.080 0.094 0.079 0.142 0.196 0.045 -0.010 0.019 0.063 0.067 0.148 
F4 0.115 0.090 0.155 0.099 0.098 0.080 0.154 0.168 0.100 0.015 0.078 0.130 0.096 0.167 
F5 0.154 0.103 0.144 0.092 0.126 0.107 0.135 0.129 0.084 0.034 0.030 0.061 0.071 0.116 
F6 0.048 0.038 0.053 0.088 0.131 0.070 0.115 0.076 0.382 0.262 0.567 0.202 0.284 0.206 
F8 0.021 0.002 0.007 0.035 0.069 0.043 0.054 0.048 0.015 0.011 0.009 -0.016 0.005 0.070 
F9 0.059 0.024 0.038 0.031 0.050 0.080 0.036 0.055 0.074 0.156 0.056 -0.007 0.051 -0.030 
F10 0.002 -0.002 0.025 0.007 0.009 0.040 0.021 0.036 -0.003 0.104 -0.001 -0.048 -0.001 -0.048 
F11 0.247 0.209 0.163 0.205 0.231 0.208 0.248 0.191 0.069 0.056 0.064 0.037 0.004 0.106 
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Continued from page 226 (Inter-item correlations) 
 D1 D2 D3 D4 D5 E1 E2 E3 E5 E6 E7 E8 E9 E10 
E3 0.094 0.122 0.172 0.125 0.169 0.256 0.163 1.000 0.233 0.281 0.296 0.274 0.270 0.320 
E5 0.096 0.230 0.412 0.370 0.341 0.613 0.451 0.233 1.000 0.815 0.669 0.692 0.628 0.444 
E6 0.134 0.205 0.362 0.357 0.321 0.566 0.414 0.281 0.815 1.000 0.643 0.650 0.712 0.501 
E7 0.076 0.258 0.488 0.434 0.379 0.662 0.567 0.296 0.669 0.643 1.000 0.803 0.637 0.463 
E8 0.106 0.281 0.490 0.461 0.384 0.589 0.496 0.274 0.692 0.650 0.803 1.000 0.718 0.467 
E9 0.141 0.265 0.448 0.436 0.429 0.560 0.445 0.270 0.628 0.712 0.637 0.718 1.000 0.521 
E10 0.092 0.253 0.379 0.305 0.350 0.422 0.352 0.320 0.444 0.501 0.463 0.467 0.521 1.000 
E11 0.121 0.235 0.231 0.230 0.206 0.247 0.202 0.078 0.152 0.180 0.172 0.193 0.169 0.183 
E12 0.099 0.203 0.171 0.178 0.124 0.185 0.130 0.139 0.157 0.135 0.160 0.166 0.161 0.214 
E14 0.147 0.121 0.101 0.068 0.170 0.136 0.107 0.164 0.112 0.154 0.101 0.097 0.119 0.167 
E15 0.116 0.112 0.075 0.060 0.149 0.131 0.074 0.178 0.112 0.164 0.111 0.100 0.134 0.209 
E19 0.155 0.146 0.143 0.152 0.118 0.210 0.167 0.276 0.220 0.249 0.223 0.204 0.196 0.304 
E21 0.106 0.254 0.191 0.237 0.165 0.314 0.245 0.218 0.201 0.218 0.243 0.236 0.231 0.267 
F1 0.134 0.251 0.394 0.363 0.322 0.491 0.355 0.182 0.581 0.602 0.548 0.608 0.639 0.416 
F2 -0.091 -0.013 0.052 0.022 0.012 0.182 0.170 -0.033 0.116 0.121 0.108 0.079 0.114 0.072 
F3 0.071 0.152 0.200 0.129 0.172 0.207 0.148 0.162 0.186 0.214 0.187 0.104 0.137 0.208 
F4 0.124 0.168 0.179 0.123 0.191 0.179 0.114 0.181 0.166 0.200 0.146 0.084 0.152 0.206 
F5 0.139 0.175 0.179 0.126 0.189 0.222 0.144 0.238 0.181 0.205 0.174 0.118 0.158 0.265 
F6 0.072 0.188 0.129 0.123 0.187 0.080 0.067 0.097 0.005 0.026 0.056 0.062 0.108 0.054 
F8 0.035 0.079 0.155 0.144 0.082 0.150 0.124 0.056 0.127 0.101 0.144 0.115 0.128 0.115 
F9 0.053 0.043 0.084 0.040 0.021 -0.037 -0.132 0.022 0.019 0.057 -0.008 0.089 0.030 -0.010 
F10 0.008 0.031 0.039 0.012 -0.006 -0.033 -0.142 -0.013 -0.017 0.032 -0.042 0.037 -0.005 -0.008 
F11 0.070 0.209 0.343 0.324 0.263 0.285 0.254 0.182 0.233 0.222 0.305 0.315 0.260 0.269 
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Continued from page 227 (Inter-item correlations) 
 E12 E14 E15 E19 E21 F1 F2 F3 F4 F5 F6 F8 F9 F10 F11 
E3 0.139 0.164 0.178 0.276 0.218 0.182 -0.033 0.162 0.181 0.238 0.097 0.056 0.022 -0.013 0.182 
E5 0.157 0.112 0.112 0.220 0.201 0.581 0.116 0.186 0.166 0.181 0.005 0.127 0.019 -0.017 0.233 
E6 0.135 0.154 0.164 0.249 0.218 0.602 0.121 0.214 0.200 0.205 0.026 0.101 0.057 0.032 0.222 
E7 0.160 0.101 0.111 0.223 0.243 0.548 0.108 0.187 0.146 0.174 0.056 0.144 -0.008 -0.042 0.305 
E8 0.166 0.097 0.100 0.204 0.236 0.608 0.079 0.104 0.084 0.118 0.062 0.115 0.089 0.037 0.315 
E9 0.161 0.119 0.134 0.196 0.231 0.639 0.114 0.137 0.152 0.158 0.108 0.128 0.030 -0.005 0.260 
E10 0.214 0.167 0.209 0.304 0.267 0.416 0.072 0.208 0.206 0.265 0.054 0.115 -0.010 -0.008 0.269 
E11 0.258 0.168 0.114 0.242 0.477 0.178 0.159 0.237 0.219 0.266 0.181 0.141 0.031 -0.018 0.205 
E12 1.000 0.308 0.320 0.373 0.330 0.123 0.112 0.284 0.269 0.295 0.193 0.102 0.055 0.010 0.088 
E14 0.308 1.000 0.752 0.566 0.364 0.084 -0.020 0.350 0.315 0.321 0.139 0.153 -0.078 -0.096 0.099 
E15 0.320 0.752 1.000 0.606 0.356 0.110 -0.024 0.310 0.277 0.285 0.124 0.157 -0.015 -0.065 0.104 
E19 0.373 0.566 0.606 1.000 0.525 0.182 0.008 0.342 0.290 0.344 0.165 0.171 -0.008 -0.064 0.139 
E21 0.330 0.364 0.356 0.525 1.000 0.210 0.063 0.291 0.244 0.306 0.178 0.199 -0.026 -0.074 0.192 
F1 0.123 0.084 0.110 0.182 0.210 1.000 0.155 0.119 0.123 0.181 0.081 0.196 0.013 -0.033 0.360 
F2 0.112 -0.020 -0.024 0.008 0.063 0.155 1.000 0.056 0.077 0.080 0.078 0.048 -0.033 0.021 0.117 
F3 0.284 0.350 0.310 0.342 0.291 0.119 0.056 1.000 0.812 0.570 0.158 0.211 -0.056 -0.072 0.190 
F4 0.269 0.315 0.277 0.290 0.244 0.123 0.077 0.812 1.000 0.657 0.222 0.201 -0.079 -0.083 0.192 
F5 0.295 0.321 0.285 0.344 0.306 0.181 0.080 0.570 0.657 1.000 0.141 0.181 -0.056 -0.082 0.173 
F6 0.193 0.139 0.124 0.165 0.178 0.081 0.078 0.158 0.222 0.141 1.000 0.205 -0.073 -0.133 0.159 
F8 0.102 0.153 0.157 0.171 0.199 0.196 0.048 0.211 0.201 0.181 0.205 1.000 -0.236 -0.283 0.322 
F9 0.055 -0.078 -0.015 -0.008 -0.026 0.013 -0.033 -0.056 -0.079 -0.056 -0.073 -0.236 1.000 0.777 -0.171 
F10 0.010 -0.096 -0.065 -0.064 -0.074 -0.033 0.021 -0.072 -0.083 -0.082 -0.133 -0.283 0.777 1.000 -0.182 
F11 0.088 0.099 0.104 0.139 0.192 0.360 0.117 0.190 0.192 0.173 0.159 0.322 -0.171 -0.182 1.000 
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